ࡱ> )` R bjbj {{_&0,0,0,0,0,0,0,D,8D,"jLfhhhhhh$!hC$0,#"##0,0,y4===#0,0,f=#f==fsp0,0,y vh+vHʎ<Xv$$/$yy$0,|J:b=dJJJ<dJJJ####D,D, 9dlD#D,D,9lD,D,D,0,0,0,0,0,0, Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.q\qge兡N gPlQSShandong Xinhua Pharmaceutical Company Limiteda joint stock company established in the People s Republic of China with limited liability Stock Code: 0719 2014 ANNUAL RESULTS ANNOUNCEMENTThe board of directors (the  Board ) and directors (Directors) of Shandong Xinhua Pharmaceutical Company Limited (the Company) hereby announce the audited consolidated results of the Company and its subsidiaries (the Group) for the year ended 31 December 2014. The following financial information has been prepared in accordance with Hong Kong Generally Accepted Accounting Principles (HKGAAP) and the Peoples Republic of China (the PRC) accounting standards. This results announcement (the Announcement) is summarised from the annual report (the Annual Report) and investors are advised to read the full text of the Annual Report to understand the full details. The Announcement is published in Chinese and English. If there are any discrepancies between the Chinese version and the English version, the Chinese version shall prevail. I. Financial summary(i) Prepared in accordance with HKGAAP (Audited)Consolidated Statement of Profit or Loss (after adjustment)Item2014 RMB0002013 RMB000 2012RMB000Restated Restated Revenue3,533,1783,338,5123,209,457Profit before tax90,58963,24650,454Income tax expense (23,016)(14,270)(11,416)Profit for the year67,57348,97639,038Non-controlling interests17,60910,8389,445Profit for the year attributable to owners of the Company49,96438,13829,593Consolidated Statement of Financial Position (after adjustment)Item2014RMB 0002013 RMB 0002012 RMB 000Restated Restated Total assets4,249,5184,019,1743,794,560Total liabilities(2,332,623)(2,130,037)(1,924,737)Non-controlling interests(91,179)(80,314)(84,635)Equity attributable to owners of the Company1,825,7161,808,8231,785,188Prepared in accordance with PRC accounting standards (Audited) Principal Financial DataItem2014 RMB 2013RMBChange as compared to the last year (%)2012RMBBefore adjustmentAfter adjustmentAfter adjustmentBefore adjustmentAfter adjustmentTotal operating income3,589,749,770.933,169,653,150.693,391,228,655.295.852,971,519,619.903,248,484,539.15Profit attributable to the equity holders of the Company50,725,311.0536,745,414.3839,153,122.0529.5623,663,577.9630,839,069.57Net cash flow from operating activities346,342,064.0092,636,929.72104,990,785.05229.8837,817,990.3940,477,776.49Basic earnings per share0.110.080.0922.220.050.07Diluted earnings per share0.110.080.0922.220.050.07ItemAs at 31 December 2014RMBAs at 31 December 2013RMBChange as compared to the end of last year (%)As at 31 December 2012RMBBefore adjustmentAfter adjustmentBefore adjustmentAfter adjustmentAfter adjustmentTotal assets 4,245,149,713.773,849,353,234.204,009,560,374.105.883,628,270,364.033,787,773,747.51Net asstes attributable to equity holders of the Company1,820,690,172.441,759,529,934.581,803,036,178.870.981,737,287,914.321,778,386,450.94(iii) Reconciliation of accounts prepared in accordance with PRC accounting standards and HKGAAPProfit attributable to equity holders of the CompanyRMBNet assetsRMB20142013As at 31 December 2014As at 1 January 2014Prepared under PRC accounting standards50,725,311.0539,153,122.051,820,690,172.441,803,036,178.87HKGAAP adjustments:Deferred taxation134,688.95175,877.95(888,172.44)(1,023,178.87)Provision for education fund(896,000.00)(1,191,000.00)5,914,000.006,810,000.00Prepared under HKGAAP 49,964,000.0038,138,000.001,825,716,000.001,808,823,000.00 Note: Explanation of the difference between the PRC accounting standards and HKGAAP:1. Education expenses are regarded as actual expenditure without the need of provision under HKGAAP. As at 31 December 2014, the balance of education expenses was RMB5,914,000.00 under the PRC accounting standards, and the education expenses were RMB896,000.00 for 2014;2. The aforesaid difference also led to the difference in the Companys deferred income tax, with the difference in accumulated deferred income tax being RMB888,172.44 and the deferred income tax of the current period being RMB134,688.95.II. DIVIDENDSThe Board has announced and proposed a final dividend for the year ended 31 December 2014 of RMB0.02 per share in the Company (the Share) (approximately HK$0.025 per Share, including income tax) on 307,312,830 A Shares and 150,000,000 H Shares in issue. The proposed dividend is subject to approval by the shareholders of the Company at the Companys annual general meeting for the year 2014. In respect of the book closure period of the proposed dividend, please see the announcement dated 27 March 2015 headed 2014 Final Dividend Distribution and Enterprise Income Tax Withholding of Overseas Non-resident Enterprises for details. III. MAIN BUSINESS AND FINANCIAL SITUATIONThe Group is mainly engaged in the development, production and sale of bulk pharmaceuticals, preparations, chemical products and other products. The profit of the Group is mainly attributable to its principal operations.Analysis of financial situation and operating results in accordance with PRC accounting standardsTotal assets of the Group as at 31 December 2014 was approximately RMB4,245,150,000, increased by approximately RMB235,589,000 or 5.88%, as compared with the figure of approximately RMB4,009,560,000 at the beginning of the year. The increase in total assets was mainly due to the increase of investment in fixed assets and the increase of the fair value of available-for-sale financial assets.Cash of the Group as at 31 December 2014 was approximately RMB328,769,000, decreased by approximately RMB94,657,000 or 22.36%, as compared with the figure of approximately RMB423,426,000 at the beginning of the year. The decrease in cash was mainly due to the payment of RMB102,000,000 for merger of Shandong Zibo XinCat Pharmaceutical Company Limited by the Company this year.Total equity attributable to the shareholders of the Company as at 31 December 2014 was approximately RMB1,820,690,000, increased by approximately RMB17,654,000 or 0.98%, as compared with the figure of approximately RMB1,803,036,000 at the beginning of the year. This increase was mainly attributable to the profits this year.The total liabilities of the Group as at 31 December 2014 were approximately RMB2,333,281,000, representing an increase of approximately RMB207,071,000 or 9.74%, as compared with the figure of approximately RMB2,126,210,000 at the beginning of the year. The increase in liabilities was mainly attributable to an increase in investment for relocation of the Park, leading to new borrowings raised by the Company.Operating profit of the Group amounted to RMB54,559,000 for the year of 2014, while the operating loss of the Group amounted to RMB29,946,000 for the same period last year, representing an increase of approximately RMB84,505,000 as compared with the same period last year. The main reasons for the change were due to the following initiatives adopted by the Company: active and significant adjustment to the product structure, increase in marketing efforts, expansion of the sales scale, and implementation of in depth research on product technology, energy-saving and emission reduction, leading to decrease in the consumption of raw material and power and reduction of production costs.The Groups net decrease in cash and cash equivalents for the year of 2014 was approximately RMB29,591,000. The decrease in currency funds was mainly attributable to the continuous expenditure on relocation projects.Analysis under HKGAAPAs at 31 December 2014, the current ratio and the quick ratio of the Group was 90% and 58% respectively, and the rate of accounts receivable turnover (rate of accounts receivable turnover = revenue/average trade and bill receivables100%) and the rate of stock turnover (rate of stock turnover = cost of sales/average inventories100%) were 830.39% and 561.50% respectively.The Groups demand for working capital did not show significant seasonal fluctuation throughout the year.The Groups main source of funds was loans. As at 31 December 2014, the total amount of outstanding loans was approximately RMB1,474,836,000. As at 31 December 2014, cash on hand and in bank of the Group amounted to approximately RMB328,770,000 (including bank acceptance drafts deposits of approximately RMB34,685,000 and frozen deposits from Shandong Zibo Xincat Pharmaceutical Company Limited of approximately RMB12,740,000).As at 31 December 2014, the Group put the land use rights in Hutianzhen, Zhangdian on charge with a bank for loans. The total original value of the land use rights is RMB73,109,000, net value is RMB65,188,000. As at 31 December 2014, Shandong Xinhua (Shouguang) Company Limited, a wholly-owned subsidiary of the Group pledged the bank acceptance to a bank to handle bank acceptance, and the amount of pledged note was RMB6,000,000. Apart from this, there was no other charge on the Groups assets except the above charged assets.The Company invested RMB8,000,000 to establish Shandong Xinhua Mechanical Engineering Company Limited during 2014.During 2014, the Company acquired 40% equity interests of Shandong Zibo Xincat Pharmaceutical Company Limited from Hualu Holdings Company Limited, the ultimate controller of the Company with a consideration of RMB102,000,000. The Company successfully acquired six residential buildings (the total floor area is 6240.89 square meters) in Honggou Road, Zhangdian District, Zibo City owned by Shandong Xinhua Pharmaceutical Group Company Limited and the occupied land use rights (the area of land use rights is 4,425.32 m2) and two pieces of equipment with the listed price of RMB13,000,000.Apart from the above transactions, the Group did not have any material investment, acquisitions or any disposal of assets during the reporting period.As at 31 December 2014, the number of staff employed by the Group was 6,602, and the total amount of salaries and wages for 2014 was approximately RMB297,184,000.The debt-to-capital ratio of the Group was 80.78% (debt-to-capital ratio = total borrowings / equity attributable to owners of the Company 100%).The bank balance of the Company will mainly be used as working capital for project construction and relocation of the Company.The assets and liabilities of the Group were mainly recorded in Renminbi. For the year 2014, the revenue from the Groups exports was approximately US$190,162,000, which exposed the Group to certain risks associated with the fluctuation of exchange rates. Therefore, the Group has taken the following measures to lower the risks from the fluctuation of exchange rates: (1) the Group has increased the price of its export products to decrease the risks from the fluctuation of exchange rates; (2) the Group has made arrangements with overseas customers when entering into significant export contracts that the risks associated with the fluctuation in exchange rates shall be borne by both parties if the fluctuation exceeds the range of exchange rate fluctuation agreed by both parties; (3) Foreign currency accounts receivable pledge loans, reducing the risk of exchange rate fluctuations.IV. business reviewIn 2014, the Group captured opportunities amid changes in the pharmaceutical market. By increasing marketing activities, stepping up restructuring, promoting technological progress and enhancing fundamental management, the Groups development has been satisfactory. 1. Focusing on key areas of development whilst refining organizational structureThe preparations business has undergone the quickest development in recent years under our innovative marketing model and increased marketing activities. In 2014, the sales revenue of preparation industrial products amounted to RMB873 million, representing an increase of 12.8% as compared to the corresponding period of last year. Sales volume of the five major strategic varieties including rabeprazole have increased by 43.5% over the corresponding period of last year. Sales revenue of the preparation segment accounted of 43.9% of the total, representing an increase of 1.8% as compared to the corresponding period of last year. A more complete industry chain has been achieved as the scale advantage of pharmaceutical raw material business has been greater. Our competitive advantages have become greater as the projects of relocation for the production of Analgin and Aspirin series using new techniques and equipment have been successfully completed. In addition, the Group has stepped up the relocation of the production of its new products to its multi-function industrialization center and further explored the market of featured pharmaceutical raw materials. As a result, the profit margin of its featured pharmaceutical raw materials has widened. International strategy has been developed with the expansion of product variety. The Group has stepped up its business on commissioned processing from multinational corporations in addition to its steady exports of pharmaceutical raw materials. As a result, the revenue from overseas commissioned processing of preparations amounted to RMB97 million, representing an increase of 11.7% as compared to the corresponding period of last year. New opportunities of merger and acquisitions in pharmaceutical industry have been captured by conducting feasibility analysis on related companies. In 2014, the Company successfully acquired 40% equity interest in Shandong Zibo Xincat Pharmaceutical Company Limited in an open tender. At present, the Company has control over Shandong Zibo Xincat Pharmaceutical Company Limited as it directly holds 60% equity interest in that company.Significant progress has been made in the innovation of business model. The online platform of Xinhua Drug Store officially commenced operation in July. In addition, our online flagship store on JD.com as well as the stores on TMall.com and YHD.com have also commenced operations. 2. Accelerating transformation of findings by technological innovationIn 2014, the Company obtained approvals for the production of its new class 3.1 drugs calcium polycarbophil and preparation medicine, and the progress of clinical studies on the two new products was satisfactory. In addition, the report and inspection on new products for our five pharmaceutical raw materials and seven preparation products were also completed. At present, the Company has 34 applications of new products pending approval from the Center for Drug Evaluation (CDE) of the PRC government. Several breakthroughs were accomplished by the antibody-drug conjugate jointly developed by the Company. Production transformation on nine of our products, including Carbidopa, glimepiride and rabeprazole sodium, was completed. Twelve key projects on technological breakthroughs have been completed or have preliminary results achieved. Consequently, the costs of producing comparable products have been significantly reduced. The Company was granted 18 patents and successfully admitted to the National Torch Program as a key high-tech enterprise again. 3. Satisfactory progress in project development under scientific planning for parksThe relocation of our main factory in the headquarter was nearly completed. The necessary adjustments and replenishments for the phase II factory of Analgin series were successfully completed, forming a solid foundation for the effective production of the products. The project on the necessary adjustments and replenishments for the Aspirin series was also completed on time, providing a favorable environment for capturing market opportunities and accomplishing repaid development. The phase II of the construction of sewage treatment facilities for factory II was successfully completed. In addition, the development of the projects for innovation platforms of the industrialization center and biological laboratories have also been completed. Furthermore, development of online systems for the management of the security, environment, fire services, energy and production have also been completed. The transformation projects for exploring the potential production capacity on Ibuprofen, Caffeine and L-380 of factory I has been completed and the related capacity and efficiency have been utilized and delivered during the year.4. Enhancing basic management for improving overall competitivenessThe Group has improved the organizational structure of its parks for increasing the efficiency of management. In addition, it has pressed on to conduct with the review and evaluation on its personnel and adjusted the wages for boosting efficiency. The control and assessment on the funds allocated to finished goods and the amount of account receivables were enhanced. In addition, operating risks were effectively controlled by managing credit risk and funding allocation. The Group has successfully obtained the accreditations of the FDA of the US, the GMP of Europe and the new GMP. Furthermore, it has passed more than 130 foreign reviews and its injection workshop has passed the review of IDA (International Dispensary Association). In addition, Xinhua Medical and Trading as well as Xinhua Drug Store have passed the new GSP certification. The Group has implemented 37 general safety measures and 16 key environment measures with the objective to develop the Group as an intrinsic safety enterprise. In addition, the Group has actively managed and controlled basic work safety with no major safety or environmental incident occurred during the year. The Company has finished 20 energy saving projects and successfully reduced energy consumption by RMB35.55 million. It was appointed as a drafting unit for the National Standards on Online Energy Management System for the Pharmaceutical Industry. V. ProspectsIn 2015, the bulk purchase prices of global raw materials, such as crude oil, have been moderately decreasing. In addition, the devaluation of the Renminbi and the rapid migration of the industries of high-end pharmaceutical raw materials and preparations from developed countries have provided rare opportunities for businesses to reduce purchase costs, expand exports as well as restructure and fine-tune organizational structures. Pharmaceutical consumption will continue to increase amid increasing government support to the biopharmaceutical industry, ageing population, expanded coverage of medical insurance and self-awareness on healthcare. On the other hand, improvement in the bidding process of basic medicines and the introduction of government policies such as the low priced medicine catalog will be favorable to the rapid execution of the Group strategy of greater preparations of the Group. Uncertainties to development of businesses also exist. More uncertainties may arise amid sluggish global economy, which may have an impact on the exports of drugs. In addition, competition may still be fierce as the PRC economy is still under downward pressure. Due to relocation of parks, environmental control and investment in human resources, pressure on the profit margin of the Group may increase. As a result, focus of the Group for 2015 will be as follows,1. Develop new growth engines with emphasis on marketing activitiesThe Group will press on with its strategy on greater preparations with the objective to fully leverage its advantages in self-developed pharmaceutical raw materials, such that a new development model with synergy from pharmaceutical raw materials and preparations can be established. In addition, the Group will capture the opportunities from the latest round of medical reforms and introduction of low priced medicine policies in order to leverage its overall advantages in branding as well as quality. It will also focus on the bidding of basic medicines and step up its development of key basic medicines and preparations. On the other hand, the Group will delicately develop strategic product categories with an aim to maintain rapid growth in the sales of related items and advancing to a new stage for the development of its preparations. The Group will consolidate its competitive advantages in developing pharmaceutical raw materials by aggressively exploring domestic and overseas markets. In addition, it will steadily dominate the pricing in the markets of pharmaceutical raw materials. The Group will also increase its exploration in the market of featured pharmaceutical raw materials in order to expand its new growth engines as soon as possible. With its multi-functional industrialization center, the Group will step up the commercialization process of its new products and aggressively step up its development of new featured pharmaceutical raw materials. 2. Enhance on-going development capacity by stepping up technological advancementThe Group will further increase its investment in technology development and innovation in its research and development system. It will mainly better utilize its own capacity while adopting models of collaboration and outsourcing for stepping up the development of products. The Groups objective is to obtain acceptance of 5-8 patent applications and more than 40 products pending approval at the CDE by the end of the 2015. The Group will focus on the development of key product categories and new preparations. It will also aggressively develop technologies in preparations, including RNA (ribonucleic acid), sustained-release and osmotic pump etc for advancing development of its new products. The Group will step up the technological progress of its existing products. It will further increase the rewards to efficiency improvement and technological progress in order to accomplish major breakthroughs in new techniques and technologies as well as further increase the competitiveness of its products. 3. Accelerate execution of globalization strategy on opportunities from global industrial line migrationThe Group will further consolidate its collaboration with multinational corporations. It will fully make use of its existing customer base and industrial advantages to expand its collaboration with renowned multinational corporations such that it can accomplish its export target for the whole year. The Group will step up the execution of its co-operative preparations projects. In addition to improving the organization on its production of Redoxon, Saridon and Ibuprofen, the Group will capture the opportunities arising from the migrations of production line of multinational pharmaceutical corporations with an aim to leverage its overall advantages on stepping up the progress of its co-operative projects for further increasing the exports of its preparations The Group will fully leverage on the advantages of its wholly-owned subsidiaries overseas. Whilst focusing on the marketing activities of its products, the Group will aggressively pursue its drugs to be ANDA registered in Europe and the US in order to export the preparation products of its own brands to developed markets such as Europe and the US as soon as possible. 4. On-going improvement on parks and aggressive development on projects The Group will ensure efficient production of its relocated products. It will solidly capture the opportunities from the market of the Aspirin series. The Group will leverage on the advantages after the relocation of factory by accomplishing efficient production. In addition, it will leverage on the technological advantage of the Analgin series after the transformation by the way of application of new technologies, new materials, new processes and new equipment, such that it can reduce the costs of production. The Group will focus on the development of its subsequent projects. In order to ensure the fulfillment of market demand by the production of its preparations, the Group will focus on the design, evaluation and project development of the international cooperation center for modern pharmacy in the park area of the headquarters. Following the completion of the development of the second multi-functional industrialization center of factory II, the Group will continue to press on with the development of the subsequent projects such as public utilities systems in its parks. 5. On-going enhancement of basic management for the basis of corporate development The Group will further liberalize its ideology and update its concepts. It will be more down-to-earth and focus on long-term development. In addition, it will prepare its Thirteen Five-Year plan with a reformative and innovative mind. The Group will co-ordinate its corporate management and improve its resources allocation by adopting information technology, with the objective to increase operating efficiency and strictly execute its budget for cost control purposes. Besides, the Group will maximize the efficiency of its funding and to ensure the safety of its funds. The Group will boost its product quality so as to pass government inspections and customer review. The Group will fully implement 5S management in its production units in order to raise the standard of site management and develop as an intrinsic safety enterprise. It will increase investment in environmental protection and import new technology and equipment. In addition, the Group will increase its control on basic work safety in order to ensure no major safety or environmental incident to happen in the year. VI. Important IssuesStaff and RemunerationThe Groups staff remuneration was determined in accordance with state policies, the Companys profit in the corresponding period and the average income of local residents.As at 31 December 2014, the number of staff employed by the Group was 6,602, and the total amount of their salaries and wages for the year 2014 was approximately RMB297,184,000.Purchase, Sale or Redemption of the Companys Listed SecuritiesDuring the year ended 31 December 2014, the Company did not redeem the Companys listed securities. Neither the Company nor its subsidiaries, purchased, sold or redeemed any of the Companys listed securities.Connected TransactionsSignificant connected transactions carried out in the normal course of the Groups business are summarised as follows:Item2014 RMB0002013 RMB000With holding company and its subsidiariesSale of water, electricity, steam and waste materials 12,444  7,680Sale of bulk pharmaceuticals and chemical raw materials -  60,972  Purchase of raw materials  94,275  70,286  Payment of annual trademark licence fee 10,300  10,300 Acquisition of land use rights26,220-Total 143,239149,238Repair service income890-0 Rental expenses 608 500 Others total697500With ultimate holding company  Interest expenses of loan 40,850  40,850  Underwriting expenses of loan 2,100  2,100 Total42,95042,950With minority shareholders Sale of bulk pharmaceuticals and chemical raw materials140,764 141,659  Purchase of customer list-  2,439 Total140,764144,098Grand total 327,650 336,786  In the opinion of the Directors (including the independent non-executive Directors), the above transactions were carried out in the ordinary and usual course of the Groups business and on normal commercial terms. The aggregate amount of the above transactions for each of the years 2013 and 2014 did not exceed the annual cap approved in the general meeting of the Company.AuditorsThe accounts of the Company and the Group for this year prepared in accordance with HKGAAP and PRC accounting standards have been audited by SHINEWING (HK) CPA Limited (practicing certified public accountants in Hong Kong) and ShineWing Certified Public Accountants (certified public accountants in the PRC) respectively.The Company intends to re-appoint ShineWing Certified Public Accountants as international auditors and PRC auditors of the Company respectively for the year 2015 at the annual general meeting for the year 2014 to be held in 2015.Corporate Governance Code The Directors (including the independent non-executive Directors) are of the opinion that for the year ended 31 December 2014, the Company complied with all code provisions set out in the Corporate Governance Code contained in Appendix 14 to the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.The Company has always strived to comply with the best corporate governance practices in the Corporate Governance Code. Material Litigation and ArbitrationThe Group was not involved in any material litigation or arbitration and no material litigation or arbitration is pending or threatened or was made against the Group during the reporting period.Sale of AssetsDuring 2014, the Company acquired 40% equity interests in Shandong Zibo Xincat Pharmaceutical Company Limited from Hualu Holdings Company Limited, the ultimate controller of the Company with a consideration of RMB102,000,000. The Company successfully acquired six residential buildings (the total floor area was 6240.89 square meters) in Honggou Road, Zhangdian District, Zibo City owned by Shandong Xinhua Pharmaceutical Group Company Limited and the land use rights of the occupied land (the area with land use rights was 4,425.32 m2) and two pieces of equipment with the listed price of RMB13,000,000.Apart from the above transactions, the Group did not have any material investment, acquisitions or any disposal of assets during the reporting period.Amendments to the ArticlesDuring the reporting period, there were no amendments to the articles of association of the Company.Audit CommitteeThe audit committee has, together with the management, reviewed the accounting principles, practices and methods adopted by the Group and has reviewed the auditing, internal control and financial reporting of the Group. The audit committee has convened four meetings to review the audited financial statements for 2013, the unaudited 1st quarterly financial statements for 2014, the unaudited interim statements for 2014 and the unaudited 3rd quarterly financial statements for 2014.The audit committee convened a meeting on 27 March 2015 to review the 2014 audited accounts and annual results announcement.VII. FINANCIAL REPORTSThe financial reports of the Company and the Group for the financial year ended 31 December 2014 have been audited by SHINEWING (HK) CPA Limited (practicing certified public accountants in Hong Kong) and ShineWing Certified Public Accountants (certified public accountants in the PRC) in accordance with HKGAAP and PRC accounting standards respectively. In their respective auditors reports there was no qualified opinion.CONSOLIDATED financial statements AND NOTES PREPARED UNDER HKGAAPCONSOLIDATED STATEMENT OF PROFIT OR LOSSNOTES20142013RMB000RMB000(Restated)Revenue3,533,1783,338,512Cost of sales(2,812,611)(2,760,875)Gross profit720,567577,637Investment income11,2287,572Other income128,925112,097Other expenses(92,857)(32,452)Distribution and selling expenses(317,763)(276,426)Administrative expenses(281,721)(253,455)Finance costs4(77,790)(71,727)Profit before tax90,58963,246Income tax expense5(23,016)(14,270)Profit for the year667,57348,976Profit for the year attributable to:Owners of the Company49,96438,138Non-controlling interests17,60910,83867,57348,976Earnings per share basic and diluted8RMB 0.109RMB0.083CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOMENOTE20142013RMB000RMB000(Restated)Profit for the year67,57348,976Other comprehensive (expense) incomeItems that maybe reclassified subsequently to profit or loss:Exchange differences arising on translation of a foreign operation(1,746)(456)Fair value gain (loss) arising on available-for-sale financial assets93,179(28,891)Income tax relating to items that may be reclassified subsequently(13,977)4,334Other comprehensive income (expense) for the year, net of tax77,456(25,013)Total comprehensive income for the year145,02923,963Total comprehensive income attributable to:Owners of the Company128,03913,208Non-controlling interests16,99010,755 145,02923,963CONSOLIDATED STATEMENT OF FINANCIAL POSITIONNOTES31/12/201431/12/20131/1/2013RMB000RMB000RMB000(Restated)(Restated)Non-current assetsIntangible assets9,37713,24814,686Property, plant and equipment1,978,1651,454,1841,474,047Construction in progress177,782540,483274,367Prepaid lease payments on land use rights293,506252,878239,159Investment properties69,58563,92668,906Available-for-sale financial assets220,591127,412156,303Deferred tax assets25,87120,96321,438Goodwill-2,7162,716Prepayments for acquisition of buildings-7,399 - Prepayments for acquisition of land use rights15,40015,40063,5552,790,2772,498,6092,315,177Current assetsInventories 514,562487,250524,418Properties under development74,32674,316 74,316 - - Trade and other receivables9507,271500,048456,509Prepaid lease payments on land use rights7,8586,5185,995Amounts due from immediate holding company-15,46719,827Amounts due from fellow subsidiaries5,6389,7183,971Tax recoverable4823,8213,275Short-term deposits20,334--Restricted bank balances47,425112,40150,900Bank balances and cash281,345311,026414,4881,459,2411,520,5651,479,383Current liabilitiesTrade and other payables10737,991580,212544,943Dividend payables5,3115,3115,311Amounts due to fellow subsidiaries9,3584,6162,558Amount due to ultimate holding company13,000 -  13,500Tax payable6,5161,1902,725Provisions9,4409,4409,440Loan from ultimate holding company199,400--Borrowings 639,487500,666528,3701,620,5031,101,4351,106,847Net current (liabilities) assets(161,262)419,130372,536Total assets less current liabilities2,629,0152,917,7392,687,713Capital and reservesShare capital457,313457,313457,313Reserves1,359 ,2571,342,3641,323,302Proposed final dividend9,146 9,1464,573Equity attributable to owners of the Company1,825,7161,808,8231,785,188Non-controlling interests91,17980,31484,635Total equity1,916,8951,889,1371,869,823Non-current liabilitiesDeferred tax liabilities15,8857,03412,331Loan from ultimate holding company497,000694,300496,500Borrowings138,949194,467221,147Deferred income60,286132,80187,912712,1201,028,602817,8902,629,0152,917,7392,687,713NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS UNDER HKGAAP1. BASIS OF PREPARATIONThe audited consolidated financial statements are prepared in accordance with Hong Kong Financial Reporting Standards (HKFRSs), Hong Kong Accounting Standards (HKASs) issued by Hong Kong Institute of Certified Public Accountants (HKICPA) and the disclosure requirements of Appendix 16 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.Adoption of merger accountingDuring the year, the Group acquired 40% equity interest in Shandong Zibo Xincat Pharmaceutical Company Limited (Xincat) from its ultimate holding company, Hualu, details are set out in note 12. The Group resulting from the above mentioned transaction is regarded as a continuing entity. Accordingly, the consolidated financial statements of the Group have been prepared using the principles of merger accounting in accordance with Accounting Guideline 5 Merger Accounting for Common Control Combinations as if the group structure under the group reorganisation had been in existence from the date when the combining entities first came under the control of Hualu.The net assets of the combining entities or business are consolidated using existing book values from the controlling parties perspective. No amounts is recognised in respect of goodwill or excess of acquirers interest in the net fair value of acquirees identifiable assets, liabilities and contingent liabilities over cost at the time of common control combination, to the extent of the continuation of the controlling partys interest.The consolidated statement of profit or loss includes the results of each of the combining entities or business from the earliest date presented or since the date when the combing entities or business first came under the common control, where this is a shorter period regardless of the date of the common control combination.The comparative amounts in the consolidated financial statements are presented as if the entities or business had been combined at the end of the previous reporting period or when they first came under common control, whichever is shorter. Accordingly, comparative figures were restated. The impact on the consolidated reserves of the Group arising from the common control combination is disclosed in note 12.Basis of preparation of the consolidated financial statementsThe consolidated financial statements have been prepared on a going concern basis notwithstanding the Group had net current liabilities of approximately RMB161,262,000 as at 31 December 2014.In the opinion of the directors of the Company, the Group should be able to maintain itself as a going concern in the next twelve months from 31 December 2014 by taking into consideration the followings:At 31 December 2014, the Group has undrawn borrowings facilities available for immediate use and which will not be expiring in the next twelve months from 31 December 2014 of approximately RMB 458,000,000 .Accordingly the directors of the Company consider that the Group will have sufficient working capital to meet its financial obligations when they fall due for the next twelve months from 31 December 2014 and satisfy that it is appropriate to prepare these consolidated financial statements on a going concern basis. The consolidated financial statements do not include any necessary adjustments to write down the value of assets to their recoverable amounts and to provide for further liabilities which might arise and to reclassify non-current asset as current assets should the Group be unable to continue as a going concern.2. APPLICATION OF NEW AND REVISED HONG KONG FINANCIAL REPORTING STANDARDS (HKFRSs)In the current year, the Group has applied the following new and revised HKFRSs, which include HKFRSs, Hong Kong Accounting Standards (HKAS(s)), amendments and Interpretations (Int(s)), issued by the Hong Kong Institute of Certified Public Accountants (the HKICPA).Amendments to HKFRS 10, HKFRS 12 and HKAS 27Investment EntitiesAmendments to HKAS 32Offsetting Financial Assets and Financial LiabilitiesAmendments to HKAS 36Recoverable Amount Disclosures for Non-Financial AssetsAmendments to HKAS 39 Novation of Derivatives and Continuation of Hedge AccountingHong Kong (International Financial Reporting Interpretation Committee) (HK(IFRIC)) Int 21LeviesExcept as described below, the application of other new and revised HKFRSs in the current year has had no material impact on the Groups financial performance and positions for the current and prior years and/ or on the disclosures set out in these consolidated financial statements. Amendments to HKFRS 10, HKFRS 12 and HKAS 27 Investment Entities The Group has applied amendments to HKFRS 10, HKFRS 12 and HKAS 27 Investment Entities for the first time in the current year. The amendments to HKFRS 10 define an investment entity and introduce an exception to consolidating subsidiaries for an investment entity, except where the subsidiaries provide services that relate to the investment entity's investment activities. Under the amendments to HKFRS 10, an investment entity is required to measure its interests in subsidiaries at fair value through profit or loss. To qualify as an investment entity, certain criteria have to be met. Specifically, an entity is required to: obtain funds from one or more investors for the purpose of providing them with professional investment management services; commit to its investor(s) that its business purpose is to invest funds solely for returns from capital appreciation, investment income, or both; and measure and evaluate performance of substantially all of its investments on a fair value basis. Consequential amendments to HKFRS 12 and HKAS 27 have been made to introduce new disclosure requirements for investment entities. As the Company is not an investment entity, the directors of the Company consider that the application of the amendments has had no impact on the disclosures or the amounts recognised in the Groups consolidated financial statement Amendments to HKAS 32 Offsetting Financial Assets and Financial Liabilities The Group has applied amendments to HKAS 32 Offsetting Financial Assets and Financial Liabilities for the first time in the current year. The amendments to HKAS 32 clarify existing application issues relating to the offset of financial assets and financial liabilities requirements. Specifically, the amendments clarify the meaning of currently has a legally enforceable right of set-off and simultaneous realisation and settlement. The amendments have been applied retrospectively. As the Group does not have any financial assets and financial liabilities that qualify for offset, the application of the amendments has had no impact on the disclosures or on the amounts recognised in the Groups consolidated financial statements.Amendments to HKAS 36 Recoverable Amount Disclosures for Non-Financial Assets The Group has applied amendments to HKAS 36 Recoverable Amount Disclosures for Non-Financial Assets for the first time in the current year. The amendments to HKAS 36 require disclosures on additional information about the fair value measurement when the recoverable amount of impaired assets is based on fair value less costs of disposal. If the recoverable amount is fair value less costs of disposal, an entity shall disclose the level of the fair value hierarchy within which the fair value measurement of the asset or cash generating unit is catergorised in its entirety. The Group is required to make additional disclosures for Level 2 and Level 3 of the fair value hierarchy: a description of the valuation techniques used to measure the fair value less costs of disposals. If there is any change in valuation techniques, the fact and the reason should also be disclosed; each key assumption on which management has based its determination of fair value less costs of disposal; the discount rates used in the current and previous measurement if fair value less costs of disposal is measured using a present value technique. Amendments to HKAS 39 Novation of Derivatives and Continuation of Hedge Accounting The Group has applied amendments to HKAS 39 Novation of Derivatives and Continuation of Hedge Accounting for the first time in the current year. The amendments to HKAS 39 introduce an exception to the requirements for the discontinuation of hedge accounting in HKAS 39 if specific conditions are met. The amendments to HKAS 39 state that the novation of a hedging instrument is not be considered an expiration or termination if the novation (a) is required by laws or regulations; (b) results in a central counterparty or an entity acting in a similar capacity becoming the new counterparty to each of the parties to the novated derivative and (c) does not result in changes to the terms of the original over-the-counter derivatives other than the changes directly attributable to the novation. For all other novations outside the scope of the exemption, an entity should assess if they meet the derecognition criteria and the conditions for continuation of hedge accounting. The amendments have been applied retrospectively. The Group does not have any derivatives that are subject to novation, the application of the amendments has had no impact on the disclosures or on the amounts recognised in the Groups consolidated financial statements HK(IFRIC) Int 21 Levies The Group has applied HK(IFRIC) Int 21 Levies for the first time in the current year. HK(IFRIC) Int 21 addresses the issue as to when to recognise a liability to pay a levy imposed by government. The interpretation defines a levy, and specifies that the obligating event that gives rise to the liability is the activity that triggers the payment of the levy, as identified by legislation. The interpretation provides guidance on how different levy arrangements should be accounted for, in particular, it clarifies that neither economic compulsion nor the going concern basis of financial statements preparation implies that an entity has a present obligation to pay a levy that will be triggered by operating in a future period. HK(IFRIC) Int 21 has been applied retrospectively. The application of this interpretation has had no material impact on the disclosures or on the amounts recognised in the Groups consolidated financial statements.New and revised HKFRSs issued but not yet effectiveThe Group has not early applied the following new and revised HKFRSs that have been issued but are not yet effective: HKFRS 9 (2014) Financial Instruments4HKFRS 15 Revenue from Contracts with Customers3Amendments to HKFRSs Annual Improvements to HKFRSs 2010 2012 Cycle1Amendments to HKFRSsAnnual Improvements to HKFRSs 2011 2013 Cycle1Amendments to HKFRSsAnnual Improvements to HKFRSs 2012 2014 Cycle2Amendments to HKAS 19Defined Benefit Plans: Employee Contributions1Amendments to HKAS 16 and HKAS38 Clarification of Acceptable Methods of Depreciation and Amortisation2 Amendments to HKAS 16 and HKAS 41 Agriculture: Bearer Plants2Amendments to HKAS 27 Equity Method in Separate Financial Statements2Amendments to HKFRS 10 and HKAS 28 Sale or Contribution of Assets between an Investor and its Associate or Joint Venture2Amendments to HKFRS 11Accounting for Acquisitions of Interests in Joint Operations21 Effective for annual periods beginning on or after 1 July 2014. 2 Effective for annual periods beginning on or after 1 January 2016. 3 Effective for annual periods beginning on or after 1 January 2017. 4 Effective for annual periods beginning on or after 1 January 2018. The directors of the Company anticipate that the application of new and revised HKFRSs will have no material impact on the results and the financial position of the Group.HKFRS 9 (2014) Financial Instruments HKFRS 9 issued in 2009 introduces new requirements for the classification and measurement of financial assets. HKFRS 9 was amended in 2010 and includes the requirements for the classification and measurement of financial liabilities and for derecognition. In 2013, HKFRS 9 was further amended to bring into effect a substantial overhaul of hedge accounting that will allow entities to better reflect their risk management activities in the financial statements. A finalised version of HKFRS 9 was issued in 2014 to incorporate all the requirements of HKFRS 9 that were issued in previous years with limited amendments to the classification and measurement by introducing a fair value through other comprehensive income (FVTOCI) measurement category for certain financial assets. The finalised version of HKFRS 9 also introduces an expected credit loss model for impairment assessments. Key requirements of HKFRS 9 (2014) are described as follows: All recognised financial assets that are within the scope of HKAS 39 Financial Instruments: Recognition and Measurement to be subsequently measured at amortised cost or fair value. Specifically, debt investments that are held within a business model whose objective is to collect the contractual cash flows, and that have contractual cash flows that are solely payments of principal and interest on the principal outstanding are generally measured at amortised cost at the end of subsequent accounting periods. Debt instruments that are held within a business model whose objective is achieved both by collecting contractual cash flows and selling financial assets, and that have contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding, are measured at FVTOCI. All other debt investments and equity investments are measured at their fair values at the end of subsequent reporting periods. In addition, under HKFRS 9, entities may make an irrevocable election to present subsequent changes in the fair value of an equity investment (that is not held for trading) in other comprehensive income, with only dividend income generally recognised in profit or loss. With regard to the measurement of financial liabilities designated as at fair value through profit or loss, HKFRS 9 requires that the amount of change in the fair value of the financial liability that is attributable to changes in the credit risk of that liability is presented in other comprehensive income, unless the recognition of the effects of changes in the liabilitys credit risk in other comprehensive income would create or enlarge an accounting mismatch in profit or loss. Changes in fair value of financial liabilities attributable to changes in the financial liabilities credit risk are not subsequently reclassified to profit or loss. Under HKAS 39, the entire amount of the change in the fair value of the financial liability designated as fair value through profit or loss was presented in profit or loss. In the aspect of impairment assessments, the impairment requirements relating to the accounting for an entitys expected credit losses on its financial assets and commitments to extend credit were added. Those requirements eliminate the threshold that was in HKAS 39 for the recognition of credit losses. Under the impairment approach in HKFRS 9 (2014) it is no longer necessary for a credit event to have occurred before credit losses are recognised. Instead, expected credit losses and changes in those expected credit losses should always be accounted for. The amount of expected credit losses is updated at each reporting date to reflect changes in credit risk since initial recognition and, consequently, more timely information is provided about expected credit losses. HKFRS 9 introduces a new model which is more closely aligns hedge accounting with risk management activities undertaken by companies when hedging their financial and non-financial risk exposures. As a principle-based approach, HKFRS 9 looks at whether a risk component can be identified and measured and does not distinguish between financial items and non-financial items. The new model also enables an entity to use information produced internally for risk management purposes as a basis for hedge accounting. Under HKAS 39, it is necessary to exhibit eligibility and compliance with the requirements in HKAS 39 using metrics that are designed solely for accounting purposes. The new model also includes eligibility criteria but these are based on an economic assessment of the strength of the hedging relationship. This can be determined using risk management data. This should reduce the costs of implementation compared with those for HKAS 39 hedge accounting because it reduces the amount of analysis that is required to be undertaken only for accounting purposes..HKFRS 9 (2014) will become effective for annual periods beginning on or after 1 January 2018 with early application permitted. The directors of the Company anticipate that the adoption of HKFRS 9 (2014) in the future may have significant impact on the amounts reported in respect of the Groups financial assets and financial liabilities. HKFRS 15 Revenue from Contracts with Customers The core principle of HKFRS 15 is that an entity should recognise revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Thus, HKFRS 15 introduces a model that applies to contracts with customers, featuring a contract-based five-step analysis of transactions to determine whether, how much and when revenue is recognised. The five steps are as follows: i) Identify the contract with the customer; ii) Identify the performance obligations in the contract; iii) Determine the transaction price; iv) Allocate the transaction price to the performance obligations; and v) Recognise revenue when (or as) the entity satisfies a performance obligation. HKFRS 15 also introduces extensive qualitative and quantitative disclosure requirements which aim to enable users of the financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. HKFRS 15 will supersede the current revenue recognition guidance including HKAS 18 Revenue, HKAS 11 Construction Contracts and the related interpretations when it becomes effective. HKFRS 15 will become effective for annual periods beginning on or after 1 January 2017 which early application permitted. The directors of the Company anticipate that the application of HKFRS 15 in the future may have a material impact on the amounts reported and disclosures made in the Groups consolidated financial statements. Annual Improvements to HKFRSs 2010 2012 Cycle The Annual Improvements to HKFRSs 2010-2012 Cycle include a number of amendments to various HKFRSs, which are summarised below. The amendments to HKFRS 2 (i) change the definitions of vesting condition and market condition; and (ii) add definitions for performance condition and service condition which were previously included within the definition of vesting condition. The amendments to HKFRS 2 are effective for share-based payment transactions for which the grant date is on or after 1 July 2014. The amendments to HKFRS 3 clarify that contingent consideration that is classified as an asset or a liability should be measured at fair value at each reporting date, irrespective of whether the contingent consideration is a financial instrument within the scope of HKFRS 9 or HKAS 39 or a non-financial asset or liability. Changes in fair value (other than measurement period adjustments) should be recognised in profit and loss. The amendments to HKFRS 3 are effective for business combinations for which the acquisition date is on or after 1 July 2014.The amendments to HKFRS 8 (i) require an entity to disclose the judgements made by management in applying the aggregation criteria to operating segments, including a description of the operating segments aggregated and the economic indicators assessed in determining whether the operating segments have similar economic characteristics; and (ii) clarify that a reconciliation of the total of the reportable segments assets to the entitys assets should only be provided if the segment assets are regularly provided to the chief operating decision-maker. The amendments to the basis for conclusions of HKFRS 13 clarify that the issue of HKFRS 13 and consequential amendments to HKAS 39 and HKFRS 9 did not remove the ability to measure short-term receivables and payables with no stated interest rate at their invoice amounts without discounting, if the effect of discounting is immaterial. The amendments to HKAS 16 and HKAS 38 remove perceived inconsistencies in the accounting for accumulated depreciation/amortisation when an item of property, plant and equipment or an intangible asset is revalued. The amended standards clarify that the gross carrying amount is adjusted in a manner consistent with the revaluation of the carrying amount of the asset and that accumulated depreciation/amortisation is the difference between the gross carrying amount and the carrying amount after taking into account accumulated impairment losses. The amendments to HKAS 24 clarify that a management entity providing key management personnel services to a reporting entity is a related party of the reporting entity. Consequently, the reporting entity should disclose as related party transactions the amounts incurred for the service paid or payable to the management entity for the provision of key managementThe directors of the Company do not anticipate that the application of the amendments included in the Annual Improvements to HKFRSs 2010-2012 Cycle will have a material effect on the Groups consolidated financial statements .Annual Improvements to HKFRSs 2011 2013 Cycle The Annual Improvements to HKFRSs 2011-2013 Cycle include a number of amendments to various HKFRSs, which are summarised below. The amendments to HKFRS 3 clarify that the standard does not apply to the accounting for the formation of all types of joint arrangement in the financial statements of the joint arrangement itself. The amendments to HKFRS 13 clarify that the scope of the portfolio exception for measuring the fair value of a group of financial assets and financial liabilities on a net basis includes all contracts that are within the scope of, and accounted for in accordance with, HKAS 39 or HKFRS 9, even if those contracts do not meet the definitions of financial assets or financial liabilities within HKAS 32. The amendments to HKAS 40 clarify that HKAS 40 and HKFRS 3 are not mutually exclusive and application of both standards may be required. Consequently, an entity acquiring investment property must determine whether: (a) the property meets the definition of investment property in terms of HKAS 40; and (b) the transaction meets the definition of a business combination under HKFRS 3. The directors of the Company do not anticipate that the application of the amendments included in the Annual Improvements to HKFRSs 2011-2013 Cycle will have a material effect on the Groups consolidated financial statements .Annual Improvement to HKFRSs 2012 2014 Cycle The Annual Improvements to HKFRSs 2012-2014 Cycle include a number of amendments to various HKFRSs, which are summarised below. The amendments to HKFRS 5 clarify that changing from one of the disposal methods (i.e. disposal through sale or disposal through distribution to owners) to the other should not be considered to be a new plan of disposal, rather it is a continuation of the original plan. There is therefore no interruption of the application of the requirements in HKFRS 5. Besides, the amendments also clarify that changing the disposal method does not change the date of classification. The amendments to HKFRS 7 clarify that a servicing contract that includes a fee can constitute continuing involvement in a financial asset. An entity must assess the nature of the fee and arrangement against the guidance for continuing involvement in HKFRS 7 in order to assess whether the additional disclosures for any continuing involvement in a transferred asset that is derecognised in its entirety are required. Besides, the amendments to HKFRS 7 also clarify that disclosures in relation to offsetting financial assets and financial liabilities are not required in the condensed interim financial report, unless the disclosures provide a significant update to the information reported in the most recent annual report. The amendments to HKAS 19 clarify that the market depth of high quality corporate bonds is assessed based on the currency in which the obligation is denominated, rather than the country where the obligation is located. When there is no deep market for high quality corporate bonds in that currency, government bond rates must be used. HKAS 34 requires entities to disclose information in the notes to the interim financial statements if not disclosed elsewhere in the interim financial report. The amendments to HKAS 34 clarify that the required interim disclosures must either be in the interim financial statements or incorporated by cross-reference between the interim financial statements and wherever they are included within the greater interim financial report. The other information within the interim financial report must be available to users on the same terms as the interim financial statements and at the same time. If users do not have access to the other information in this manner, then the interim financial report is incomplete. The directors of the Company do not anticipate that the application of the amendments included in the Annual Improvements to HKFRSs 2012-2014 Cycle will have a material effect on the Groups consolidated financial statements .Amendments to HKAS 19 Defined Benefit Plans Employee Contributions The amendments to HKAS 19 simplify the accounting for contributions that are independent of the number of years of employee service, for example, employee contributions that are calculated according to a fixed percentage of salary. Specifically, contributions that are linked to services are attributed to periods of services as a negative benefit. The amendments to HKAS 19 specifies that such negative benefit are attributed in the same way as the gross benefit, i.e. attribute to periods of services under the plans contribution formula or on a straight-line basis. Besides, the amendments also states that if the contributions are independent of the number of years of employee service, such contributions may be recognised as a reduction of the service cost as they fall due. The amendments to HKAS 19 will become effective for annual periods beginning on or after 1 July 2014 with early application permitted. The directors of the Company anticipate that the application of the amendments to HKAS 19 will have no material impact to the Group. Amendments to HKAS 16 and HKAS 38 Clarification of Acceptable Methods of Depreciation and Amortisation The amendments to HKAS 16 prohibit the use of revenue-based depreciation methods for property, plant and equipment under HKAS 16. The amendments to HKAS 38 introduce a rebuttable presumption that the use of revenue-based amortisation methods for intangible assets is inappropriate. This presumption can be rebutted only in the following limited circumstances: i) when the intangible asset is expressed as a measure of revenue; ii) when a high correlation between revenue and the consumption of the economic benefits of the intangible assets could be demonstrated. The amendments to HKAS 16 and HKAS 38 will become effective for financial statements with annual periods beginning on or after 1 January 2016. Earlier application is permitted. The amendments should be applied prospectively. The Group use straight-line method for depreciation of property, plant and equipment, the directors of the Company do not anticipate that the application of the amendments to HKAS 16 and HKAS 38 will have a material impact on the Groups consolidated financial statements.Amendments to HKAS 16 and HKAS 41 Agriculture: Bearer Plants The amendments to HKAS 16 and HKAS 41 define bearer plants. Biological assets that meet the definition of bearer plants are no longer accounted for under HKAS 41, but under HKAS 16 instead. The produce growing on bearer plants continues to be accounted for in accordance with HKAS 41. The amendments to HKAS 16 and HKAS 41 will become effective for financial statements with annual periods beginning on or after 1 January 2016. Earlier application is permitted. The amendments should be applied retrospectively. The Group does not have any biological assets, the directors of the Company do not anticipate that the application of the amendments to HKAS 16 and HKAS 41 will have a material impact on the Groups consolidated financial statements .Amendments to HKAS 27 Equity Method in Separate Financial Statements The amendments to HKAS 27 allow an entity to apply the equity method to account for its investments in subsidiaries, joint ventures and associates in its separate financial statements. As a result of the amendments, the entity can choose to account for these investments either: i) at cost; ii) in accordance with HKFRS 9 (or HKAS 39); or iii) using the equity method as described in HKAS 28. The amendments to HKAS 27 will become effective for financial statements with annual periods beginning on or after 1 January 2016. Earlier application is permitted. The amendments should be applied retrospectively. The Company does not have any investment in associates or joint ventures, the directors of the Company do not anticipate that the application of the amendments to HKAS 27 will have a material impact on the Companys financial statements .Amendments to HKFRS 10 and HKAS 28 Sale or Contribution of Assets between an Investor and its Associate or Joint Venture The amendments provide guidance on addressing the acknowledged inconsistency between the requirements in HKFRS 10 and those in HKAS 28, in dealing with the sale or contribution of assets between an investor and its joint venture and associate. An investing entity is required to recognise the gain or loss arising from selling or contributing assets that constitutes or contains a business to a joint venture or associate in full. An investing entity is required to recognise the gain or loss arising from selling or contributing assets that does not constitute or contain a business to a joint venture or associate only to the extent of the unrelated investors interests in that joint venture or associate. The amendments to HKFRS 10 and HKAS 28 will become effective for financial statements with annual periods beginning on or after 1 January 2016. Earlier application is permitted. The amendments should be applied prospectively. The Company does not have any investment in joint operations, the directors of the Company do not anticipate that the application of the amendments to HKFRS 10 and HKAS 28 will have a material impact on the Companys financial statements.Amendments to HKFRS 11 Accounting for Acquisition of Interests in Joint Operations The amendments provide new guidance on how to account for the acquisition of an interest in a joint operation that constitutes a business as defined in HKFRS 3 Business Combination. Specifically, the amendments state that the relevant principles on accounting for business combinations in HKFRS 3 and other standards should be applied. The same requirements should be applied to the formation of a joint operation if and only if an existing business is contributed to the joint operation by one of the parties that participate in the joint operation. A joint operator is also required to disclose the relevant information required by HKFRS 3 and other standards for business combinations. The amendments to HKFRS 11 will become effective for financial statements with annual periods beginning on or after 1 January 2016. Earlier application is permitted. The amendments should be applied prospectively. The Company does not have any investment in joint operations, the directors of the Company do not anticipate that the application of the amendments to HKFRS 11 will have a material impact on the Companys financial statements.3. SEGMENTAL INFORMATIONThe Groups operating segments, based on information reported to the board of directors of the Company, being the chief operating decision maker, for the purposes of resource allocation and assessment of segment performance focuses on the types of goods supplied. The principal types of goods supplied are bulk pharmaceuticals, preparations, chemical and other products, commerce circulations and property development and management. The board of directors of the Company decided the property development and management segment should be separately presented to facilitate a better presentation of segment information in 2014 so that the comparative figures in 2013 had been restated to conform with current years presentation. No operating segments identified by the chief operating decision makers have been aggregated in arriving at the reporting segments of the Group. The Groups reportable segments under HKFRS 8 are as follows:Bulk pharmaceuticals:Development, production and sales of bulk pharmaceuticalsPreparations:Development, production and sales of preparations (e.g. tablets and injections)Commerce circulations:Trading of pharmaceutical products (including retail and wholesale)Chemical and other products:Production and sales of chemical and other products Property development and managementDevelopment and sale of properties and provision of property management serviceInformation regarding the above segments is reported below. Segment revenues and resultsThe following is an analysis of the Groups revenue and results by reportable and operating segment.For the year ended 31 December 2014Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other productsProperty development and managementEliminationsTotalRMB000RMB000RMB000RMB000RMB000RMB000REVENUE External sales1,514,545876,967818,589321,6671,410-3,533,178Inter-segment sales3,821313,183109,176345,207-(771,387)-Total 1,518,3661,190,150927,765666,8741,410(771,387)3,533,178Segment profit (loss)120,739 43,596 (1,697)19,969 (128)182,479Unallocated income21,619Unallocated expenses(35,719)Finance costs(77,790)Profit before tax 90,589For the year ended 31 December 2013 as restated.Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other productsProperty development and managementEliminationsTotalRMB000RMB000RMB000RMB000RMB000RMB000REVENUE External sales1,518,928769,157810,525238,7901,112-3,338,512Inter-segment sales9,034280,18125,536308,372-(623,123)-Total 1,527,9621,049,338836,061547,1 621,112(623,123)3,338,512Segment profit101,43635,7463,05914,640225155,106Unallocated income17,299Unallocated expenses (37,432)Finance costs(71,727)Profit before tax 63,246The accounting policies of reportable segments are the same as the Groups accounting policies described. Segment profit/loss represents the profit earned by/loss from each segment without allocation of investment and other income (exclude government grants, waiver of trade payables, reversal of impairment loss on trade and other receivables and gain or loss on disposal of property, plant and equipment and prepaid lease payment on land use rights), depreciation for investment properties,other expenses and finance costs. This is the measure reported to the chief operating decision maker for the purposes of resource allocation and performance assessment. Inter-segment sales are charged at prevailing market rates.Segment assets and liabilitiesThe following is an analysis of the Groups assets and liabilities by reportable and operating segment:At 31 December 2014Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other productsProperty development and managementTotalRMB000RMB000RMB000RMB000RMB000RMB000Segment assets1,905,836718,567208,437675,43475,6113,583,885Unallocated corporate assets665,633Consolidated assets4,249,518Segment liabilities406,893218,75352,529151,469431830,075Unallocated corporate liabilities1,502,548Consolidated liabilities2,332,623At 31 December 2013, as restatedBulk pharmaceuticalsPreparationsCommerce circulationsChemical and other productsProperty development and managementTotalRMB000RMB000RMB000RMB000RMB000Segment assets1,697,087727,180189,506690,99474,8583,379,625Unallocated corporate assets639,549Consolidated assets4,019,174Segment liabilities330,710160,86162,424172,866208727,069Unallocated corporate liabilities1,402,968Consolidated liabilities2,130,037For the purposes of monitoring segment performances and allocating resources among segments:all assets are allocated to reportable segments other than deferred tax assets, available-for-sale financial assets, investment properties, tax recoverable, short-term deposits, restricted bank balances, bank balances and cash. Assets used jointly by reportable segments are allocated on the basis of revenues earned by individual reportable segments; andall liabilities are allocated to reportable segments other than liabilities associated with dividend payables, deferred tax liabilities, loan from ultimate holding company, borrowings and tax payable. Liabilities for which reportable segments are jointly liable are allocated on the basis of revenues earned by individual reportable segments. Other segment informationFor the year ended 31 December 2014Amounts included in the measure of segment profit or loss or segment assets:Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other productsProperty development and managementTotalRMB000RMB000RMB000RMB000RMB000RMB000Addition to non-current assets (Note) 306,841105,9461,71450,5841,205466,290Depreciation and amortisation (excluded depreciation for investment properties)105,81740,6671,92248,13522196,563Impairment losses recognised in respect of property, plant and equipment-1,635-105-1,740Gain or loss on disposal of property, plant and equipment and prepaid lease payment on land use rights(47,060)(14,319)1(3)-(61,381)Impairment losses recognised in respect of trade and other receivables 4963582737,9975409,664Impairment losses recognised in goodwill-2,716---2,716Waiver of trade payables1,33747887--1,902Reversal of impairment loss on trade and other receivables-(1,819)(2,294)(4)-(4,117)Reversal of allowance for inventories(2,992)(1,952)(572)(1,033)-(6,549)Write-down of inventories1,500(203)(1,290)2,254-2,261Note: Non-current assets excluded financial instruments, investment properties and deferred tax assets. Goodwill is allocated in the reportable segments.For the year ended 31 December 2014Amounts regularly provided to the chief operating decision maker but not included in the measure of segment profit or segment assets:Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other productsProperty development and managementTotalRMB000RMB000RMB000RMB000RMB000Interest income1,8331,0718231873,311Finance costs(58,797)(18,437)(552)(4)-(77,790)Income tax expense(3,318)(5,600)(6,107)(7,991)-(23,016)For the year ended 31 December 2013, as restatedAmounts included in the measure of segment profit or loss or segment assets:Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other productsProperty development and managementTotalRMB000RMB000RMB000RMB000RMB000Addition to non-current assets (Note) 307,44180,6043,12678,464-469,635Depreciation and amortisation (excluded depreciation for investment properties)104,39135,4002,76143,1011185,654Impairment losses recognised in respect of property, plant and equipment-142-148-290Gain on disposal of property, plant and equipment and prepaid lease payment on land use rights33,9238,92789-42,867Impairment losses recognised in respect of trade and other receivables 4141105,62625-6,175Waiver of trade payables1,81054791--2,448Reversal of impairment loss on trade and other receivables(32)30 (1,381)(10)-(1,453)Reversal of allowance for inventories(6,549)(2,007)(1,054)(3,316)-(12,926)Write-down of inventories4,0861,6671,0491,034-7,836Note: Non-current assets excluded financial instruments, investment properties, deferred tax assets. Goodwill is allocated in the reportable segments.For the year ended 31 December 2013, as restatedAmounts regularly provided to the chief operating decision maker but not included in the measure of segment profit or segment assets:Bulk pharmaceuticalsPreparationsCommerce circulationsChemical and other productsProperty development and managementTotalRMB000RMB000RMB000RMB000RMB000Interest income1,864607362345163,194Finance costs(53,479)(14,610)-(3,638)-(71,727)Income tax expense(8,101)(3,450)(902)(1,817)(14,270)Geographical informationThe Groups customers are mainly located in the PRC, Europe, America and other countries. Information about the Groups revenue from external customers is presented based on the location of the customers.Revenues from external customers20142013RMB000RMB000(Restated)PRC 2,350,370 2,095,750Europe 417,601 440,490America 461,146 594,071Others 304,061 208,2013,533,1783,338,512Over 99% (2013 as restated: 99%) of the Groups non-current assets are located in the PRC and therefore the analysis of non-current assets by geographical location of the assets is not presented.Information about major customersThe Groups customer base includes a wide range of different customers. During the year ended 31 December 2014 and 2013, the Group had no single customer that contributed 10% or more of the Groups revenue. Therefore, there was no significant concentration of source of income from a particular customer.4. FINANCE COSTS20142013RMB000RMB000(Restated)Interest on:- Bank loans wholly repayable within 5 years36,32327,918 Government loans wholly repayable within 5 years1,1971,197 Loan from ultimate holding company40,85040,85078,37069,965Less: interest capitalised on the specific borrowing pool at a rate of 5.85 6.40% (2013: 5.85 6.40%) per annum(3,553)(3,965)74,81766,000Discount charges on bank acceptance notes-3,627Other incidental borrowing costs2,9732,10077,79071,7275. INCOME TAX EXPENSE20142013RMB000RMB000(Restated)PRC enterprise income tax (EIT) - Current29,63812,468 - Under-provision in prior years3,4122,29033,05014,758Deferred tax(10,034)(488)23,01614,270Under the Law of the PRC on EIT (the EIT Law) and Implementation Regulation of the EIT Law, the tax rate of the PRC companies is 25% for both years. No provision for Hong Kong profits taxation has been made as the Groups income neither arise in, nor is derived from, Hong Kong.Pursuant to the relevant laws and regulations in the PRC, the Company was accredited as a high-tech enterprise. The accreditation is valid for three years. The Company is entitled to the preferential tax rate of 15% for a period of three years from 1 January 2011 to 31 December 2013. In the current year, the accreditation is extended for three years from 1 January 2014 to 31 December 2016.Pursuant to the relevant laws and regulations in the PRC, the Groups subsidiary, Xincat, operating in the PRC was accredited as a high-tech enterprise. The accreditation is valid for three years. Xincat entitled to the preferential tax rate of 15% for a period of three years from 1 January 2014 to 31 December 2016.The tax charge for the year can be reconciled to the profit before tax per the consolidated income statement as follows:20142013RMB000RMB000(Restated)Profit before tax90,58963,246Tax at the domestic income tax rate of 25% (2013: 25%)22,64715,812Effect of preferential tax rate in the PRC(3,684)(6,049)Effect of different tax rates of subsidiaries operating in other jurisdictions(156)(92)Tax effect of income not taxable for tax purpose(842)(1,529)Tax effect of expenses not deductible for tax purpose3,4245,877Tax effect of additional allowance (Note)(2,423)(1,819)Tax effect of tax losses not recognised1,802_-Tax effect of deductible temporary differences not recognised539735Utilisation of deductible temporary differences not previously recognised(363)(4)Utilisation of tax losses not previously recognised(1,340)(951)Under-provision in prior years3,4122,290Tax charge for the year23,01614,270Note: The amount represents the tax effect of additional tax allowance granted to the Group in respect of research and development expenditure as stipulated in the relevant tax rules in the PRC.6. PROFIT FOR THE YEARProfit for the year has been arrived at after charging (crediting):20142013RMB000RMB000(Restated)Depreciation for property, plant and equipment185,776175,209Depreciation for investment properties4,2434,980Amortisation of prepaid lease payments on land use rights6,9166,568Amortisation of intangible assets3,8713,877Total depreciation and amortisation200,806190,634Auditors remuneration840840Research and development costs recognised as an expense51,57349,323Operating lease rentals on land and buildings2,8102,008Impairment losses recognised in property, plant and equipment1,740290Impairment losses recognised in goodwill2,716-Impairment losses recognised in respect of trade and other receivables (Note 9)9,6646,175Loss on disposal of property, plant and equipment and prepaid lease payments on land use rights61,381-Reversal of allowance for inventories (included in cost of sales)(6,549)(12,926)Write-down of inventories (included in cost of sales)2,2617,836Staff costs (excluding directors, chief executives and supervisors emoluments) 430,068347,872Cost of inventories recognised as an expense2,801,8802,747,9677. DIVIDENDS20142013RMB000RMB000Dividends recognised as distribution during the year:- 2013 final dividend: RMB0.02 per share9,146-- 2012 final dividend: RMB0.01 per share-4,5739,1464,573For the year ended 31 December 2014, final dividend of RMB0.02 (2013: RMB0.02) per share (approximately HK$0.025(2013: HK$0.025) per share, including income tax of A shares) on 307,312,830 A shares and 150,000,000 H shares has been proposed by the directors of the Company and is subject to approval by shareholders at the annual general meeting and has been included as a dividend reserve in the consolidated financial statements.8. EARNINGS PER SHAREThe calculation of the basic earnings per share is based on the Groups profit for the year attributable to the owners of the Company of approximately RMB49,964,000 (2013 as restated:RMB38,138,000) and based on the weighted average number of 457,312,830 (2013: 457,312,830) shares in issue during the year.Basic earnings per share and diluted earnings per share for two years ended 31 December 2014 and 2013 are the same as there were no dilutive events existed during both years.9. TRADE AND OTHER RECEIVABLES20142013RMB000RMB000(Restated)Trade and bills receivables497,506481,170Less : Allowance for doubtful debts of trade receivables(61,927)(65,780)435,579415,390Other receivables, deposits and prepayments82,82780,536VAT recoverable4,36810,329Consideration receivable on disposal of land use rights8,0008,000 Less : Allowance for doubtful debts of other receivables(23,503)(14,207)71,69284,658Total trade and other receivables507,271500,048The Group does not hold any collateral over these balances.Included in the trade receivables are the following amounts denominated in foreign currencies other than the functional currencies of the relevant group entities to which they relate: 20142013RMB 000RMB 000(Restated)USD157,751180,239GBP3,0224,911EUR381-The Groups revenue from export sales is on letter of credit or documents against payment. The credit period is agreed upon and stipulated in the sales contract. Except for some particular customers where payment in advance is normally required, the Group allows an average credit period of 30days to its local trade customers and 90 days for local hospital customers.The following is an aged analysis of the trade and bills receivables net of allowance for doubtful debts presented based on the invoice date, which approximated to the revenue recognition dates, at the end of the reporting period.20142013RMB000RMB000(Restated)Within one year434,825413,599More than one year but within two years420961More than two years but within three years334830Total435,579415,390Included in the Groups trade and bills receivable balance are debtors with aggregate carrying amount of approximately RMB10,453,000 (2013 as restated: RMB14,893,000) which are past due as at the reporting date for which the Group has not provided for impairment loss.In respect of trade and bill receivables, individual credit evaluations are performed on all customers requiring credit over a certain amount. These evaluations focus on the customers past history of making payments when due and current liability to pay, and take into account information specific to the customer as well as pertaining to the economic environment in which the customers operate. 98% (2013 as restated: 96%) of the trade and bill receivables that are neither past due nor impaired have good settlement history under the Groups individual credit evaluations. Ageing of trade receivables which are past due but not impaired20142013RMB000RMB000(Restated)Within one year9,80414,163More than one year but within two years345204More than two years but within three years304526Total10,45314,893Receivables that were past due but not impaired relate to a number of independent customers that have a good track record with the Group. Based on past experience, management believes that no impairment allowance is necessary in respect of these balances as there has not been a significant change in credit quality and the balances are still considered fully recoverable. Movements in the allowance for doubtful debts of trade receivables20142013RMB000RMB000(Restated)At 1 January65,78067,274Impairment losses reversed(4,114)(1,409)Amounts written off as uncollectible(104)(856)Impairment losses recognised365771At 31 December61,92765,780In determining the recoverability of trade receivables, the Group considers any change in the credit quality of the trade receivables from the date credit was initially granted up to the end of the reporting period. The concentration of credit risk is limited due to the customer base being large and unrelated.Included in the allowance for doubtful debts are individually impaired trade receivables with an aggregate balance of approximately RMB61,927,000 (2013 as restated: RMB 65,780,000) which were found to be under severe financial difficulties.Movements in the allowance for doubtful debts of other receivables20142013RMB000RMB000(Restated)At 1 January14,2078,887Impairment losses reversed(3)(44)Amounts written off as uncollectible-(40)Impairment loss recognised9,2995,404At 31 December23,50314,207Included in the allowance for doubtful debts are individually impaired other receivables with an aggregate balance of approximately RMB23,503,000 (2013 as restated: RMB 14,207,000) which were found to be under severe financial difficulties. As at 31 December 2014, certain secured bank loans were secured by trade and bills receivables of the Group with an aggregate carrying values of nil (2013 as restated: RMB61,579,000) (Note 36).As at 31 December 2014, bills receivable of approximately RMB6,000,000 was pledged to bank to secure banking facilities granted to the Group in respect of bills issuance and operation.10. TRADE AND OTHER PAYABLES20142013RMB000RMB000(Restated)Trade payables473,920377,632Other payables and accrued charges102,04684,047Accrued construction expenses162,025118,533737,991580,212The following is an aged analysis of trade payables presented based on the invoice date at the end of the reporting period. 20142013RMB000RMB000(Restated)Within one year465,803369,239More than one year but less than two years2,7443,400More than two years but less than three years1,5742,247Over three years 3,7992,746473,920377,632The average credit period on purchases of goods is approximately 30 days. The Group has financial risk management policies in place to ensure that all payables are settled within the credit timeframe.11. RELATED PARTY TRANSACTIONS(a) Except as disclosed elsewhere in the consolidated financial statements, the other significant related party transactions, which were carried out in the normal course of the Groups business are detailed as follows:20142013RMB000RMB000Restated Immediate holding company:SXPGC:- Payment of annual trademark licence fee (Note i)10,30010,300- Rental expense500500- Acquisition of land use rights, buildings, construction in progress and equipment26,220-Ultimate holding company:Hualu:- Interest expenses on loan from ultimate holding company40,85040,850- Share of underwriting expenses of loan from ultimate holding company2,1002,100Fellow subsidiaries:- Sale of water, electricity, steam and waste materials12,4447,680- Sale of bulk pharmaceuticals and chemical products-60,972- Purchase of raw materials94,27570,286- - Mechanical and electrical engineering services income89-- Rental expense108-Non-controlling interest shareholders:- Purchase of customer list-2,439- Sale of bulk pharmaceuticals and chemical raw materials140,764141,659Notes:On 7 December 1996, the Group was granted the exclusive right to use the trademark Xinhua (Trademark) by SXPGC for its existing and future products in and outside the PRC at an initial annual fee of RMB600,000 increasing at the rate of an extra RMB100,000 per year until the annual fee reaches the cap amount of RMB1,100,000, which shall stay as such until the agreement is terminated. The terms of the agreement shall continue to have effect during the validity period of the Trademark, being 28 February 2013, subject to further renewal of the registration of the Trademark.On 23 March 2012, the Group entered into the supplemental trademark licence agreement with SXPGC, pursuant to which the annual licence fee to use the Trademark is RMB10,000,000 for the period between 1 April 2012 to 31 December 2014. Other terms of the trademark licence agreement remain unchanged.Xincat entered into the trademark licence agreement with SXPGC, pursuant to which the annual licence fee to use the Trademark is RMB300,000 for the period between 1 January 2013 to 31 December 2016.The Group operates in an economic environment predominated by enterprises directly or indirectly owned or controlled by the PRC government through its numerous authorities, affiliates or other organisations (collectively State-owned Enterprises). During the year ended 31 December 2014, the Group had transactions with State-owned Enterprises including, but not limited to, sales of pharmaceutical products and purchases of raw materials. The directors of the Company consider that transactions with other State-owned Enterprises are activities in the ordinary course of business, and that dealings of the Group have not been significantly controlled or owned by the PRC government. The Group has also established pricing policies for products and such pricing policies do not depend on whether or not the customers are State-owned Enterprises. Having due regard to the substance of the relationships, the directors of the Company are of the opinion that none of these transactions is a material related party transaction that requires separate disclosure.(b) As at 31December 2014, the ultimate holding company provides guarantee in respect of bank loans to the Group amounted to RMB293,158,000 (2013 as restated: RMB169,157,000).As at 31December 2014, the immediate holding company provides guarantee in respect of bank loans to the Group is nil (2013 as restated: RMB25,000,000).(c) Compensation of key management personnelThe remuneration of directors and other members of key management during the year was as follows:20142013RMB000RMB000Short-term benefits5,5134,280Post-employment benefits3322665,8454,546The remuneration of directors and key executives is determined by the remuneration committee having regard to the performance of individuals and market trends.12. BUSINESS COMBINATION UNDER COMMON CONTROLThe Group adopts merger accounting for common control combinations in respect of the following transactions occurred during the year ended 31 December 2014.On 29 September 2014, the Company had entered into the acquisition agreement with Hualu to acquire 40% equity interest of Xincat, which is principally engaged in in the business of manufacturing and trading of medicine in the PRC, at a consideration of RMB102,000,000 by cash, The acquisition has been completed on 23 October 2014.The immediate holding company of Xincat prior to the acquisition by the Group is Hualu while Hualu is the ultimate holding company of the Group. As the Group had held 20% equity interest in Xincat immediately before this transaction, Xincat becomes a subsidiary of the Group after this acquisition. The aforesaid transactions are regarded as business combinations under common control.No significant adjustments were made to the net assets and net results of Xincat as a result of the common control combination to achieve consistency of accounting policies. The Group(excludingXincat)XincatAdjustmentThe Group(includingXincat)RMB000RMB000RMB000RMB000(as originallyreported)(Note)(Restated)As at 31 December 2014Non-current assetsIntangible assets9,377  -  - 9,377 Property, plant and equipment1,924,479 54,792 (1,106)1,978,165 Construction in progress177,599 183  - 177,782 Prepaid lease payments on land use rights286,087 7,631 (212)293,506 Investment properties69,585  -  - 69,585 Interest in an associate67,400  - (67,400) - Available-for-sale financial assets220,591  -  - 220,591 Deferred tax assets23,591 2,081 199 25,871 Prepayments for acquisition of land use rights15,400--15,4002,794,109 64,687 (68,519)2,790,277 Current assetsInventories 480,760 33,802  - 514,562 Properties under development74,326  -  - 74,326 Trade and other receivables487,984 19,287  - 507,271 Prepaid lease payments on land use rights7,555 315 (12)7,858 Amounts due from fellow subsidiaries5,638 8,654 (8,654)5,638 Tax recoverable167 315  - 482 Short-term deposits - 20,334  - 20,334 Restricted bank balances26,685 20,740  - 47,425 Bank balances and cash264,676 16,669  - 281,345 1,347,791 120,116 (8,666)1,459,241 Current liabilitiesTrade and other payables692,964 45,027  - 737,991 Dividend payables5,311--5,311Amounts due to fellow subsidiaries5,019 4,339 9,358 Amount due to subsidiaries8,654  - (8,654) - Amount due to ultimate holding company13,000  -  - 13,000 Tax payable6,516  -  - 6,516 Provisions-9,440-9,440Loan from ultimate holding company199,400  -  - 199,400 Borrowings 639,487  -  - 639,487 1,570,351 58,806 (8,654)1,620,503 Net current liabilities(222,560)61,310 (12)(161,262)Total assets less current liabilities2,571,549 125,997 (68,531)2,629,015 The Group(excludingXincat)XincatAdjustmentThe Group(includingXincat)RMB000RMB000RMB000RMB000(Note)As at 31 December 2014 (Continued)Capital and reservesShare capital457,313 84,930 (84,930)457,313 Reserves1,354,041 41,067 (35,851)1,359,257 Proposed final dividend9,146--9,146Equity attributable to owners of the Company1,820,500 125,997 (120,781)1,825,716 Non-controlling interests38,929  - 52,250 91,179 Total equity1,859,429 125,997 (68,531)1,916,895 Non-current liabilitiesDeferred tax liabilities15,885  -  - 15,885 Loan from ultimate holding company497,000  -  - 497,000 Borrowings138,949  -  - 138,949 Deferred income60,286  -  - 60,286 712,120  -  - 712,120 2,571,549 125,997 (68,531)2,629,015 The Group(excludingXincat)XincatAdjustmentThe Group(includingXincat)RMB000RMB000RMB000RMB000(as originallyreported)(Note)(Restated)As at 31 December 2013Non-current assetsIntangible assets13,248--13,248Property, plant and equipment1,409,62545,741(1,182)1,454,184Construction in progress540,030453540,483Prepaid lease payments on land use rights249,5323,570(224)252,878Investment properties63,926--63,926Interest in an associate24,910-(24,910)-Available-for-sale financial assets127,412--127,412Deferred tax assets18,7052,04521320,963Goodwill2,716--2,716Prepayments for acquisition of buildings-7,399-7,399Prepayments for acquisition of land use rights15,400--15,4002,465,50459,208(26,103)2,498,609Current assetsInventories 457,67629,574-487,250Properties under development74,316-- 74,316 Trade and other receivables460,42539,309314500,048Prepaid lease payments on land use rights6,363167(12)6,518Amounts due from immediate holding company-15,467-15,467Amounts due from fellow subsidiaries9,717447(446)9,718Tax recoverable3,8174-3,821Restricted bank balances97,90114,500-112,401Bank balances and cash282,82228,204-311,0261,393,037127,672(144)1,520,565Current liabilitiesTrade and other payables540,53339,679-580,212Dividend payables5,311--5,311Amounts due to fellow subsidiaries4,6079-4,616Amount due to an associate25-(25) - Amount due to immediate holding company-74(74)-Tax payable1,190--1,190Provisions-9,440-9,440Borrowings 475,66625,000-500,6661,027,33274,202(99)1,101,435Net current assets365,70553,470(45)419,130Total assets less current liabilities2,831,209112,678(26,148)2,917,739The Group(excludingXincat)XincatAdjustmentThe Group(includingXincat)RMB000RMB000RMB000RMB000(Note)As at 31 December 2013 (Continued)Capital and reservesShare capital457,31384,930(84,930)457,313Reserves1,298,85827,74815,7581,342,364Proposed final dividend9,146--9,146Equity attributable to owners of the Company1,765,317112,678(69,172)1,808,823Non-controlling interests37,290-43,02480,314Total equity1,802,607112,678(26,148)1,889,137Non-current liabilitiesDeferred tax liabilities7,034--7,034Loan from ultimate holding company694,300--694,300Borrowings194,467--194,467Deferred income132,801--132,8011,028,602--1,028,6022,831,209112,678(26,148)2,917,739The Group(excludingXincat)XincatAdjustmentThe Group(includingXincat)RMB000RMB000RMB000RMB000(as originallyreported)(Note)(Restated)As at 1 January 2013Non-current assetsIntangible assets14,686  -  - 14,686 Property, plant and equipment1,426,187 49,118 (1,258)1,474,047 Construction in progress273,977 390  - 274,367 Prepaid lease payments on land use rights235,658 3,737 (236)239,159 Investment properties68,906  -  - 68,906 Interest in an associate24,963  - (24,963) - Available-for-sale financial assets156,303  -  - 156,303 Deferred tax assets19,168 2,044 226 21,438 Goodwill2,716  -  - 2,716 Prepayments for acquisition of land use rights63,555  -  - 63,555 2,286,119 55,289 (26,231)2,315,177 Current assetsInventories 489,673 34,745  - 524,418 Trade and other receivables428,468 28,101 (60)456,509 Prepaid lease payments on land use rights5,840 167 (12)5,995 Amounts due from immediate holding company - 19,827  - 19,827 Amounts due from fellow subsidiaries3,971 514 (514)3,971 Tax recoverable3,275  -  - 3,275 Restricted bank balances46,600 4,300  - 50,900 Bank balances and cash375,544 38,944  - 414,488 1,353,371 126,598 (586)1,479,383 Current liabilitiesTrade and other payables522,747 22,196  - 544,943 Dividend payables5,311--5,311Amounts due to fellow subsidiaries1,484 1,074  - 2,558 Amount due to an associate514  - (514) - Amount due to ultimate holding company13,500  -  - 13,500 Tax payable883 1,842  - 2,725 Provisions-9,440-9,440Borrowings 493,370 35,000  - 528,370 1,037,809 69,552 (514)1,106,847 Net current assets315,562 57,046 (72)372,536 Total assets less current liabilities2,601,681 112,335 (26,303)2,687,713 The Group(excludingXincat)XincatAdjustmentThe Group(includingXincat)RMB000RMB000RMB000RMB000(Note)As at 1 January 2013 (Continued)Capital and reservesShare capital457,313 84,930 (84,930)457,313 Reserves1,282,204 27,405 13,693 1,323,302 Proposed final dividend4,573  -  - 4,573 Equity attributable to owners of the Company1,744,090 112,335 (71,237)1,785,188 Non-controlling interests39,701  - 44,934 84,635 Total equity1,783,791 112,335 (26,303)1,869,823 Non-current liabilitiesDeferred tax liabilities12,331  -  - 12,331 Loan from ultimate holding company496,500  -  - 496,500 Borrowings221,147  -  - 221,147 Deferred income87,912  -  - 87,912 817,890  -  - 817,890 2,601,681 112,335 (26,303)2,687,713 The Group(excludingXincat)XincatAdjustmentThe Group(includingXincat)RMB000RMB000RMB000RMB000(as originallyreported)(Note)(Restated)Results for the year ended 31 December 2014Revenue3,301,665 232,584 (1,071)3,533,178 Cost of sales(2,674,341)(139,430)1,160 (2,812,611)Gross profit627,324 93,154 89 720,567 Investment income14,392851(4,015)11,228 Other income128,348 577  - 128,925 Other expenses(92,926)69  - (92,857)Distribution and selling expenses(263,891)(53,872) - (317,763)Administrative expenses(262,082)(19,639) - (281,721)Finance costs(77,307)(483) - (77,790)Profit before tax73,858 20,657 (3,926)90,589 Income tax expense(20,293)(2,709)(14)(23,016)Profit for the year53,565 17,948 (3,940)67,573 Profit for the year attributable to: Owners of the Company49,810 17,948 (17,794)49,964 Non-controlling interests3,755  - 13,854 17,609 53,565 17,948 (3,940)67,573  The Group(excludingXincat)XincatAdjustmentThe Group(includingXincat)RMB000RMB000RMB000RMB000(as originallyreported)(Note)(Restated)Results for the year ended 31 December 2014 (Continued)Profit for the year53,565 17,948 (3,940)67,573 Other comprehensive (expense) incomeItems that maybe reclassified subsequently to profit or loss:----Exchange differences arising on translation of a foreign operation(1,746) -  - (1,746)Fair value (loss) gain arising on available-for-sale financial assets 93,179  -  - 93,179 Income tax relating to components of other comprehensive income(13,977) -  - (13,977)Other comprehensive (expense) income for the year, net of tax77,456  -  - 77,456 Total comprehensive income for the year131,021 17,948 (3,940)145,029 Owners of the Company127,885 17,948 (17,794)128,039 Non-controlling interests3,136  - 13,854 16,990 131,021 17,948 (3,940)145,029 The Group(excludingXincat)XincatAdjustmentThe Group(includingXincat)RMB000RMB000RMB000RMB000(as originallyreported)(Note)(Restated)Results for the year ended 31 December 2013Revenue3,118,781220,746(1,015)3,338,512Cost of sales(2,626,865)(135,114)1,104(2,760,875)Gross profit491,91685,63289577,637Investment income7,415157-7,572Other income112,02473-112,097Other expenses(32,452)--(32,452)Distribution and selling expenses(224,074)(52,352)-(276,426)Administrative expenses(236,942)(16,513)-(253,455)Finance costs(71,307)(420)-(71,727)Share of profit of an associate2,742-(2,742)-Profit before tax49,32216,577(2,653)63,246Income tax expense(12,028)(2,228)(14)(14,270)Profit for the year37,29414,349(2,667)48,976Profit for the year attributable to: Owners of the Company35,73014,34911,941) 38,138Non-controlling interests1,564-9,27]q r s   x z . 0 2 4 T éÑo`Q`Q>%1h*ih-B*CJOJPJQJaJnHphtH%h*ih-B*CJOJQJaJphh*ih-CJOJQJaJh*ih-CJOJQJaJh*ih-5CJOJQJaJ"h*ih-5CJOJQJaJo(.h*ih-5CJOJPJQJaJnHo(tH2jh*ih-5CJOJQJUmHnHo(uh*ih-5CJOJQJo(+h*ih-6KHOJPJQJaJnHtH+h_W:h-6KHOJPJQJaJnHtHq r t u v  x 2 X uv$%:;lmT^`gd-gd-gd-^gd-$dT^a$gd-$UDb]a$gd-$a$gd-gd-M  T V X \ ` b   G N ккzezLzLzezezez1h*ih-B*CJOJPJQJaJnHphtH(h*ih-5B*CJOJQJaJph%h*ih-B*CJOJQJaJphh*ih-B*OJQJph:h*ih-5B*CJOJPJQJ\aJnHo(phtH+h*ih-5B*CJOJQJ\aJph7h*ih-5B*CJOJPJQJ\aJnHphtH%h*ih-B*CJOJQJaJph W]dno Tsuv#$%;?ҽ夽ҤҤҽҕ҂s]+h*ih-5B*CJOJQJ\aJphh*ih-CJOJQJaJ%h*ih-B*CJOJQJaJphh*ih-CJOJQJaJ1h*ih-B*CJOJPJQJaJnHphtH(h*ih-5B*CJOJQJaJph%h*ih-B*CJOJQJaJph4h*ih-B*CJOJPJQJaJnHo(phtH"?Ilmz̽⡍r]rI8-h*ih-CJaJ h*ih-56CJ\]aJ&h*ih-5CJPJ\aJnHtH)h*ih-5CJPJ\aJnHo(tHh*ih-5CJ\aJh*ih-CJKHaJ&h*ih-5CJPJ]aJnHtH7h*ih-5B*CJOJPJQJ\aJnHphtHh*ih-CJOJQJaJ+h*ih-5B*CJOJQJ\aJph:h*ih-5B*CJOJPJQJ\aJnHo(phtHm[{kd$$Ifl,\ 5" p!644 laytIm$1$IfWDd`gdIm$$1$Ifa$gdIm^gd- (*,.<>z|˾˾mmY'h*ih-CJKHOJQJ^JaJo($h*ih-CJKHOJQJ^JaJ h*ih-CJPJaJnHtHh*ih-5CJ\aJ&h*ih-5CJPJ]aJnHtHh*ih-CJaJh*ih-CJKHaJh*ih-6CJ]aJ&h*ih-6CJPJ]aJnHtH#h*ih-CJPJaJnHo(tH!,.>RfzpbTTT$$1$Ifa$gdIm$$1$Ifa$gdImkd$$Ifl,\ 5" p!644 lag3ytIm$$1$Ifa$gdIm z|uggg$$1$Ifa$gdIm$$1$Ifa$gdIm{kd"$$Ifl,\ 5" p!644 laytIm*uggg$$1$Ifa$gdIm$$1$Ifa$gdIm{kd$$Ifl,\ 5" p!644 laytIm(*,RT|~&2Rz|~ƹƹƹƹt_I+h*ih-CJOJPJQJaJnHo(tH(h*ih-CJOJPJQJaJnHtH7h*ih-5B*CJOJPJQJ\aJnHphtHh*ih-CJaJo(#h*ih-CJPJaJnHo(tHh*ih-CJaJh*ih-CJKHaJ'h*ih-CJKHOJQJ^JaJo($h*ih-CJKHOJQJ^JaJ$h*ih-CJKHPJaJnHtH*,Tbp~uggg$$1$Ifa$gdIm$$1$Ifa$gdIm{kdF$$Ifl,\ 5" p!644 laytIm~uggg$$1$Ifa$gdIm$$1$Ifa$gdIm{kd$$Ifl,\ 5" p!644 laytImR`n|aSSS$$1$Ifa$gdIm!v$ .$IfWD^`.a$gdIm{kdj$$Ifl,\ 5" p!644 laytIm|~zffff>(<TPL HD@< ^gd-TQ gd-^gd-{kd$$Ifl,\ 5" p!644 laytIm   .048:ⳟqYH=+#h*ih-CJPJaJnHo(tHh*ih-CJaJ h*ih-56CJ\]aJ/h*ih-56CJPJ\]aJnHo(tH)h*ih-5CJPJ\aJnHo(tHh*ih-5CJ\aJh*ih-CJaJ&h*ih-5CJPJ]aJnHtH1h*ih-B*CJOJPJQJaJnHphtH+h*ih-5B*CJOJQJ\aJph:h*ih-5B*CJOJPJQJ\aJnHo(phtH   0<LZj;$1$IfWD`;gdIm$$1$Ifa$gdIm(<TPL HD@< ^gd-.<TPL HD@< WD^`gd- :<JLPTXZhlnprtȶޢӎȶoȶo[H[H[$h*ih-CJKHOJQJ^JaJ'h*ih-CJKHOJQJ^JaJo( h*ih-CJPJaJnHtHh*ih-5CJ\aJ&h*ih-5CJPJ]aJnHtH&h*ih-6CJPJ]aJnHtH#h*ih-CJPJaJnHo(tHh*ih-CJaJh*ih-CJaJh*ih-6CJ]aJ&h*ih-5CJPJ\aJnHtHjlnpuuuu$$1$Ifa$gdIm{kd$$Ifl,\S "b :::"644 la]ytImxjjj$$1$Ifa$gdIm $1$IfgdIm{kd $$Ifl,\S "b :::"644 la]ytIm%1xjjj$$1$Ifa$gdIm $1$IfgdIm{kd$$Ifl,\S "b :::"644 la]ytIm $%12KLTU]^ghoYo+h*ih-5B*CJOJQJ\aJph:h*ih-5B*CJOJPJQJ\aJnHo(phtH1h*ih-B*CJOJPJQJaJnHphtH#h*ih-CJPJaJnHo(tHh*ih-CJaJ$h*ih-CJKHOJQJ^JaJ'h*ih-CJKHOJQJ^JaJo(h*ih-CJaJh*ih-CJaJ12LU^gxjjj$$1$Ifa$gdIm $1$IfgdIm{kd$$Ifl,\S "b :::"644 la]ytImghn```$$1$Ifa$gdIm$$1$IfWD^`$gdIm{kd$$Ifl,\S "b :::"644 la]ytIm[SJJ^gd- & Fgd-(<TPL HD@< ^gd-{kd$$Ifl,\S "b :::"644 la]ytIm #&)ʱv_NA-h*ih-6CJ]aJ'h*ih-CJKHPJaJnHo(tHh*ih-CJKHaJ h*ih-56CJ\]aJ,h*ih-56CJPJ\]aJnHtH-h*ih-5CJKHPJ\aJnHo(tHh*ih-5CJKH\aJ'h*ih-5CJKHPJaJnHtH1h*ih-B*CJOJPJQJaJnHphtH:h*ih-5B*CJOJPJQJ\aJnHo(phtH.h*ih-5B*CJOJQJ\aJo(ph !&*+SX\ $$Ifa$gdIm$$1$Ifa$gdIm(<TPL HD@< ^gd- )+SUX[\]^_`qr /0]İߍİߍߍߍz`zč3h*ih-CJKHOJPJQJ^JaJnHo(tH$h*ih-CJKHOJQJ^JaJ$h*ih-CJKHPJaJnHtHh*ih-5CJKH\aJ'h*ih-5CJKHPJaJnHtHh*ih-CJKHaJh*ih-6CJ]aJ'h*ih-CJKHPJaJnHo(tHh*ih-CJKHaJ \]^_qoaaUUaa $$Ifa$gdIm$$1$Ifa$gdImkd$$Ifl4r '"DD644 laytIm\NNBBBB $$Ifa$gdIm$$1$Ifa$gdImkdj$$Ifl4ֈ '"""D644 laytIm=/$$1$Ifa$gdImkd0 $$Ifl4֞ o!'"""""644 laytIm $$Ifa$gdIm/ $$Ifa$gdIm$$1$Ifa$gdIm/0iwJ<.$$1$Ifa$gdIm$$1$Ifa$gdImkd $$Ifl֞ o!'"""""644 laytIm]bi  ,-.G[\efg˱ˤސːːːwːˤ˱ː˱ːc'h*ih-5CJKHPJaJnHtH0h*ih-CJKHOJPJQJ^JaJnHtH'h*ih-CJKHOJQJ^JaJo(h*ih-CJKHaJ3h*ih-CJKHOJPJQJ^JaJnHo(tH$h*ih-CJKHOJQJ^JaJ$h*ih-CJKHPJaJnHtHh*ih-CJKHaJo(!w$$1$Ifa$gdIm $$Ifa$gdImJ<.$$1$Ifa$gdIm$$1$Ifa$gdImkd $$Ifl֞ o!'"""""644 laytIm -$$1$Ifa$gdIm $$Ifa$gdIm-.GLQJ?1% $$Ifa$gdIm$$1$Ifa$gdIm $1$IfgdImkdN $$Iflv֞ o!'"""""644 laytImQV\afg0kd $$Iflv֞ o!'"""""644 laytIm $$Ifa$gdIm$$1$Ifa$gdImg $$Ifa$gdIm$$1$Ifa$gdIm $1$IfgdImJ<.$$4$Ifa$gdIm$$1$Ifa$gdImkd $$Iflv֞ o!'"""""644 laytIm #'()Gkda$$Ifl4r '"DD644 laytIm$$1$Ifa$gdIm$$4$Ifa$gdIm $$Ifa$gdIm #&'()*+<=MOPQRTVghxyz{}~ɶֶɩֶֶֶֶֶֶ֩ɂhֶ3h*ih-CJKHOJPJQJ^JaJnHo(tH$h*ih-CJKHOJQJ^JaJ'h*ih-5CJKHPJaJnHtHh*ih-CJKHaJ$h*ih-CJKHPJaJnHtHh*ih-CJKHaJ'h*ih-CJKHPJaJnHo(tH*h*ih-5CJKHPJaJnHo(tH()*<MNO$$1$Ifa$gdIm $$Ifa$gdIm$$4$Ifa$gdImOPQRSTU\N@@@N$$4$Ifa$gdIm$$1$Ifa$gdImkd1$$Ifl4ֈ '"""D644 laytImUgxyz=/$$1$Ifa$gdImkd$$Ifl4֞ o!'"""""644 laytIm $$Ifa$gdImz{|}$$1$Ifa$gdIm$$4$Ifa$gdImI;-$$1$Ifa$gdIm$$1$Ifa$gdImkd$$Ifl4֞ o!'"""""644 laytIm$$1$Ifa$gdIm $$Ifa$gdIm4EJ<.$$1$Ifa$gdIm$$1$Ifa$gdImkd$$Ifl֞ o!'"""""644 laytIm(-4kl̲̥q[D;,h*ih-CJPJnHtHh*ih-CJ,h*ih-B*OJPJQJnHo(phtH+h*ih-5B*CJOJQJ\aJph+h*ih-CJOJPJQJaJnHo(tH:h*ih-5B*CJOJPJQJ\aJnHo(phtHh*ih-CJKHaJ3h*ih-CJKHOJPJQJ^JaJnHo(tH$h*ih-CJKHOJQJ^JaJh*ih-CJKHaJo($h*ih-CJKHPJaJnHtHEVgl}$$1$Ifa$gdIm $$Ifa$gdImJA<,T^`gd-gd-^gd-kdS$$Ifl֞ o!'"""""644 laytIm)-8<=>CH_tjckd$$If4FLt%u<d&    4 ahf4ytIm $$Ifa$gdIm%6TPL HD@<%^gd- -;<>BCGH^_stu'+56RST^aegmost| h*ih-h*ih-CJOJQJo(h*ih-CJOJQJ"h*ih-5CJPJnHo(tH&h*ih-5CJPJQJnHo(tHh*ih-CJ#h*ih-CJPJQJnHo(tHh*ih-CJPJnHo(tH0tuul```` $$Ifa$gdIm $IfgdImkd$$If4rLt%ud&4 ahf4ytImxo4o:kd$$IfL%d&d&4 ahytIm $IfgdImkdD$$IfrLt%ud&4 ahytIm&56S`o|lc $IfgdImkdL$$IfrLt%ud&4 ahytIm $$Ifa$gdIm xocccc $$Ifa$gdIm $IfgdImkd$$IfrLt%ud&4 ahytImGHWXGHxQLLLLLLgd-&9TPL HD@<%^gd-kd$$IfrLt%ud&4 ahytImU]b"#'1?ABLMN[`9;EGHӽx h*ih-CJOJPJQJaJ(h*ih-CJOJPJQJaJnHtHh*ih-CJOJQJaJh*ih-CJOJQJaJo(+h*ih-CJOJPJQJaJnHo(tH1h*ih-B*CJOJPJQJaJnHphtH%h*ih-B*OJQJnHphtH)HVW !!!@"A"##F%G%&&+(,(**++++ ^`gd-$^`a$gd-^gd-gd-gd-HWesLU ! " # = > E F P Q X Y \ ] ުުުzzzzêz(h*ih-B*CJOJQJaJo(ph4h*ih-5B*CJOJPJQJaJnHphtH1h*ih-B*CJOJPJQJaJnHphtH4h*ih-B*CJOJPJQJaJnHo(phtH%h*ih-B*CJOJQJaJphh*ih-CJOJQJaJ* !!!!!!" "*"+"A"p"q"u"v"s######$$$$+%3%:%D%%%&&''''')(Ҽllllllllllllll(h*ih-B*CJOJQJaJo(ph1h*ih-B*CJOJPJQJaJnHphtH%h*ih-B*CJOJQJaJphh*ih-CJOJQJaJ+h*ih-CJOJPJQJaJnHo(tH4h*ih-B*CJOJPJQJaJnHo(phtH$h*ih-B*PJnHo(phtH*)(6(<(w((((((((((\)b)))))))))))******F*G*****'+(+++++++ׇq+h*ih-CJOJPJQJaJnHo(tH"h*ih-5CJOJQJ\aJh*ih-B*ph.h*ih-hL! B*CJOJQJaJo(ph4h*ih-B*CJOJPJQJaJnHo(phtH(h*ih-B*CJOJQJaJo(ph%h*ih-B*CJOJQJaJph,+,, ,&,(,,,,-#-*-0-6-;-n------9.:.U.V...... /-/./=/A/N/R/U/W/X/\/u/v/G0H0I0J0000!111111111111!2T2Z2ӸӸ(h*ih-B*CJOJQJaJo(ph4h*ih-B*CJOJPJQJaJnHo(phtH1h*ih-B*CJOJPJQJaJnHphtH%h*ih-B*CJOJQJaJph@+F-G---_/`/r1s111445444p5q566669::::!;";gd-gd-^gd-Z2x2~222222222334454o4s4{4444444445555/515K5N5c5n5p5q555555555׼s4h*ih-B*CJOJPJQJaJnHo(phtH1h*ih-B*CJOJPJQJaJnHphtH(h*ih-B*CJH*OJQJaJph4h*ih-B*CJOJPJQJaJnHo(phtH(h*ih-B*CJOJQJaJo(ph%h*ih-B*CJOJQJaJph-55555P6666666777 7#7'7/7K768>899999::Ѿuuuuuuuu_I+h*ihMCJOJPJQJaJnHo(tH+h*ih-CJOJPJQJaJnHo(tH(h*ih-B*CJOJQJaJo(ph1h*ih-B*CJOJPJQJaJnHphtH4h*ih-B*CJOJPJQJaJnHo(phtH%h*ih-B*CJOJQJaJph4h*ih-B*CJOJPJQJaJnHo(phtH%h*ih-B*CJOJQJaJph::: ;";*;-;1;r;;<<===>!>$>7>8>d@f@BB B#BiBkBCCCCCDDDDDEEEEE9EPE!H)H-HSHTHkHjIIIIIIKKKKQMSMTMWM9N]NgNN֮îîîîîîîîîîîîî֮îîîîîîîîîîîîîîîî(h*ih-B*CJOJQJaJo(ph%h*ih-B*CJOJQJaJph4h*ih-B*CJOJPJQJaJnHo(phtHh*ih-CJOJQJaJD";s;t;==e@f@BBCCDD:E;E!H"HlImIIIKKRMSM:N;NNN^gd-NyOzO^P_PQQSSTTTTWWEYFYYYYY]]____$dpG$H$a$gd-$a$gd-^gd-NyOO]PzPPPQQS$S TTTTTTWWDYYYYYBZ]]___`aaaabbbbccccddGddueeKggggh׼+h*ih-h]|B*CJOJQJaJphh*ih-KHPJnHo(tHh*ih-CJOJQJaJ4h*ih-B*CJOJPJQJaJnHo(phtH(h*ih-B*CJOJQJaJo(ph%h*ih-B*CJOJQJaJph5_aabbccHdIdwexeLgMghh i ikkUmVmmmnnooSpTp^gd-hhhhii iGikkkkTmUmVmmmmmmnnnnnoooopppRpUpVpXpqqqqqrr&r*r맘.h*ih-5CJOJPJQJ\aJnHtHh*ih-CJOJQJaJ+h*ih-CJOJPJQJaJnHo(tH4h*ih-B*CJOJPJQJaJnHo(phtH%h*ih-B*CJOJQJaJph(h*ih-B*CJOJQJaJo(ph,Tpqqrr%r&rrrsssstttt*u+u$ T^`a$gd-T^T`gd-gd- ^`gd- +gd-^gd-*r2rgrhrrrrs sssasbscsdsysssssssstt-tTtUt_tatetftitttttuu)u*uӸӸӸӠӸӸӸӠxfxfx"h*ih-5CJOJQJ\aJ1h*ih-5CJOJPJQJ\aJnHo(tHh*ih-CJOJQJaJ.h*ih-5CJOJPJQJ\aJnHtH4h*ih-B*CJOJPJQJaJnHo(phtH%h*ih-B*CJOJQJaJph1h*ih-B*CJOJPJQJaJnHphtH(*u+u0u2u5u6u=u>u@uBuCuDuKuLuMu͸{i[G[6+h*ih-nHtH h*ih-CJPJaJnHtH&h*ih-6CJPJ]aJnHtHh*ih-6CJ]aJ#h*ih-CJPJaJnHo(tHh*ih-CJaJh*ih-5nHtH h*ih-56CJ\]aJ)h*ih-56CJPJ]aJnHtH)h*ih-5CJPJ\aJnHo(tHh*ih-5CJ\aJh*ih-PJnHo(tH+h*ih-CJOJPJQJaJnHo(tH+u0u5u>uDuLuMuwu\)6TPL HD@<{$If^gdIm`kd;$$IflF! $  !    4 la ytIm$V$If^V`a$gdImMuaubuwuxuzu{uuuuuuuuuvvvv,v-vjvkvlvmvvvvvvvvvvüugV!h*ih-5CJKH\aJo(h*ih-CJKHaJo(h*ih-aJo(h*ih-CJKHaJ'h*ih-CJKHPJaJnHo(tH$h*ih-CJKHPJaJnHtHh*ih-aJ h*ih-h*ih-5:h*ih-5B*CJOJPJQJ\aJnHo(phtH+h*ih-5B*CJOJQJ\aJph!wuxuyuzuuuueWW$$1$Ifa$gdIm v${$IfVDFWDj^`a$gdIm`kd$$IflF! $  !    4 la ytIm$V$If^V`a$gdImuuvv,v}oo$$1$Ifa$gdIm v${$IfVDFWDj^`a$gdIm`kd;$$IflF! $  !    4 la ytIm,v-vJv[vjvww$$1$Ifa$gdImVi$IfVD$WD2^V`igdIm`kd$$IflF! $  !    4 la ytImjvkvvvvww$$1$Ifa$gdIm%$IfVDOWDU^%`gdIm`kdG$$IflF! $  !    4 la ytImvvvvvww$$1$Ifa$gdIm.$IfVDPWD^`.gdIm`kd$$IflF! $  !    4 la ytImvvvvv~~$$1$Ifa$gdIm{$IfgdIm`kdS$$IflF! $  !    4 la ytImvvvv wxxxxx x xtxvxxxxxxxxxxxxxܹܣt^tOAh*ih-hCJaJh*ih-h5CJaJ*h*ih-5CJKHPJaJnHo(tHh*ih-5CJKHaJo(h*ih-5CJKHaJ!h*ih-5CJKH\aJo(+h*ih-CJKHPJQJaJnHo(tHh*ih-CJKHQJaJ'h*ih-CJKHPJaJnHo(tHh*ih-CJKHaJ h*ih-h*ih-5CJKH\aJvvwx xww$$1$Ifa$gdImVi$IfVD$WD2^V`igdIm`kd$$IflF! $  !    4 la ytIm x x.xPxtxww$$1$Ifa$gdImVi$IfVD$WD2^V`igdIm`kd_$$IflF! $  !    4 la ytImtxvxxxx~~$$1$Ifa$gdIm{$IfgdIm`kd$$IflF! $  !    4 la ytImxxxxxtt$d$If]a$gdIm$d$If]^a$gdIm`kdk$$IflF! $  !    4 la ytImxxy@ydyww$$1$Ifa$gdIm.$IfVDPWD^`.gdIm`kd$$IflF! $  !    4 la ytImxydyfyhyjyyyyy z zz'z(z)z*z~zzzzzzừ᫕jYN:'h*ih-CJKHPJaJnHo(tHh*ihZeCJaJ!hZeCJKHPJaJnHo(tH(h*ih-CJOJPJQJaJnHtH+h*ih-5CJOJPJQJaJnHtH*h*ih-5CJKHPJ\aJnHtHh*ih-5CJKH\aJh*ih-5CJ\aJo(h*ih-CJaJh*ih-CJaJo( h*ih-h*ih-CJKHaJh*ih-CJaJdyfyyyyww$$1$Ifa$gdIm.$IfVDPWD^`.gdIm`kdw$$IflF! $  !    4 la ytImyyyz z~~$$1$Ifa$gdIm{$IfgdIm`kd$$IflF! $  !    4 la ytIm z z'z(z)zzz$d$Ifa$gdImV$If^V`gdIm`kd$$IflF! $  !    4 la ytIm)z*zdzlz~zww$$1$Ifa$gdIm$IfVDIWDj^`gdIm`kd $$IflF! $  !    4 la ytIm~zzzzzww$$1$Ifa$gdIm$IfVDIWDj^`gdIm`kd$$IflF! $  !    4 la ytImzzzzzzzzzzzzzz{{{M{ٲtaVC%h*ih-B*CJOJQJaJphh*ih-OJQJ%h*ih-B*CJOJQJaJph/h*ih-5B*OJPJQJ\nHphtH#h*ih-5B*OJQJ\ph'h*ih-CJKHPJaJnHo(tH-h*ih-5CJKHPJ\aJnHo(tHh*ih-5CJKH\aJ!h*ih-5CJKH\aJo(h*ih-aJh*ih-CJKHaJzzzzz$$1$Ifa$gdIm$IfgdIm`kd$$IflF! $  !    4 la ytImzzzzz$$1$Ifa$gdIm$IfgdIm`kd$$IflF! $  !    4 la ytImzz{{||||}}vqhUUPhhgd-$d^`a$gd-^gd-gd-(6TPL HD@<{d<^gd-`kd! $$IflF! $  !    4 la ytIm M{N{Y{Z{]{^{{{&|3|7|8|;|=|>|G|Z|d|||||||||-}6}H}e}p}}}}}}~+~~~~~~~~~~~~ؽؽؽؽؽؤؽؤ|ؽؤؤؤؤؤؽh*ih-CJOJQJaJ1h*ih-5CJOJPJQJ\aJnHo(tH1h*ih-B*CJOJPJQJaJnHphtH4h*ih-B*CJOJPJQJaJnHo(phtH%h*ih-B*CJOJQJaJph(h*ih-B*CJOJQJaJo(ph0~~~~~~~(@acjҀӀ]a칪쑹zkVk)h*ih-B*OJPJQJnHphtHh*ih-B*OJQJph,h*ih-B*OJPJQJnHo(phtH1h*ih-B*CJOJPJQJaJnHphtHh*ih-CJOJQJaJ.h*ih-5CJOJPJQJ\aJnHtH4h*ih-B*CJOJPJQJaJnHo(phtH%h*ih-B*CJOJQJaJph}~~~~23рҀ/0)$a$gd-gd-d^`gd-^gd-݁߁7=P{~y?CKWgyjh*ih-CJOJQJaJ.h*ih-5CJOJPJQJ\aJnHtH(h*ih-B*CJH*OJQJaJph4h*ih-B*CJOJPJQJaJnHo(phtH%h*ih-B*CJOJQJaJph(h*ih-B*CJOJQJaJo(ph+h*ih-CJOJPJQJaJnHo(tH#0GHefƅ -1lnˆ҆Ԇí؅؅؅jjjUj؅jUj(h*ih-B*CJH*OJQJaJph4h*ih-B*CJOJPJQJaJnHo(phtH1h*ih-B*CJOJPJQJaJnHphtHh*ih-CJOJQJaJ+h*ih-CJOJPJQJaJnHo(tH(h*ih-B*CJOJQJaJo(ph%h*ih-B*CJOJQJaJph'h*ih-CJPJ^JaJnHo(tH! ?ABGJL]_ GHSTӸӸӸӸӣnnS4h*ihmB*CJOJPJQJaJnHo(phtH(h*ih-B*CJOJQJaJo(phh*ih-CJOJQJaJ h*ih-@CJOJQJaJ(h*ih-CJOJPJQJaJnHtH4h*ih-B*CJOJPJQJaJnHo(phtH1h*ih-B*CJOJPJQJaJnHphtH%h*ih-B*CJOJQJaJph0STz%<TPL HD@<e C^&9TPL HD@<e C^gdk"7TPL HD@<e C^dgd-gd-^gd- TavȩuWD0'h*ih5B*CJOJQJo(ph$h*ih5B*CJOJQJph:h*ihRv5B*CJOJPJQJ\aJnHo(phtH:h*ihm5B*CJOJPJQJ\aJnHo(phtH+h*ihm5B*CJOJQJ\aJph=h*ihqk5;B*CJOJPJQJ\aJnHo(phtH.h*ihm5;B*CJOJQJ\aJph=h*ihk5;B*CJOJPJQJ\aJnHo(phtH‰ȉ͉҉%$!d$Ifa$gd$VZd$If^Z`gd$Vdgd(<TPL HD@<e C^gd‰ˉ͉Љ҉Ӊ.9:;=?@LN]^_jqr~ξΐΐ~ΡΐΡΐ~qΐqqΐh*ihCJPJaJ#h*ih5CJPJaJnHtH h*ihCJPJaJnHtH h*ih+h*ih>*CJOJPJQJaJnHtHh*ih>*CJOJQJaJh*ihCJaJh*ih5CJaJ3h*ih5B*CJOJPJQJnHo(phtH,҉ӉԉՉ݉ufff$d$Ifa$gd$VZd$If^Z`gd$Vukd $$If\r#+vvv$44 ayt$VufUB$d$If]a$gd$V$d$4$Ifa$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vukd!$$If\r#+vvv$44 ayt$VufWW$d$Ifa$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vukd!$$If\r#+vvv$44 ayt$V!".:ufNN$d$&dIfPa$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vukd "$$If\r#+vvv$44 ayt$V:;<=>?ufWW$d$Ifa$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vukd"$$If\r#+vvv$44 ayt$V?@MNV^ufWK $$Ifa$gd$V$d$Ifa$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vukd"$$If\r#+vvv$44 ayt$V^_qryufWK $$Ifa$gd$V$d$Ifa$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vukdk#$$If\r#+vvv$44 ayt$VufWK $$Ifa$gd$V$d$Ifa$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vukd#$$If\r#+vvv$44 ayt$VufWK $$Ifa$gd$V$d$Ifa$gd$V$d$Ifa$gd$VZd$If^Z`gd$VukdW$$$If\r#+vvv$44 ayt$VŠԊ&'(678IJKLMOPbqr}Ëċȋɋ݋ދоВ۾즾n#h*ih5CJPJaJnHtH#h*ihCJPJaJnHo(tH&h*ihhCJPJaJnHtHh*ih5CJaJh*ihCJaJo(#h*ih{CJPJaJnHo(tHh*ihCJaJ h*ihCJPJaJnHtH h*ihh*ihCJPJaJ+ŠufWK $$Ifa$gd$V$d$Ifa$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vukd$$$If\r#+vvv$44 ayt$V'ufWK $$Ifa$gd$V$d$Ifa$gd$V$d$Ifa$gd$VZd$If^Z`gd$VukdC%$$If\r#+vvv$44 ayt$V'(68AJufN9$$&dIfPa$gd$V$d$&dIfPa$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vukd%$$If\r#+vvv$44 ayt$VJKLMNOsdUU$d$Ifa$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vwkd/&$$Ifb\r#+vvv$44 ayt$VOPbcjqufWW$d$Ifa$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vukd&$$If\r#+vvv$44 ayt$VqrufNN$d$&dIfPa$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vukd'$$If\r#+vvv$44 ayt$VufWW$d$Ifa$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vukd'$$If\r#+vvv$44 ayt$VËufNN$d$&dIfPa$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vukd ($$If\r#+vvv$44 ayt$VËċŋƋNjȋufWW$d$Ifa$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vukd($$If\r#+vvv$44 ayt$VȋɋufSS$nd$If]na$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vukd($$If\r#+vvv$44 ayt$V whYY$d$Ifa$gd$V$d$Ifa$gd$Vd$IfVDG^gdukdm)$$If\r#+vvv$44 ayt$V03:@ABFGWX\]wųq_MCh*ih5CJ"h*ih-5CJPJnHo(tH"h*ih5CJPJnHo(tH:h*ih5B*CJOJPJQJ\aJnHo(phtH#h*ihCJPJaJnHo(tH#h*ih{CJPJaJnHo(tH#h*ih5CJPJaJnHtHh*ih5CJaJh*ihCJaJh h*ihh*ihCJaJ h*ihCJPJaJnHtH23:AwhPP$d$&dIfPa$gd$V$d$Ifa$gd$Vd$IfVDG^gdukd)$$If\r#+vvv$44 ayt$VABCDEFufWW$d$Ifa$gd$V$d$Ifa$gd$VZd$If^Z`gd$VukdY*$$If\r#+vvv$44 ayt$VFGHIPWufNN$d$&dIfPa$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vukd*$$If\r#+vvv$44 ayt$VWXYZ[\ufWW$d$Ifa$gd$V$d$Ifa$gd$VZd$If^Z`gd$VukdE+$$If\r#+vvv$44 ayt$V\]ufNN#$d$&dIfPa$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vukd+$$If\r#+vvv$44 ayt$V_WWWWWK d$Ifgd$Vdgd(<TPL HD@<e C^gdwkd1,$$If\r#+vvv$44 ayt{Ќ .34¶¦¶zezYG#h*ih5CJPJaJnHtHh*ih5CJaJ(h*ihCJOJPJQJaJnHtHh*ihCJOJQJaJ h*ih+h*ih>*CJOJPJQJaJnHtHh*ih>*CJOJQJaJh*ih>*CJaJh*ihCJaJ h*ihCJPJaJnHtHh*ih5CJnH o(tH "h*ih5CJPJnHo(tH dX d$Ifgd$Vwkd,$$IfW\r+$3%44 ayt$V%$!d$Ifa$gd$V$d$Ifa$gd$V sdO7%$!d$If]a$gd$V%$!d$4$Ifa$gd$V$d$Ifa$gd$V$d$IfWD^`$gd$Vukd;-$$If\r+$3%44 ayt$VsdPP%$!d$Ifa$gd$V$d$Ifa$gd$V$d$IfWD^`$gd$Vukd-$$If\r+$3%44 ayt$V34;BsdHH%$!d$&dIfPa$gd$V$d$Ifa$gd$VZd$If^Z`gd$VwkdS.$$If\r+$3%44 ayt$V4;ABCEGHlmnpqލ%;KLM]^ ³͑͑͢‘‘͑‘ͅs#h*ih5CJPJaJnHtHh*ih5CJaJ h*ihCJPJaJnHtH h*ihCJPJaJnH tH h*ihCJaJnH tH h*ihCJaJ h*ih(h*ihCJOJPJQJaJnHtH+h*ihCJOJPJQJaJhnHtH-BCDEFGufRR%$!d$Ifa$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vukd.$$If\r+$3%44 ayt$VGHmnopufRR%$!d$Ifa$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vukdu/$$If\r+$3%44 ayt$VpqufRR%$!d$Ifa$gd$V$d$Ifa$gd$Vd$If^`gd$Vukd0$$If\r+$3%44 ayt$VufRR%$!d$Ifa$gd$V$d$Ifa$gd$Vd$If^`gd$Vukd0$$If\r+$3%44 ayt$VLMT]sdPP%$!d$Ifa$gd$V$d$Ifa$gd$V4d$IfWDt^4`gd$Vukd+1$$If\r+$3%44 ayt$V]^sddHH%$!d$&dIfPa$gd$V$d$Ifa$gd$V4d$IfWDt^4`gd$Vukd1$$If\r+$3%44 ayt$VufRR%$!d$Ifa$gd$V$d$Ifa$gd$VZd$If^Z`gd$VukdO2$$If\r+$3%44 ayt$VsdHH%$!d$&dIfPa$gd$V$d$Ifa$gd$V:d$IfWD^`:gd$Vukd2$$If\r+$3%44 ayt$V ufRR%$!d$Ifa$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vukds3$$If\r+$3%44 ayt$V 0456EFHJKwxɏʏ̏ΏϏяػ们tZLh*ih{5CJ\aJ3h*ih5B*CJOJPJQJnHo(phtH$h*ih5B*CJOJQJph)h*ih5CJPJ\aJnHo(tHh*ih5CJOJQJaJh*ihCJOJQJaJh*ihCJaJ#h*ih5CJPJaJnHtHh*ih5CJaJ h*ih(h*ihCJOJPJQJaJnHtH 56>EufJJ%$!d$&dIfPa$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vukd4$$If\r+$3%44 ayt$VEFGHIJufRR%$!d$Ifa$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vukd4$$If\r+$3%44 ayt$VJKwxx;)nd$IfWD2`ngd$V<kd5$$Ifr$%%44 ayt$V%!d$Ifgd$Vukd)5$$If\r+$3%44 ayt$VfTnd$IfWD2`ngd$Vukd5$$If\r+$3%44 ayt$V%$!d$Ifa$gd$V$d$Ifa$gd$Vɏʏˏ̏͏mYJ6%$!d$Ifa$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vukd6$$If\r+$3%44 ayt$V%$!d$&dIfPa$gd$V͏ΏϏЏяُuaR66%$!d$&dIfPa$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vukd#7$$If\r+$3%44 ayt$V%$!d$Ifa$gd$VYYM>$d$$Ifa$gd$V d$$Ifgd$V(<TPL HD@<e C^gddgdukd7$$If\r+$3%44 ayt$V"#-.6789:=ABEJMRSTUV`ak̺̪̪zfSzfzfSBSB h*ih{CJPJaJnHtH$h*ih{0JCJPJaJnHtH'h*ih{0J5CJPJaJnHtHh*ih{0J5CJaJh*ih{0JCJaJh*ih{5CJ\aJ h*ih{h*ih{5>*CJPJaJ"h*ih{0J5>*CJPJaJ*h*ih{0J5>*CJPJaJnHtHh*ih{5>*CJaJh*ih{0J5>*CJaJ#.78+kdG8$$IflrG )Q0v644 layt{$d$$Ifa$gd$V$d$$Ifa$gd~89:BJR$d$$Ifa$gd$V d$$Ifgd$VRSTUVaI===.$d$$Ifa$gd$V d$$Ifgd$Vkd%9$$IflrG )Q0v644 layt{alm:.. d$$Ifgd$Vkd:$$IflrG )Q0v644 layt{$d$$Ifa$gd$VklmːߐHXY`abxÑđˑ̑͑戯戯h*ih{CJ\aJh*ih{CJPJaJh*ih{0J5CJaJ h*ih{CJPJaJnHtHh*ih{CJaJh*ih{5CJ\aJh*ih{0JCJaJ h*ih{$h*ih{0JCJPJaJnHtH5.kd:$$IflrG )Q0v644 layt{ d$$Ifgd$V$d$$Ifa$gd$V $$Ifa$gd$V$d$$Ifa$gd$V$d$$Ifa$gd$Vd$$IfWDd`gd$Vː̐I7($d$$Ifa$gd$Vd$$IfWDd`gd$Vkd;$$IflrG )Q0v644 layt{̐֐.kd<$$IflrG )Q0v644 layt{ $$Ifa$gd$V$d$$Ifa$gd$V $$Ifa$gd$V$d$$Ifa$gd$V$d$$Ifa$gd$Vd$$IfWDd`gd$VHII1"$d$$Ifa$gd$V$d$$IfVDdWD^`$gdkd{=$$IflrG )Q0v644 layt{IQYab.kdY>$$IflIrG )Q0v644 layt{ $$Ifa$gd$V$d$$Ifa$gd$Vbxy $$Ifa$gd$V$d$$Ifa$gd$V$d$$Ifa$gd$Vd$$IfWDd`gd$VI7($d$$Ifa$gd$Vd$$IfWDd`gd$Vkd7?$$IflrG )Q0v644 layt{đ̑͑.kd@$$IflrG )Q0v644 layt{ $$Ifa$gd$V$d$$Ifa$gd$V͑ $$Ifa$gd$V$d$$Ifa$gd$V$d$$Ifa$gd$Vd$$IfWDd`gd$VI7($d$$Ifa$gd$Vd$$IfWDd`gd$Vkd@$$IflrG )Q0v644 layt{ :=BCTUV’ÒҒ֒ג#)678IJKghĽĽĽܽĽѽĽљęĽ#h*ihMCJPJaJnHo(tHh*ih~CJaJh*ih{0JCJaJh*ih{CJ\aJ h*ih{h*ih{CJPJaJh*ih{CJaJ h*ih{CJPJaJnHtH#h*ih{CJPJ\aJnHtH4 .kdA$$IflrG )Q0v644 layt{ $$Ifa$gd$V$d$$Ifa$gd$V:;=CU $$Ifa$gd$V$d$$Ifa$gd$V$d$$Ifa$gd$V$d$$IfVDdWD^`$gd~UVI1"$d$$Ifa$gd$V$d$$IfVDdWD^`$gdkdB$$Ifl,rG )Q0v644 laytM.kdC$$IflZrG )Q0v644 layt{ $$Ifa$gd$V$d$$Ifa$gd$V$d$$Ifa$gd$V$d$$Ifa$gd$V d$$Ifgd$VI=.$d$$Ifa$gd$V d$$Ifgd$VkdD$$IflrG )Q0v644 layt{’Ò.kdE$$IflrG )Q0v644 layt{ $$Ifa$gd$V$d$$Ifa$gd$VÒҒӒԒՒ֒$d$$Ifa$gd$V$d$$Ifa$gd$V d$$Ifgd$V֒גI7($d$$Ifa$gd$Vd$$IfWDd`gd$VkdF$$IflrG )Q0v644 layt{.kduG$$IflrG )Q0v644 layt{ $$Ifa$gd$V$d$$Ifa$gd$V#7J $$Ifa$gd$V$d$$Ifa$gd$V$d$$Ifa$gd$Vd$$IfWDd`gd$VJKgiI7($d$$Ifa$gd$Vd$$IfWDd`gd$VkdSH$$IflrG )Q0v644 layt{hixy"#./456FPQVWXlmtxy”єҔٔڔ۔ܔޔ± ±±± h*ih{CJPJaJnH tH h*ih{CJPJaJnHtHh*ih{CJ\aJ h*ih{h*ih{CJPJaJh*ih{CJaJ#h*ih{CJPJaJnHo(tH=iqy.kd?I$$IflrG )Q0v644 layt{ $$Ifa$gd$V$d$$Ifa$gd$V $$Ifa$gd$V$d$$Ifa$gd$V$d$$Ifa$gd$V$d$$IfVDdWD^`$gdI1"$d$$Ifa$gd$V$d$$IfVDdWD^`$gdkd+J$$IflPrG )Q0v644 layt{.kd K$$IflerG )Q0v644 layt{ $$Ifa$gd$V$d$$Ifa$gd$V"#)/5 $$Ifa$gd$V$d$$Ifa$gd$V$d$$Ifa$gd$V$d$$IfVDdWD^`$gd~56FGI7($d$$Ifa$gd$Vd$$IfWDd`gd$VkdK$$IflrG )Q0v644 layt~GKQWX.kdL$$IflrG )Q0v644 layt{ $$Ifa$gd$V$d$$Ifa$gd$VXlmtvx $$Ifa$gd$V$d$$Ifa$gd$V$d$$Ifa$gd$Vd$$IfWDd`gd$VxyI7($d$$Ifa$gd$Vd$$IfWDd`gd$VkdM$$IflrG )Q0v644 layt{.kdN$$IflrG )Q0v644 layt{ $$Ifa$gd$V$d$$Ifa$gd$V”ʔҔڔ $$Ifa$gd$V$d$$Ifa$gd$V$d$$Ifa$gd$Vd$$IfWDd`gd$Vڔ۔ܔݔI7($d$$Ifa$gd$Vd$$IfWDd`gd$VkdmO$$IflrG )Q0v644 layt{ݔޔߔ.kdgP$$IflrG )Q0v644 layt{ $$Ifa$gd$V$d$$Ifa$gd$V $$Ifa$gd$V$d$$Ifa$gd$V$d$$Ifa$gd$Vd$$IfWDd`gd$VI=.$d$$Ifa$gd$V d$$Ifgd$VkdaQ$$IflrG )Q0v644 layt{467FGNOPbnotuvԕ#$/0567Z[cghtu°ԒԒԒ h*ih{CJPJaJnHtHh*ih{CJPJaJ#h*ih{CJPJaJnHo(tH#h*ihMCJPJaJnHo(tHh*ih{CJ\aJ h*ih{h*ih{CJaJh*ih{5CJ\aJ9:kdMR$$IflrG )Q0v644 layt{$d$$Ifa$gd$V47?GO $$Ifa$gd$V$d$$Ifa$gd$V$d$$Ifa$gd$Vd$$IfWDd`gd$VOPbcI7($d$$Ifa$gd$Vd$$IfWDd`gd$Vkd9S$$IflrG )Q0v644 layt{ciouv.kd%T$$IflrG )Q0v644 layt{ $$Ifa$gd$V$d$$Ifa$gd$Vv $$Ifa$gd$V$d$$Ifa$gd$V$d$$Ifa$gd$V$d$$IfVDdWD^`$gd~ԕՕI1"$d$$Ifa$gd$V$d$$IfVDdWD^`$gdkdU$$IflrG )Q0v644 layt~Օܕ.kdU$$IflrG )Q0v644 layt{ $$Ifa$gd$V$d$$Ifa$gd$V  $$Ifa$gd$V$d$$Ifa$gd$V$d$$Ifa$gd$Vd$$IfWDd`gd$V#$I7($d$$Ifa$gd$Vd$$IfWDd`gd$VkdV$$IflrG )Q0v644 layt{$*067.kdW$$IflrG )Q0v644 layt{ $$Ifa$gd$V$d$$Ifa$gd$V7Z[ceg $$Ifa$gd$V$d$$Ifa$gd$V$d$$Ifa$gd$Vd$$IfWDd`gd$VghtuI7($d$$Ifa$gd$Vd$$IfWDd`gd$VkdX$$IflrG )Q0v644 layt{u}.kdY$$IflrG )Q0v644 layt{ $$Ifa$gd$V$d$$Ifa$gd$V$d$$Ifa$gd$V$d$$Ifa$gd$Vd$$IfWDd`gd$VI7($d$$Ifa$gd$Vd$$IfWDd`gd$Vkd}Z$$IflrG )Q0v644 layt{ǖɖӖՖܖ$89BCDY]^lm|}õõÓpch*ihCJPJaJ h*ihCJPJaJnHtH h*ihh*ihCJaJh*ih5CJ\aJ&h*ih{5CJPJ\aJnHtHh*ih{5CJ\aJ h*ih{h*ih{CJPJaJ h*ih{CJPJaJnHtHh*ih{CJaJh*ih{CJ\aJ&.kdw[$$IflrG )Q0v644 layt{ $$Ifa$gd$V$d$$Ifa$gd$V$d$$Ifa$gd$V$d$$Ifa$gd$Vd$$IfWDd`gd$VܖݖI=.$d$$Ifa$gd$V d$$Ifgd$Vkdc\$$IflrG )Q0v644 layt{ݖ.kd]]$$IflrG )Q0v644 layt{ $$Ifa$gd$V$d$$Ifa$gd$V $$Ifa$gd$V$d$$Ifa$gd$V$d$$Ifa$gd$Vd$$IfWDd`gd$V$%I=.$d$$Ifa$gd$V d$$Ifgd$VkdW^$$IflrG )Q0v644 layt{%/9CD.kdQ_$$IflrG )Q0v644 layt{ $$Ifa$gd$V$d$$Ifa$gd$VDYZ[\]^>kdK`$$IflrG )Qv644 layt{$d$Ifa$gd$V$d$Ifa$gd$VZd$If^Z`gd$V^lmu}6kd`$$IflrG )Qv644 layt{ $$Ifa$gd$V$d$Ifa$gd$V$d$Ifa$gd$Vd$IfVDG^gd}ޗߗ&'012LbchivҘӘߘ #$%/01@AHIJZ[qrstwxyh*ihCJOJQJaJh*ih5CJ\aJ h*ihCJPJaJnHtH h*ihh*ihCJPJaJh*ihCJaJF6kda$$IflrG )Qv644 layt{ $$Ifa$gd$V$d$Ifa$gd$V$d$Ifa$gd$Vd$IfVDG^gdȗɗҗؗޗߗ9kdDb$$IflrG )Qv644 layt{$d$&dIfPa$gd$V$d$Ifa$gd$Vd$IfVDG^gdߗ@kdb$$IflrG )Qv644 layt{$d$Ifa$gd$V$d$Ifa$gd$VZd$If^Z`gd$V'12Hkdc$$IflrG )Qv644 layt{ $$Ifa$gd$V$d$Ifa$gd$V$d$Ifa$gd$V2LMT[bc7kd9d$$IflrG )Qv644 layt{$d$&dIfPa$gd$V$d$Ifa$gd$VZd$If^Z`gd$Vcdefghiv@kdd$$IflrG )Qv644 layt{$d$Ifa$gd$V$d$Ifa$gd$VZd$If^Z`gd$VvwK7Zd$If^Z`gd$Vkde$$IflrG )Qv644 layt{$d$&dIfPa$gd$V$d$Ifa$gd$VT@Zd$If^Z`gd$Vkd.f$$IflrG )Qv644 layt{$d$Ifa$gd$V$d$Ifa$gd$VҘӘژcQB$d$Ifa$gd$Vd$IfVDG^gdkdf$$IflrG )Qv644 layt{$d$Ifa$gd$Vژ fN?$d$Ifa$gd$V$d$IfVDGWD^`$gd~kd|g$$IflrG )Qv644 layt{ $$Ifa$gd$V $%01WE6$d$Ifa$gd$Vd$IfVDG^gdkd#h$$IflrG )Qv644 layt{ $$Ifa$gd$V$d$Ifa$gd$V19AIJZ[WE6$d$Ifa$gd$Vd$IfVDG^gdkdh$$IflrG )Qv644 layt{ $$Ifa$gd$V$d$Ifa$gd$V[bjqrstZH9$d$Ifa$gd$Vd$IfVDG^gdkdqi$$IflrG )Qv644 layt{$d$&dIfPa$gd$VtuvwxyzcJ;$d$Ifa$gd$V%!Zd$If^Z`gd$Vkdj$$IflrG )Qv644 layt{$d$Ifa$gd$VzZA%!Zd$If^Z`gd$Vkdj$$IflrG )Qv644 layt{$d$&dIfPa$gd$VT@Zd$If^Z`gd$Vkdfk$$IflrG )Qv644 layt{$d$Ifa$gd$V$d$Ifa$gd$VX0(<TPL HD@<e C^gdkdl$$Ifl?rG )Qv644 layt{$d$&dIfPa$gd$VϙݙʰwiT8)h*ih5CJ\aJo(6h*ih5CJKHOJPJQJ\^JaJnHtH)h*ih5CJPJ\aJnHo(tHh*ih5CJ\aJ:h*ih5B*CJOJPJQJ\aJnHo(phtH5h*ih5CJOJPJQJ\^JaJnHo(tH2h*ih5CJOJPJQJ\^JaJnHtH5h*ih-5CJOJPJQJ\^JaJnHo(tH3h*ih5B*CJOJPJQJnHo(phtH WXYZ35$d^a$gdK$d^a$gd7d^7`gd(<TPL HD@<e C^gdgd} 5:D34ѣܣ¤ä ǷǨsch*ihKCJaJnH o(tH h*ihKCJPJaJnHtH#h*ihKCJPJaJnHo(tH#h*ih:CJPJaJnHo(tHh*ihKCJaJnHtHh*ihKCJaJnHo(tHh*ihKCJaJh*ihCJaJo(h*ihCJaJ+h*ihCJOJPJQJaJnHo(tH!5¤Ĥ bcst$$IfWDd`a$gd$V $$Ifa$gd$V d^gd$;d^`;a$gd$d^a$gd$d^a$gdK brstVW567yzĻ|oaQEh*ihKCJ\aJh*ihK5PJaJnHtHh*ihK5CJ\aJh*ihPJnH tH h*ihPJnHo(tH *h*ih\]aJ h*ih h*ihCJPJaJnHtHh*ih56aJh*ihaJh*ihCJaJh*ih5CJaJ)h*ih5CJPJ\aJnHo(tHh*ih5CJ\aJo(ϩv$$IfWDd`a$gd$V $$Ifa$gd$V$$$IfWD^`$a$gd$VTkdl$$Ifl0R"$' $a t44 la1yt$VEVWn7Tkdm$$Ifl0R"$' $a t44 la1yt$V$$IfWDd`a$gd$V $$Ifa$gd$VTkd8m$$Ifl0R"$' $a t44 la1yt$VnѪv$$$IfWD^`$a$gd$VTkd8n$$Ifl0R"$' $a t44 la1yt$V$$IfWDd`a$gd$V $$Ifa$gd$V56yzo}j}}}Z$ & Fd$VDa$gdba$d$7$8$H$^a$gdK$d$^a$gdK$d^a$gd$d8^a$gdTkdn$$Ifl0R"$' $a t44 la1yt$V ofgԱձ"#ٳڳUVǸ2Źƹ$d^a$gd$d$^a$gdK$d$7$8$H$^a$gdK$ & Fd$VDa$gdbafgԱձ"UŹƹ{|bcdeõе맵еМЃr`rr`rr`rr`rr`#h*ihKCJH*PJaJnHtH h*ihKCJPJaJnHtHh*ihKPJnHtHh*ihK5CJaJh*ihKCJaJh*ihPJnHo(tHh*ihK5CJ\aJh*ihK56\aJh*ihKCJ\aJh*ihKPJaJnHtH(h*ihKCJOJPJQJaJnHtH%ƹ{| $$Ifa$gd$V$7$8$H$^a$gdK$d^a$gdK$d^a$gdKE5$$If^a$gd$VWkdo$$Ifl0x&$$ tg44 la1ytK $$Ifa$gd$VWkd8o$$Ifl0x&$$ tg44 la1ytK3dezEWkdp$$Ifl0x&$$ tg44 la1ytK $$Ifa$gd$VWkdBp$$Ifl0x&$$ tg44 la1ytKY[\]_`abBCz{_`Ĵynh*ihKB*phh*ihKCJ\aJh*ihK5CJ\aJ#h*ihKCJPJ\aJnHtHh*ihKPJaJnHtHh*ihKH*PJaJnHtHh*ihKPJnHo(tH#h*ihKCJH*PJaJnHtHh*ihKCJaJ h*ihKCJPJaJnHtH' EWkdq$$Ifl0x&$$ tg44 la1ytK $$Ifa$gd$VWkdLq$$Ifl0x&$$ tg44 la1ytK \]wtt $$Ifa$gd$VWkdVr$$Ifl0x&$$ tg44 la1ytK$$$IfWD^`$a$gdK$n$IfWD2`na$gdK E/$$$IfWD^`$a$gdKWkd`s$$Ifl0x&$$ tg44 la1ytK $$Ifa$gd$VWkdr$$Ifl0x&$$ tg44 la1ytK aby/Wkdjt$$Ifl0x&$$ tg44 la1ytK $$Ifa$gd$VWkds$$Ifl0x&$$ tg44 la1ytK$$$IfWD^`$a$gdKB{| !_`[\$dVD^a$gdK$ & FdVDa$gdba)$a$gdK$d^a$gdK $^a$gdK$7$8$H$^a$gdK$d^a$gd`[\v(X 뽩weXwD&h*ihKCJPJ\aJnHo(tHh*ihKPJnHtH#h*ihKCJPJaJnHo(tHh*ihK5CJ\aJh*ihKCJ\aJ h*ihK h*ihKOJPJQJnHtH'h*ihKCJOJQJ\aJnHtHh*ihKOJQJ#h*ihCJPJaJnHo(tH h*ihKCJPJaJnHtH(h*ihKCJOJPJQJaJnHtHQR'(XYOP}'yz;$d^a$gd$d^a$gdKgdK$dVD^a$gdK$ & FdVDa$gdba;<<=lm]$7$8$H$^a$gdK$d^a$gdK Z* 6 ijo79q`U`h*ih_CJaJ h*ih_CJPJaJnHtH4h*ihB*CJOJPJQJaJnHo(phtHh*ih5CJ\aJh*ih5CJ\aJo(h*ihKCJaJh*ihKPJnHtH#h*ihKCJPJaJnHo(tHh*ihK5CJ\aJh*ihKCJ\aJ#h*ihKCJPJ\aJnHtH!]^"uvYZ $d^a$gdKCD)*A  $7$8$H$^a$gdK$d^a$gdK$d^`a$gdK      6 7 O\ $d^`a$gdK$d^a$gdK!"ij/0$d$^a$gd_$d^a$gd_&9TPL HD@<+{^gdd^`gd$d7$8$H$^a$gdK$d^a$gdK92OP^1FG BCEFGHIJdefg~sh*ih_CJ]aJnH tH h*ih_CJ]aJ h*ih~ h*ih~CJPJaJnHtHh*ih_>*CJaJ h*ih_ h*ih_CJPJaJnHtHh*ih~CJaJnH tH h*ih~CJaJnH o(tH h*ih~CJaJh*ih_CJaJ(0Fhnd$$IfVDWD^n`gd_Qkdt$$If0p#  44 aSyt$V$nd$$IfVDWD^n`a$gd_Vd$$IfVD^Vgd_.Qkdu$$Ifq0p#  44 aSyt$Vnd$$IfVDWD^n`gd_$Vd$$IfVD^Va$gd_QkdXu$$If0p#  44 aSyt$VBn$Vd$$IfVD^Va$gd_Vd$$IfVD^Vgd_Qkd0v$$Ifq0p#  44 aSyt$Vnd$$IfVDWD^n`gd_BCDEF.Qkdw$$Ifq0p#  44 aSyt$Vnd$$IfVDWD^n`gd_$Vd$$IfVD^Va$gd_Qkdv$$Ifq0p#  44 aSyt$VFGHIfh$nd$$IfVDWD^n`a$gd_Qkd}w$$If0p#  44 aSyt$Vnd$$IfVDWD^n`gd_Vd$$IfVD^Vgd_1Qkdax$$If0p#  44 aSyt$Vnd$$IfVDWD^n`gd_Vd$$IfVD^Vgd_Qkdw$$If0p#  44 aSyt$VRSTq  # $ z |          ԷÓwewewewYYYh*ih_5CJaJ#h*ih_5CJPJaJnHtH h*ih_CJPJaJnHtHh*ih_CJaJ#h*ih_>*CJPJaJnHtH#h*ih_5CJPJaJnHtHh*ih_5CJaJ h*ih_CJPJaJnHtHh*ih_CJaJ h*ih_h*ih_>*CJaJh*ih_>*CJ]aJSTqzkZEE$\#d$VDQ^\`#a$gd_$Rd$VDb^Ra$gd_$d$^a$gd_Qkdx$$If0p#  44 aSyt$V$nd$$IfVDWD^n`a$gd_2$d$$IfVDWD^2`$gd_qr   # g$~d$$&dIfPUD]~a$gd_$d$$Ifa$gd$V$d$$&dIfPa$gd$V&d$$If^`&gd$V$\#d$VDQ^\`#a$gd_$Rd$VDb^R`a$gd_$\d$VDQ^\`a$gd_ # $ : V z { |     $>d$$&dIfPUD]>a$gd_$d$$&dIfPa$gd$V  kdEy$$Ifִr *$s    L0    44 ayt         $d$$Ifa$gd$V&d$$If^`&gd$V  kdGz$$Ifִr *$s    L0    44 ayt         $d$$Ifa$gd$V&d$$If^`&gd$V  kd={$$Ifִr *$s    L0    44 ayt        !!#!$!%!8!V!X!b!d!e!f!m!n!p!u!!!!!!!!!!!!!!" "оžоžűžžwjc h*ihh*ihCJPJaJ h*ihCJPJaJnHtHh*ihCJaJ#h*ihCJPJ]aJnHtHh*ihCJ]aJh*ih_CJPJaJ h*ih_h*ih_CJaJ h*ih_CJPJaJnHtHh*ih_CJ]aJ#h*ih_CJPJ]aJnHtH&         $d$$Ifa$gd$V&d$$If^`&gd$V  kd9|$$Ifִr *$s    L0    44 ayt   ! !!!!#!$d$$Ifa$gd$V&d$$If^`&gd$V#!$!kd5}$$Ifִr *$s    L0    44 ayt$!8!>!F!N!V!X!b!d!$d$$&dIfPa$gd$Vhd$$IfVDWD^`hgd_d!e!kd=~$$Ifִr *$s    L0    44 ayte!f!g!h!i!j!k!l!m!$d$$Ifa$gd$V&d$$If^`&gd$Vm!n!kdE$$Ifִr *$s    L0    44 aytn!u!!!!!!!!$d$$&dIfPa$gd$Vhd$$IfVDWD^`hgd_!!kdM$$Ifִr *$s    L0    44 ayt!!!!!!!!!$d$$Ifa$gd$V&d$$If^`&gd$V!!kdU$$Ifִr *$s    L0    44 ayt!!!!!!!!"$d$$Ifa$gd$V$d$$&dIfPa$gd$Vhd$$IfVDWD^`hgd_" "kd]$$Ifִr *$s    L0    44 ayt " """"""""$d$$Ifa$gd$V&d$$If^`&gd$V " """B"J"N"\"^""""""""""""""""#(#6#8#<#~######ĹՓĹĹչĬĹuau&h*ih_>*CJPJaJnHo(tHh*ih_>*CJaJ#h*ih_>*CJPJaJnHtH#h*ihCJPJ]aJnHtH h*ihh*ihCJPJaJh*ihCJaJ h*ihCJPJaJnHtHh*ihCJ]aJ h*ih_h*ih_CJaJh*ih_CJ]aJ"""kd_$$Ifִr *$s    L0    44 ayt"B"D"F"H"J"L"N"\"$d$$Ifa$gd$Vad$$If^`agd$V\"^"kdg$$Ifִr *$s    L0    44 ayt^"""""""""$d$$Ifa$gd$Vad$$If^`agd$V""kdo$$Ifִr *$s    L0    44 ayt"""""""""$d$$Ifa$gd$Vad$$If^`agd$V""kdw$$Ifִr *$s    L0    44 ayt"""""""""$d$$Ifa$gd$V&d$$If^`&gd$V""kd$$Ifִr *$s    L0    44 ayt"## #"#$#&#(#6#$d$$&dIfPa$gd$V$d$$Ifa$gd$Vad$$If^`agd$V6#8#kd$$Ifִr *$s    L0    44 ayt8#:########## $($$~d$$IfUDVD]~^a$gd_$d$$Ifa$gd$V$d$$&dIfPa$gd$V&d$$If^`&gd$V$\d$VDQ^\`a$gd_$\.d$VDQ^\`.a$gd_ #####K$N$[$]$c$d$e$$$$$$$$$$$$$$$ %%%'%)%0%1%5%6%7%>%?%A%F%a%b%g%i%y%z%%%%ƿƿѿ■Ɨƿѿ|ƿh*ih_CJPJaJh*ih_5CJ]aJh*ih_hewh*ih_CJ]aJ#h*ih_CJPJ]aJnHtH h*ih_h*ih_CJaJh*ih_5CJaJ#h*ih_5CJPJaJnHtH h*ih_CJPJaJnHtH0($L$M$N$[$\$]$c$$d$$&dIfPa$gd$V#$Ed$$&dIfPUDVD]^Ea$gd_c$d$kd$$Ifִr MJGB$jOT0    44 aytd$e$m$u$}$$$$$$d$$Ifa$gd$V&d$$If^`&gd$V$$kd$$Ifִr MJGB$jOT0    44 ayt$$$$$$$$$$d$$Ifa$gd$V&d$$If^`&gd$V$$kd͋$$Ifִr MJGB$jOT0    44 ayt$$$$$$$$$$d$$Ifa$gd$V&d$$If^`&gd$V$$kd$$Ifִr MJGB$jOT0    44 ayt$$$$$$$$$$d$$Ifa$gd$V&d$$If^`&gd$V$$kd$$Ifִr MJGB$jOT0    44 ayt$ %%%%'%)%3%5%$d$$&dIfPa$gd$Vhd$$IfVDWD^`hgd_5%6%kd!$$Ifִr MJGB$jOT0    44 ayt6%7%8%9%:%;%<%=%>%$d$$Ifa$gd$V&d$$If^`&gd$V>%?%kdE$$Ifִr MJGB$jOT0    44 ayt?%F%P%Z%b%l%r%|%%$d$$&d4$IfPa$gd$V$d$$&dIfPa$gd$Vhd$$IfVDWD^`hgd_%%kdi$$Ifִr MJGB$jOT0    44 ayt%%%%%%%%%$d$$Ifa$gd$V&d$$If^`&gd$V%%%%%%%%%%%%%%%%%%%%%%%%%%&&&&&&'&+&6&7&8&òçÛzlÎzzz^h*ih5CJ]aJh*ih_5CJ]aJ h*ihh*ih~CJPJaJh*ihCJPJaJh*ih5CJaJh*ih~CJaJ h*ihCJPJaJnHtHh*ihCJaJ#h*ihCJPJ]aJnHtHh*ihCJ]aJ h*ih_h*ih_5CJaJ$%%kd$$Ifִr MJGB$jOT0    44 ayt%%%%%%%%%$d$$Ifa$gd~$d$$Ifa$gd$V$d$$&dIfPa$gd~$d$$&dIfPa$gd$Vhd$$IfVDWD^`hgd_%%kd$$Ifִr MJGB$jOT0    44 ayt%%%%%%%%%$d$$Ifa$gd$V&d$$If^`&gd$V%%kdՔ$$Ifִr MJGB$jOT0    44 ayt%%%%%%%%%$d$$Ifa$gd~$d$$Ifa$gd$Vad$$If^`agd$V%%kd$$Ifִr MJGB$jOT0    44 ayt%& & & &&&&&$d$$Ifa$gd$Vad$$If^`agd$V&&kd$$Ifִr MJGB$jOT0    44 ayt&'&(&)&*&+&,&-&6&$d$$&dIfPa$gd$V$d$$Ifa$gd$Vad$$If^`agd$V6&7&kdA$$Ifִr MJGB$jOT0    44 ayt7&8&9&:&;&<&=&>&?&$d$$Ifa$gd$V&d$$If^`&gd$V8&<&>&?&@&S&Y&`&a&b&-';'}'~''''$(M(N(O(\(](`(n(4)5)6)U))̏shh]hsssssKs#h*ih_5CJPJaJnHtHh*ih:/CJaJh*ih~CJaJ h*ih_CJPJaJnHtHh*ih_CJaJ)h*ih5CJPJ\aJnHo(tHh*ihCJaJ h*ihCJPJaJnHtHh*ihCJ]aJ h*ihh*ih5CJPJaJ#h*ih5CJPJaJnHtHh*ih5CJaJ?&@&kde$$Ifִr MJGB$jOT0    44 ayt@&S&T&U&V&W&X&Y&`&$d$$&dIfPa$gd$V$d$$Ifa$gd$Vad$$If^`agd$V`&a&kd$$Ifִr MJGB$jOT0    44 ayta&b&((5)6)U)V))))))&d$If^`&gd$Vdgd_$\dVDQ^\`a$gd_$\#dVDQ^\`#a$gd_dWDh`gd_$dWDh^`a$gd_$d^a$gd_dgd )))))))))))))***M*U*V*W*****************+++++)+*+++1+2+F+]+q+r++++++亩#h*ih_CJPJ]aJnHtH h*ih_h*ih_CJaJ h*ih_CJPJaJnHtHh*ih_CJ]aJh*ih_>*CJaJ#h*ih_>*CJPJaJnHtH h*ih_CJPJaJnHtHh*ih_CJaJ4))))***N*O*U*$d$&dIfPUD]a$gd_$d$&dIfPa$gd$V$d$&dIfPUD]a$gd_U*V*W*'&d$If^`&gd$Vkd$$If֞r $:N"GJJ044 ayt$VW*_*g*o*w***$d$Ifa$gd$V***'&d$If^`&gd$Vkd$$If֞r $:N"GJJ044 ayt$V*******$d$Ifa$gd$V***'&d$If^`&gd$Vkd$$If֞r $:N"GJJ044 ayt$V*******$d$Ifa$gd$V***'&d$If^`&gd$Vkd$$If֞r $:N"GJJ044 ayt$V*******$d$&dIfPa$gd$V$d$Ifa$gd$V***'&d$If^`&gd$Vkd$$If֞r $:N"GJJ044 ayt$V*++++++$d$Ifa$gd$V+++'&d$If^`&gd$Vkd$$If֞r $:N"GJJ044 ayt$V++++++)+$d$&dIfPa$gd$V$d$Ifa$gd$V)+*+++'&d$If^`&gd$Vkd$$If֞r $:N"GJJ044 ayt$V++,+-+.+/+0+1+$d$Ifa$gd$V1+2+F+'&d$If^`&gd$Vkd$$If֞r $:N"GJJ044 ayt$VF+N+V+]+e+i+q+$d$Ifa$gd$Vq+r++'&d$If^`&gd$Vkd$$If֞r $:N"GJJ044 ayt$V+++++++$d$&dIfPa$gd$V$d$Ifa$gd$V+++'&d$If^`&gd$Vkd$$If֞r $:N"GJJ044 ayt$V+++++++++++++++++++ַzh\hK? *h*ih_CJaJ h*ih_CJPJaJnHtHh*ih_>*CJaJ#h*ih_>*CJPJaJnHtH&h*ih_>*CJPJaJnHo(tHh*ih_CJaJh*ih_CJ]aJ#h*ih_CJPJ]aJnHtHh*ih_CJaJ&h*ih_h5CJPJaJnHtH&h*ih_h CJPJaJnHtHh*ih_h CJ]aJ h*ih_+++++++$d$Ifa$gd$V+++'&d$If^`&gd$Vkd$$If֞r $:N"GJJ044 ayt$V+++++++$d$&dIfPa$gd$V$d$Ifa$gd$V+++' $da$gdMkd$$If֞r $:N"GJJ044 ayt$V++++,,,2,N,r,s,y,z$d$&dIfPUD]a$gd_$d$&dIfPa$gd$V$d$&dIfPUD]a$gd_&d$If^`&gd$Vdgd_$\#dVDQ^\`#a$gd_ +,,,,M,N,q,y,z,{,,,,,,,,,,,,,,,,,,,,-------"-#-/-7-;-@-A-B-C-D-F-G-H-N-O-c-i-s-y-z----------ѿݿݿݿѿh*ih_CJPJaJ#h*ih_CJPJ]aJnHtHh*ih_CJ]aJ h*ih_h*ih_CJaJ h*ih_CJPJaJnHtHAy,z,{,'&d$If^`&gd$Vkd˧$$If֞r $:N"GJJ044 ayt$V{,,,,,,,$d$Ifa$gd$V,,,'&d$If^`&gd$Vkd̨$$If֞r $:N"GJJ044 ayt$V,,,,,,,$d$Ifa$gd$V,,,'&d$If^`&gd$Vkd$$If֞r $:N"GJJ044 ayt$V,,,,,,,$d$Ifa$gd$V,,-'&d$If^`&gd$Vkd$$If֞r $:N"GJJ044 ayt$V-------$d$&dIfPa$gd$V$d$Ifa$gd$V---'&d$If^`&gd$Vkd$$If֞r $:N"GJJ044 ayt$V---- -!-"-$d$Ifa$gd$V"-#-7-'&d$If^`&gd$Vkd$$If֞r $:N"GJJ044 ayt$V7-8-9-:-;-<-F-$d$&dIfPa$gd$V$d$Ifa$gd$VF-G-H-'&d$If^`&gd$Vkd$$If֞r $:N"GJJ044 ayt$VH-I-J-K-L-M-N-$d$Ifa$gd$VN-O-c-'&d$If^`&gd$Vkd$$If֞r $:N"GJJ044 ayt$Vc-k-s-z----$d$Ifa$gd$V---'&d$If^`&gd$Vkd$$If֞r $:N"GJJ044 ayt$V-------$d$&dIfPa$gd$V$d$Ifa$gd$V---'&d$If^`&gd$Vkd$$If֞r $:N"GJJ044 ayt$V-----------------..///////%0?0c0m0n011ܽ|||gVVVVVVVV h*ih_CJPJaJnHtH)h*ih_5CJPJ\aJnHo(tH h*ih_CJPJaJnHtHh*ih_CJaJh*ih_CJ]aJ#h*ih_CJPJ]aJnHtH h*ih_h*ih_CJaJ&h*ih_h5CJPJaJnHtH&h*ih_h CJPJaJnHtHh*ih_h CJ]aJ -------$d$Ifa$gd$V---'&d$If^`&gd$Vkd$$If֞r $:N"GJJ044 ayt$V-------$d$&dIfPa$gd$V$d$Ifa$gd$V---'dgdkdƲ$$If֞r $:N"GJJ044 ayt$V-P.Q.//11*1+1O1P1111}&d$If^`&gd$V$\dVDQ^\`a$gd_$\#dVDQ^\`#a$gd_d$gdM$d^a$gd_$ & F da$gdbadVD^gd_$`dVDh^`a$gd_11*1+1,1M1O1P1111122 2!2Q2R2S2Y2Z2b222222̺{j{c{c{c{Q{D{ch*ih_CJPJaJ#h*ih_CJPJ]aJnHtH h*ih_ h*ih_CJPJaJnHtHh*ih_CJaJh*ih_CJ]aJh*ih_CJaJ h*ih_CJPJaJnHtHh*ih_>*CJaJ#h*ih_>*CJPJaJnHtHh*ih_CJaJnH tH #h*ih_5CJPJaJnHtH#h*ih_CJPJaJnHo(tH111111222r$d$&dIfPUD]a$gd_$d$&dIfPa$gd$V$d$&dIfPUD]a$gd_$Jd$IfUDVD]^Ja$gd_$bd$&dIfPUD]ba$gd_2 2%kdճ$$If֞rq8%FLN" 3A?044 ayte 2!2)21292A2I2Q2$d$Ifa$gd$V&d$If^`&gd$VQ2R2%kd$$If֞rq8%FLN" 3A?044 ayteR2S2T2U2V2W2X2Y2$d$Ifa$gd$V&d$If^`&gd$VY2Z2%kd$$If֞rq8%FLN" 3A?044 ayteZ22222222$d$4$Ifa$gd$V$d$Ifa$gd$V&d$If^`&gd$V22%kd$$If֞rq8%FLN" 3A?044 ayte2223 333$3%3&3m3n3p3v3x3|3~3333333ƹxxxq_S_Hh*ih-9CJaJh*ih-9CJ]aJ#h*ih-9CJPJ]aJnHtH h*iheh*iheCJaJ h*iheCJPJaJnHtHh*iheCJ]aJ#h*iheCJPJ]aJnHtH h*ih_h*ih_CJPJaJ h*ih_CJPJaJnH tH #h*ih_CJPJaJhnH tH h*ih_CJ]aJh*ih_CJaJ223 3333$3$d$4$Ifa$gd$V$d$Ifa$gd$V&d$If^`&gd$V$3%3%kd'$$If֞rq8%FLN" 3A?044 ayte%3n3p3v3x3|3~33$d$Ifa$gd$V&d$If^`&gd$V33%kd=$$If֞rq89FLN" >A?044 ayte33334444$d$Ifa$gd$V&d$If^`&gd$V333444444L4X4Y4u4v4444444445 5"56585@5A5f5g55555555555556"666i6˿˿˜˜˜˴˴h*ih_CJaJ h*ih_CJPJaJnHtH h*iheCJPJaJnHtH h*iheh*iheCJaJh*iheCJ]aJ#h*iheCJPJ]aJnHtH h*ih-9h*ih-9CJaJ h*ih-9CJPJaJnHtH.44%kdS$$If֞rq89FLN" >A?044 ayte4Y4]4a4e4k4o4u4$d$Ifa$gd$V&d$If^`&gd$Vu4v4%kdi$$If֞rq89FLN" >A?044 aytev44444444$d$Ifa$gd$V&d$If^`&gd$V44%kd$$If֞rq89FLN" >A?044 ayte44444444$d$Ifa$gd$V&d$If^`&gd$V44%kd$$If֞rq89FLN" >A?044 ayte4 5"5*5256585@5$d$Ifa$gd$V&d$If^`&gd$V@5A5%kd$$If֞rq89FLN" >A?044 ayteA5g5o5w5}5555$d$Ifa$gd$V&d$If^`&gd$V55%kd$$If֞rq89FLN" >A?044 ayte55555555$d$&d4$IfPa$gd$V$d$&dIfPa$gd$V&d$If^`&gd$V55%kd$$If֞rq89FLN" >A?044 ayte55i6j666777,7}e$d$$&dIfPa$gd$Vd$$If^`gd$V$Hd$VD^^Ha$gd_Hd$VD^^Hgd_$\#d$VDQ^\`#a$gd_dgd$[dVDnWD^[`a$gd_$>dVDaWD^`>a$gd_ i6j6k66677777777777777778!8#8,8-8?8@8`8b8k8l8m8n8888ػ{{{o]"h*ih_5CJ\aJnH tH h*ih_CJ]aJ#h*ih_CJPJ]aJnHtH h*ih_ h*ih_CJPJaJnHtHh*ih_CJaJh*ih_CJaJ h*ih_CJPJaJnHtHh*ih_>*CJaJ#h*ih_>*CJPJaJnHtH)h*ih_5CJPJ\aJnHo(tH$,7-7:7P7l7777$d$$&dIfPUD]a$gd_$d$$&dIfPa$gd$V$Gd$$&dIfPUD]Ga$gd_77%kd$$If֞rga\TQN";<<044 ayt$V77777777$d$$Ifa$gd$Vd$$If^`gd$V77%kd$$If֞rga\TQN";<<044 ayt$V77777777$d$$Ifa$gd$Vd$$If^`gd$V77%kd$$If֞rga\TQN";<<044 ayt$V77777777$d$$Ifa$gd$Vd$$If^`gd$V77%kd$$If֞rga\TQN";<<044 ayt$V78888!8#8,8$d$$Ifa$gd$Vd$$If^`gd$V,8-8%kd$$If֞rga\TQN";<<044 ayt$V-8@8H8P8X8`8b8k8$d$$&dIfPa$gd$Vd$$If^`gd$Vk8l8%kd$$If֞rga\TQN";<<044 ayt$Vl8m888888999'9ww_$d$&dIfPa$gd$V$d$&dIfPUD]a$gd_$]d$&dIfPUD]]a$gd_&d$If^`&gd$V$`d$VDh^`a$gd_;d$WD^`;gd_$\#d$VDQ^\`#a$gd_ 8888C9f9n9o9p999999999999999?:@:G:H:O:U:\:f:g:h::::::!;ͼ͵͵͵ͣͼ͖͵؅sͅͼ͵gh*ih-9CJ]aJ#h*ih_CJPJaJhnH tH h*ih_CJPJaJnH tH h*ih_CJPJaJ#h*ih_CJPJ]aJnHtH h*ih_ h*ih_CJPJaJnHtHh*ih_CJaJh*ih_CJ]aJh*ih_CJaJ h*ih_CJPJaJnHtH&'9C9g9h9n9$d$&dIfPUD]a$gd_$d$&dIfPa$gd$Vn9o9%kd$$If֞rp5 =AN" 2@E044 ayteo9p9x999999$d$Ifa$gd$V&d$If^`&gd$V99%kd $$If֞rp5 =AN" 2@E044 ayte99999999$d$Ifa$gd$V&d$If^`&gd$V99%kd$$If֞rp5 =AN" 2@E044 ayte99999999$d$4$Ifa$gd$V$d$Ifa$gd$V&d$If^`&gd$V99%kd+$$If֞rp5 =AN" 2@E044 ayte9@:H:O:U:\:^:f:$d$4$Ifa$gd$V$d$Ifa$gd$V&d$If^`&gd$Vf:g:%kdA$$If֞rp5 =AN" 2@E044 ayteg::::::::$Vd$IfVDWDX^V`a$gd_$d$Ifa$gd$Vd$$If^`gd$V::%kdW$$If֞rp54vON" =(=044 ayt$V:";);/;1;3;5;<;$Vd$IfVDWDX^V`a$gd_$d$Ifa$gd$Vd$$If^`gd$V!;";3;5;<;=;>;y;;;;;;;;;;;;;<"<$<(<*<,<F<J<Z<\<<<<<<=2=4=d=h=t=v=x=ʸwwlh*ih_CJaJ#h*ih_CJPJaJnHo(tH h*ih_ h*ih_CJPJaJnHtHh*ih_CJaJh*ih_CJ]aJ#h*ih_CJPJ]aJnHtH h*ih-9 h*ih-9CJPJaJnHtHh*ih-9CJaJ#h*ih-9CJPJ]aJnHtH*<;=;%kdm$$If֞rp54vON" =(=044 ayt#=;;;;;;;;$d$Ifa$gd$V&d$If^`&gd$V;;%kd$$If֞rp54=AN" =@E044 ayte;;;;;;;;$d$Ifa$gd$V&d$If^`&gd$V;;%kd$$If֞rp54=AN" =@E044 ayte;<"<,<<<F<J<Z<$d$Ifa$gd$V&d$If^`&gd$VZ<\<%kd$$If֞rp54=AN" =@E044 ayte\<<<<<<<<$d$Ifa$gd$V&d$If^`&gd$V<=%kd$$If֞rp54=AN" =@E044 ayte=4=@=L=X=d=h=t=$d$&d4$IfPa$gd$V$d$&dIfPa$gd$V&d$If^`&gd$Vt=v=%kd$$If֞rp54=AN" =@E044 aytev=x=S>T>>> ???#?$?1?G?c??||||||$d$$&dIfPa$gd$Vd$$If^`gd$VHd$VD^^Hgd_$Hd$VD^^Ha$gd_$\#d$VDQ^\`#a$gd_dgd$[d$VDnWD^[`a$gd_x== >S>T>U>v>>> ?????????????@@#@$@6@Ͻ{jc{c{cQ{cQ{j{cQ#h*ih_CJPJ]aJnHtH h*ih_ h*ih_CJPJaJnHtHh*ih_CJaJh*ih_CJaJ h*ih_CJPJaJnHtHh*ih_CJaJnH tH h*ih_>*CJaJ#h*ih_>*CJPJaJnHtH)h*ih_5CJPJ\aJnHo(tHh*ih_CJaJ h*ih_CJPJaJnHtH???$d$$&dIfPa$gd$V??%kd$$If֞  r#'Nnoo0%44 aSyt$V????????$d$$Ifa$gd$Vd$$If^`gd$V??%kd$$If֞  r#'Nnoo0%44 aSyt$V????????$d$$Ifa$gd$Vd$$If^`gd$V??%kd$$If֞  r#'Nnoo0%44 aSyt$V????????$d$$Ifa$gd$Vd$$If^`gd$V??%kd$$If֞  r#'Nnoo0%44 aSyt$V??@@@@@#@$d$$Ifa$gd$Vd$$If^`gd$V#@$@%kd$$If֞  r#'Nnoo0%44 aSyt$V$@7@?@G@M@U@V@_@$d$$&dIfPa$gd$Vd$$If^`gd$V6@7@C@E@_@`@a@z@{@@@@@@@@@=AHAIAJAjAkAlAmApArAŴŴŴŴŴŎoY+h*ih_>*CJOJPJQJaJnHtHh*ih_>*CJOJQJaJh*ih_CJOJQJaJ(h*ih_CJOJPJQJaJnHtH h*ih_CJPJaJnH tH h*ih_CJPJaJnHtHh*ih_CJaJ h*ih_ h*ih_CJPJaJnHtHh*ih_CJaJh*ih_CJ]aJ_@`@a@%Hd$VD^^Hgd_kd$$If֞  r#'Nnoo0%44 aSyt$Va@z@{@HAIAJAkAlAmAURkd$$If40#& 9!44 aSf4yt$V%$!d$&dIfPa$gd$V$d$IfWD^`$gd$V$RdVDb^Ra$gd_6dVDWD^`6gd_mArAwAxAyAAArcc$d$Ifa$gd$V$d$IfWD^`$gd$Vbkdv$$IfFu#&9!    44 aSyt$V%$!d$Ifa$gd$VrAuAwAxAAAAAAAAAAAAAABB B&B'B*B+B,B@BABFBKBOB\B_B`BrB~BBBC*CCCCCCCCCDDDDFD[DòáááááÒòòòòòòòÒÒÒòh*ih_CJaJnH tH h*ih_CJPJaJnH tH h*ih_CJPJaJnHtHh*ih_CJaJ h*ih_+h*ih_>*CJOJPJQJaJnHtH'h*ih_>*CJOJQJaJnHtH3AAAAAr$d$Ifa$gd$V$d$Ifa$gd$V d$Ifgd$Vbkd$$IfFu#&9!    44 aSyt$VAAAAA~~$d$Ifa$gd$V$d$Ifa$gd$Vbkdr$$IfFu#&9!    44 aSyt$VAAAAA||$d$Ifa$gd$V$d$Ifa$gd$Vdkd$$IfFu#&9!    44 aSyt$VAAAAB~~$d$Ifa$gd$V$d$Ifa$gd$Vbkdr$$IfFu#&9!    44 aSyt$VBB BB&Buu$d$&dIfPa$gd$V$d$Ifa$gd$Vbkd$$IfFu#&9!    44 aSyt$V&B'B(B)B*B$d$Ifa$gd$V d$Ifgd$Vbkdt$$IfFu#&9!    44 aSyt$V*B+B,B6B@Bww$d$&d4$IfPa$gd$V d$Ifgd$Vbkd$$IfFu#&9!    44 aSyt$V@BABBBCC)C*C[D\DpDqD~~~~~vf^dgd_d^`gddgd$d^a$gd_$d^a$gd_bkdv$$IfFu#&9!    44 aSyt$V [D\D_DbDoDpDqDrDuDwDzD|D}DDDDDDƸۤs_sXXG4$h*ih_CJOJQJaJnHtH h*ih_CJOJPJ QJaJ h*ih_'h*ih_>*CJOJQJaJnHtH+h*ih_>*CJOJPJQJaJnHtHh*ih_>*CJOJQJaJh*ih_CJaJ&h*ih_5CJPJ\aJnHtHh*ih5CJ\aJ)h*ih5CJPJ\aJnHo(tHh*ih5CJ\aJo()h*ih5CJPJ\aJnHo(tHqDrDwD|D}D~DDDtee$d$Ifa$gd$Vbkd$$IflF]-#8!    44 la1yt$V%$!d$Ifa$gd$VHd$If^H`gd$VDDDDDs^'$ d$Ifa$gd$V'$ d$Ifa$gd$VHd$If^H`gd$Vbkd[$$IflF]-#8!    44 la1yt$VDDDDDDDDDDDE&E'E(EKELEYEZE[E]E^E_EmEnEoEtEuEEEEEEEEEEFFF1F8F9F:F[FfFgFhFjFkFlFzF{F|Fչչչ湬湬湥չ湬湬չչ湬湬h*ih}CJaJ h*ih}h*ih_CJPJaJh*ih_CJaJ h*ih_CJOJPJ QJaJ h*ih_CJPJaJnHtH h*ih_#h*ih_>*CJOJPJ QJaJ5DDDDDss'$ d$Ifa$gd$VHd$If^H`gd$Vbkd$$IflF]-#8!    44 la1yt$VDDDDD~~ $$Ifa$gd$Vd$IfWDd`gd$Vbkd)$$IflF]-#8!    44 la1yt$VDDE!E'Eww $$Ifa$gd$V & F =d$1$If^=`gdbabkd$$IflF]-#8!    44 la1yt$V'E(ELESEZEnb $$Ifa$gd$V$$&dIfPa$gd$V & F =d$1$If^=`gdbabkd$$IflF]-#8!    44 la1yt$VZE[E\E]E^E $$Ifa$gd$V d$Ifgd$Vbkda$$IflF]-#8!    44 la1yt$V^E_E`EgEnE $$Ifa$gd$V d$Ifgd$Vbkd$$IflF]-#8!    44 la1yt$VnEoEEEEoc $$Ifa$gd$V$$&dIfPa$gd$Vd$IfVDWD^`gd_bkdQ$$IflF]-#8!    44 la1yt$VEEEEE $$Ifa$gd$V d$Ifgd$Vbkd$$IflF]-#8!    44 la1yt$VEEEEF $$Ifa$gd$V d$Ifgd$Vbkd3$$IflF]-#8!    44 la1yt$VFF1F3F9F $$Ifa$gd$V d$Ifgd$Vbkd$$IflF]-#8!    44 la1yt$V9F:F[FaFgF{o $$Ifa$gd$V$$&dIfPa$gd$V d$Ifgd$Vbkd$$IflF]-#8!    44 la1yt$VgFhFiFjFkF $$Ifa$gd$V d$Ifgd$Vbkd$$IflF]-#8!    44 la1yt$VkFlFmFtF{F{f$$&dIfPa$gd_$$&dIfPa$gd$V d$Ifgd$Vbkd$$IflF]-#8!    44 la1yt_{F|F}FFFFFFr^JJ%$!d$Ifa$gd$VHd$If^H`gd$V0d^`0gd_d^`gddgddkdo$$IflPF]-#8!    44 la1yt_|F}FFFFFFFFFFFFFFFFFFFFFFFFFFGG GG.G²•„qb•QQQ h*ih_CJPJaJnHtHh*ih_CJaJnH tH $h*ih_CJOJQJaJnHtH h*ih_CJOJPJ QJaJ h*ih_+h*ih_>*CJOJPJQJaJnHtHh*ih_>*CJOJQJaJh*ih_CJaJh*ih5CJ\aJh*ih5CJ\aJo()h*ih5CJPJ\aJnHo(tHFFFFFyy$d$Ifa$gd$VHd$If^H`gd$Vbkd$$IflF]-#8!    44 la1yt$VFFFFFs^'$ d$Ifa$gd$V'$ d$Ifa$gd$VHd$If^H`gd$VbkdA$$IflF]-#8!    44 la1yt$VFFFFF$d$Ifa$gd$V d$Ifgd$Vbkd$$IflF]-#8!    44 la1yt$VFFFFG$d$Ifa$gd$V d$Ifgd$Vbkd$$IflF]-#8!    44 la1yt$VGG(G.G4Gxx$d$&dIfPa$gd$V d$Ifgd$Vbkds$$IflF]-#8!    44 la1yt$V.G4G5G8G9GAGHGIGJGLGMGYGZGcGiGjGmGnGoGvG}G~GGGHHHHHHIIIIIII JJ#J$JJJJ+K:K?KIKMK`KaKbKݿݥ݂ h*ih_CJPJaJnH tH #h*ih~CJPJaJnHo(tHh*ih~CJaJh*ih_CJOJQJaJ#h*ih_CJPJaJnHo(tH *h*ih_CJaJh*ih_CJaJ h*ih_ h*ih_CJPJaJnHtH34G5G6G7G8G$d$Ifa$gd$V d$Ifgd$Vbkd$$IflF]-#8!    44 la1yt$V8G9G:GAGHG$d$Ifa$gd$V d$Ifgd$VbkdG$$IflF]-#8!    44 la1yt$VHGIGJGKGLG$d$Ifa$gd$V d$Ifgd$Vbkd$$IflF]-#8!    44 la1yt$VLGMGZGcGiGxx$d$&dIfPa$gd$V d$Ifgd$Vbkd$$IflF]-#8!    44 la1yt$ViGjGkGlGmGyy#$d$Ifa$gd$VHd$If^H`gd$Vbkd$$IflF]-#8!    44 la1yt$VmGnGoGvG}Gkk$d$&dIfPa$gd$V%!Hd$If^H`gd$Vbkd$$IflF]-#8!    44 la1yt$V}G~GGHHHH$J%JcKdKKKqqq$`dVDh^`a$gd_$d^a$gd_ $da$gd_bkdY$$IflF]-#8!    44 la1yt$V bKcKKKKKKKKKKKKKKL L LLL#L*L+L.L/L6L:LULXL^L_L`LcLfLí{{jWj{{{$h*ih_CJOJQJaJnHtH h*ih_CJOJPJ QJaJ h*ih_+h*ih_>*CJOJPJQJaJnH tH (h*ih_CJOJPJQJaJnHtH+h*ih_>*CJOJPJQJaJnHtHh*ih_>*CJOJQJaJ h*ih_CJPJaJnHtHh*ih_CJaJ h*ih_CJPJaJnH tH !KKKKKKKK|mm$d$Ifa$gd$Vbkd$$IflFp#      44 la1yt$V%$!d$Ifa$gd$V d$Ifgd$VKKKK L{f'$ d$Ifa$gd$V'$ d$Ifa$gd$V d$Ifgd$Vbkd'$$IflFp#      44 la1yt$V L LL#L*Lu]$d$&dIfPa$gd$V$d$&d4$IfPa$gd$V d$Ifgd$Vdkd$$IfltFp#      44 la1yt$V*L+L,L-L.L#$d$Ifa$gd$V d$Ifgd$Vbkd$$IflFp#      44 la1yt$V.L/LfLmLtL#$d$Ifa$gd$V d$Ifgd$Vbkdc$$IflFp#      44 la1yt$VfLmLtLuLLLLLMMM MM>MDMLMMMMMMMMMMMMMMMN+N7N8N:N;N?NCNDNSN]NsNNNNNNNNNNNNNOOO O O O&h*ih_hCJPJaJnHtH h*ih_CJPJaJnH tH h*ih_CJaJhnH tH h*ih_CJaJ h*ih_ h*ih_CJPJaJnHtHh*ih_CJaJnH tH :tLuLLLL#$d$Ifa$gd$V d$Ifgd$Vbkd$$IflFp#      44 la1yt$VLLMM M}}#$d$Ifa$gd$Vd$Ifgd$Vbkd7$$IflFp#      44 la1yt$V MM>MDMLM#$d$Ifa$gd$V d$Ifgd$Vbkd$$IflFp#      44 la1yt$VLMMMMMM#$d$Ifa$gd$V d$Ifgd$Vbkd $$IflFp#      44 la1yt$VMMMMM#$d$Ifa$gd$V d$Ifgd$Vbkdu$$IflFp#      44 la1yt$VMMMMM#$d$Ifa$gd$V d$Ifgd$Vbkd$$IflFp#      44 la1yt$VMM;N?NCNww#$d$Ifa$gd$VPd$IfWD^`Pgd$VbkdI$$IflFp#      44 la1yt$VCNDNNNNww#$d$Ifa$gd$VPd$IfWD^`Pgd$Vbkd$$IflFp#      44 la1yt$VNNNNN#$d$Ifa$gd$V d$Ifgd$Vbkd$$IflFp#      44 la1yt$VNNNOOxx#$d$&dIfPa$gd$V d$Ifgd$Vbkd$$IflFp#      44 la1yt$VOO O O O#$d$Ifa$gd$V d$Ifgd$Vbkd$$IflFp#      44 la1yt$V O O$O+O2Oss$d$&dIfPa$gd$V%!d$Ifgd$Vbkd[$$IflFp#      44 la1yt$V OOO$O+O2O3O4O:O;OOOOOOOOPPWPYPZP]Pѫy^J:h*ih_>*CJOJQJaJ&h*ih_5CJPJ\aJnHtH4h*ihB*CJOJPJQJaJnHo(phtHh*ih5CJ\aJh*ih5CJ\aJo()h*ih5CJPJ\aJnHo(tHh*ih_5CJ\aJ h*ih_ h*ih_CJPJaJnHtHh*ih_CJaJ(h*ih_CJOJPJQJaJnHtHh*ih_CJOJQJaJ2O3O4O;OOOP}ldTd^`gddgd$RdVDb^Ra$gd_$dVDbWD^`a$gd_dgd_bkd$$IflFp#      44 la1yt$VPPXPYPZP_PdP%$!d$Ifa$gd$Vd$IfWD^`gd$Vdgd_ d`gd_&9TPL HD@<+{^gd]P_PbPdPePmPnPvPwPyPPPPPPPPPPPP>Q?Q@QPQaQbQnQoQrQsQQQQQQQQQQQQQQQQRRRRGRMRNRORQRǶǶǶǩǩǩǚҶǶǶҶljǩǶǩǶҶ h*ih_CJPJaJnH tH h*ih_CJaJnH tH h*ih_CJPJaJ h*ih_CJPJaJnHtHh*ih_CJaJ h*ih_h*ih_>*CJOJQJaJ+h*ih_>*CJOJPJQJaJnHtH6dPePfPnPvPww$d$Ifa$gd$Vd$IfWD^`gd$Vbkd/$$IflF$&!    44 la1yt$VvPwPxPyPPwh#$d$Ifa$gd$V#$d$Ifa$gd$Vd$IfWD^`gd$Vbkd$$IflF$&!    44 la1yt$VPPPPPui $$Ifa$gd$V#$d$Ifa$gd$Vsd$IfVDWD^`sgd_bkd$$IflF$&!    44 la1yt$VPPPPPui $$Ifa$gd$V#$d$Ifa$gd$Vsd$IfVDWD^`sgd_bkd$$IflF$&!    44 la1yt$VPP3Q9Q?Qui $$Ifa$gd$V#$d$Ifa$gd$Vsd$IfVDWD^`sgd_bkd$$IflF$&!    44 la1yt$V?Q@QbQhQnQll#$d$&dIfPa$gd$Vsd$IfVDWD^`sgd_bkd{$$IflF$&!    44 la1yt$VnQoQpQqQrQuu#$d$Ifa$gd$Vsd$IfVDWD^`sgd_bkd$$IflF$&!    44 la1yt$VrQsQQQQll#$d$&dIfPa$gd$Vsd$IfVDWD^`sgd_bkdk$$IflF$&!    44 la1yt$VQQQQQuu#$d$Ifa$gd$Vsd$IfVDWD^`sgd_bkd$$IflF$&!    44 la1yt$VQQQQQui $$Ifa$gd$V#$d$Ifa$gd$Vsd$IfVDWD^`sgd_bkd[$$IflF$&!    44 la1yt$VQQR RRui $$Ifa$gd$V#$d$Ifa$gd$Vsd$IfVDWD^`sgd_bkd$$IflF$&!    44 la1yt$VRRARGRMRll#$d$&dIfPa$gd$Vsd$IfVDWD^`sgd_bkdQ$$IflF$&!    44 la1yt$VMRNRORPRQRuu#$d$Ifa$gd$Vsd$IfVDWD^`sgd_bkd$$IflF$&!    44 la1yt$VQRRRRRRll#$d$&dIfPa$gd$Vsd$IfVDWD^`sgd_bkdG$$IflF$&!    44 la1yt$VQRRRSRdRRRRRRRRRRRRR"S#S%S/S1S2SSSSSSSSSSSSSSSSSS+T6T7T8TYTZT[TjTkTTTTTTTT)h*ih5CJPJ\aJnHo(tH h*ih_CJPJaJnH tH h*ih_CJPJaJh*ih~CJaJ#h*ihMCJPJaJnHo(tH h*ih_CJPJaJnHtHh*ih_CJaJ h*ih_6RRRRRuu#$d$Ifa$gd$Vsd$IfVDWD^`sgd_bkd$$IflF$&!    44 la1yt$VRRRRRll#$d$&dIfPa$gd$Vsd$IfVDWD^`sgd_bkd7$$IflF$&!    44 la1yt$VRRRRRuu#$d$Ifa$gd$Vsd$IfVDWD^`sgd_bkd$$IflF$&!    44 la1yt$VRR%S+S1Sll#$d$&dIfPa$gd$Vsd$IfVDWD^`sgd_bkd'$$IflF$&!    44 la1yt$V1S2SSSSll#$d$&dIfPa$gd$Vsd$IfVDWD^`sgd~bkd$$IflF$&!    44 la1yt$VSSSSS#$d$Ifa$gd$V d$Ifgd$Vbkd$$IflF$&!    44 la1yt$VSSSSSui $$Ifa$gd$V#$d$Ifa$gd$Vsd$IfVDWD^`sgd_bkd$$IflF$&!    44 la1yt$VSS+T1T7Ti] $$Ifa$gd$V$sd$IfVDWD^`sa$gd_sd$IfVDWD^`sgd_bkd$$IflF$&!    44 la1yt$V7T8TTTTui $$Ifa$gd$V#$d$Ifa$gd$Vsd$IfVDWD^`sgd~bkd$$IflF$&!    44 la1yt$VTTTTTll#$d$&dIfPa$gd$Vsd$IfVDWD^`sgd_bkd$$IflF$&!    44 la1yt$VTTTTTTTT|fRR%$!d$Ifa$gd$V{d$IfWD^{`gd$Vdgd_d^`gdd$gdbkdu$$IflF$&!    44 la1yt$VTTTTTTTTTTTTTUUUUUHUJUKUMUSUtUzUͿvveR$h*ih_CJOJQJaJnHtH h*ih_CJPJaJnHtH h*ih_CJOJPJ QJaJ h*ih_+h*ih_>*CJOJPJQJaJnHtHh*ih_>*CJOJQJaJh*ih_CJaJh*ih_5CJ\aJh*ih5CJ\aJ)h*ih5CJPJ\aJnHo(tHh*ih5CJ\aJo(TTTUUww$d$Ifa$gd$V{d$IfWD^{`gd$Vbkd$$IflF$&!    44 la1yt$VUUUUUq\'$ d$Ifa$gd$V'$ d$Ifa$gd$V{d$IfWD^{`gd$Vbkd_$$IflF$&!    44 la1yt$VUUHUIUJUqq'$ d$Ifa$gd$V{d$IfWD^{`gd$Vbkd$$IflF$&!    44 la1yt$VJUKUtUzU|Uqq'$ d$Ifa$gd$V{d$IfWD^{`gd$VbkdI$$IflF$&!    44 la1yt$VzU{U|U}UUUUUUUUUUUUUUUUUUUVVVV6V7VrWsWuWȷȣ{ȷnȷȷȷȷ\Mh*ih5CJ\aJo(#h*ihCJPJaJnHo(tHh*ih_CJPJ aJ$h*ih_CJOJQJaJnHtH(h*ih_CJOJPJQJaJnHtH'h*ih_CJOJQJaJhnHtH h*ih_CJPJaJnHtHh*ih_CJaJ h*ih_ h*ih_CJOJPJ QJaJ(h*ih_CJOJPJ QJaJnHtH|U}UUUUii'$ d$&dIfPa$gd$V{d$IfWD^{`gd$Vbkd$$IflF$&!    44 la1yt$VUUUUUqq'$ d$Ifa$gd$V{d$IfWD^{`gd$Vbkd-$$IflF$&!    44 la1yt$VUUUUUnn$d$&dIfPa$gd$VPd$IfWD^`Pgd$Vbkd$$IflF$&!    44 la1yt$VUUUrWsWWWXXpYyiiZZZ$d^a$gd_d^`gdd$gd$d^a$gd_ d^gd_bkd$$IflF$&!    44 la1yt$V uWxWyWWWWX6XCXGXIXJXMXXXXXXYYY%Y4YnYpYqYtYxYYYYYYYYYYYYY±±±±±±±±±±~l~lee h*ih_#h*ih_>*CJPJaJnHtHh*ih_>*CJaJ)h*ih_5CJPJ\aJnHo(tH#h*ihCJPJaJnHo(tH h*ih_CJPJaJnHtHh*ih_CJaJh*ih5CJ\aJh*ih5CJ\aJo()h*ih5CJPJ\aJnHo(tH'pYqYYYYYYYYYYbbkd$$IflFp#      44 la1yt$V$d$Ifa$gd$V d$Ifgd$Vdgd_dgd$d$^a$gd YYYYYr#$d$Ifa$gd$V#$d$Ifa$gd$V d$Ifgd$Vbkd$$IflFp#      44 la1yt$VYYYYYYYZ&Z0Z9Z:Z=Z>Z?ZGZOZPZQZSZTZZZZZZZZZZZZZZZZZZZZZ5[>[?[@[B[C[D[K[R[S[T[V[W[y[ݻݙݙݙh*ih_h-CJPJaJ(h*ih_CJOJPJQJaJnHtHh*ih_CJPJaJ$h*ih_CJOJQJaJnHtHh*ih_CJOJQJaJ h*ih_h*ih_CJaJ h*ih_CJPJaJnHtH6YYYYY#$d$Ifa$gd$V d$Ifgd$VbkdW$$IflFp#      44 la1yt$VYY'Z0Z9Zpp#$d$&dIfPa$gd$Vd$If^`gd$Vbkd$$IflFp#      44 la1yt$V9Z:Z;ZZ?ZGZOZqq$d$&dIfPa$gd$V%!d$Ifgd$Vdkd$$Ifl)Fp#      44 la1yt$VOZPZQZRZSZ||$d$Ifa$gd$V%!d$Ifgd$Vbkd$$IflFp#      44 la1yt$VSZTZZZZrf $$Ifa$gd$V$d$Ifa$gd$V%!d$IfWD^`gd$Vbkdg$$IflFp#      44 la1yt$VZZZZZrf $$Ifa$gd$V$d$Ifa$gd$V%!d$IfWD^`gd$Vbkd$$IflFp#      44 la1yt$VZZZZZrf $$Ifa$gd$V$d$Ifa$gd$V%!d$IfWD^`gd$Vbkd;$$IflFp#      44 la1yt$VZZ,[5[>[pp#$d$&dIfPa$gd$Vd$If^`gd$Vbkd$$IflFp#      44 la1yt$V>[?[@[A[B[||$d$Ifa$gd$V%!d$Ifgd$Vbkd$$IflFp#      44 la1yt$VB[C[D[K[R[ss$d$&dIfPa$gd$V%!d$Ifgd$Vbkdy$$IflFp#      44 la1yt$VR[S[T[U[V[||$d$Ifa$gd$V%!d$Ifgd$Vbkd$$IflFp#      44 la1yt$VV[W[y[[[ss$d$&dIfPa$gd$V%!d$Ifgd$VbkdM$$IflFp#      44 la1yt$Vy[[[[[[[[[\\\\\\\\\\\\\\\\\\\\\\\\\\\\]<]_]n]]]]^^^^)^:^I^S^T^g^h*ih_CJaJnH tH  *h*ih_CJaJ#h*ih_>*CJPJaJnHtHh*ih_>*CJaJ h*ih:/CJPJaJnHtHh*ih:/CJaJ h*ih_ h*ih_CJPJaJnHtHh*ih_CJaJ5[[[[[\\\\\qqq_PP$d$Ifa$gd$Vd$IfVD^gd_$ d7$8$H$^` a$gd_ d`gd:/dgd_bkd$$IflFp#      44 la1yt$V \\\\\{{$d$Ifa$gd$Vd$IfVD^gd_bkd! $$IflFp#      44 la1yt$V\\\\\{l#$d$Ifa$gd$V#$d$Ifa$gd$Vd$IfVD^gd_bkd $$IflFp#      44 la1yt$V\\\\\{{#$d$Ifa$gd$Vd$IfVD^gd_bkd $$IflFp#      44 la1yt$V\\\\\{{#$d$Ifa$gd$Vd$IfVD^gd_bkdM $$IflFp#      44 la1yt$V\\\\\rr#$d$&dIfPa$gd$Vd$IfVD^gd_bkd $$IflFp#      44 la1yt$V\\\\T^U^<_=_>_pYYM d$Ifgd$V$ d7$8$H$^` a$gd_$ldWD^`la$gd_$ d7$8$H$^` a$gd_bkd! $$IflFp#      44 la1yt$Vg^^_*_4_:_;_>_A_C_F_H_I_Z_[_]_g_h_i________________` ` ` `)`ƿ俬ujh*ihAmCJaJ4h*ihB*CJOJPJQJaJnHo(phtHh*ih_CJOJQJaJh*ih_CJPJaJ$h*ih_CJOJQJaJnHtH h*ih_#h*ih_>*CJPJaJnHtHh*ih_>*CJaJ h*ih_CJPJaJnHtHh*ih_CJaJ&>_C_H_I_J_R_Z_ d$Ifgd$Vbkd $$IflFp#      44 la1yt$V$d$Ifa$gd$VZ_[_\_]_h_r#$d$Ifa$gd$V#$d$Ifa$gd$V d$Ifgd$Vbkd $$IflFp#      44 la1yt$Vh_i_y___u $$Ifa$gd$V#$d$Ifa$gd$V d$Ifgd$VbkdS $$IflFp#      44 la1yt$V_____pd $$Ifa$gd$V#$d$Ifa$gd$V%!d$IfWD^`gd$Vdkd $$Ifl>Fp#      44 la1yt$V_____iT$$&dIfPa$gd$V#$d$&dIfPa$gd$V%!d$IfWD^`gd$Vbkd+$$IflFp#      44 la1yt$V_____#$d$Ifa$gd$V d$Ifgd$Vbkd$$IflFp#      44 la1yt$V___` `ss$d$&dIfPa$gd$V%!d$Ifgd$Vbkd $$IflFp#      44 la1yt$V ` ` `aaZc[ccufffV?$d7$8$H$^`a$gdAmd^`gdAm$d^a$gdAm&9TPL HD@<+{^gdbkdu$$IflFp#      44 la1yt$V)`3```````bbbbbb[ccccccccccccccccccddddBdIdJdKdNdOdUd\dcddde f#fƿ俴z$h*ihAmCJOJQJaJnHtH$h*ihOCJOJQJaJnHtH h*ihOh*ihOCJPJaJh*ihOCJaJ h*ihAm#h*ihAm>*CJPJaJnHtHh*ihAm>*CJaJh*ihAmCJaJ h*ihAmCJPJaJnHtH0cccccccccoekd$$IflFp#      44 la1yt$V$d$Ifa$gd$V d$Ifgd$Vd^`gdAmcccccp#$d$Ifa$gd$V#$d$Ifa$gd$V d$Ifgd$VekdH$$IflFp#      44 la1yt$Vcccccs $$Ifa$gd$V#$d$Ifa$gd$V d$Ifgd$Vekd$$IflFp#      44 la1yt$Vccdddpd $$Ifa$gd$V#$d$Ifa$gd$V%!d$IfWD^`gd$Vekd$$IflFp#      44 la1yt$VddBdFdJdgR$$&dIfPa$gd$V#$d$&dIfPa$gd$V%!d$IfWD^`gd$Vekd$$IflFp#      44 la1yt$VJdKdLdMdNdp#$d$Ifa$gd$V#$d$Ifa$gd$V d$Ifgd$Vekd$$IflFp#      44 la1yt$VNdOdUd\dcdoW$d$&dIfPa$gd$V#$d$&dIfPa$gd$V%!d$Ifgd$Vgkdy$$Ifl\Fp#      44 la1yt$Vcdddedee!f"f#f{hXDPd$If^`Pgd$Vd^`gdAm$d^`a$gdAm$d7$8$H$^a$gdAm d^gdAmekd$$IflFp#      44 la1yt$V#f&f(f+f-f.f?f@fBfLfMfNf[fhfifjfffffffffffffffffffgggggHhJhhhhhhh:i;i*CJPJaJnHtHh*ihAm>*CJaJ;#f(f-f.f/f7f?fyPd$If^`Pgd$Vbkd[$$IflFp#      44 la1yt$V$d$Ifa$gd$V?f@fAfBfMfyj#$d$Ifa$gd$V#$d$Ifa$gd$VPd$If^`Pgd$Vbkd$$IflFp#      44 la1yt$VMfNf[fbfifym $$Ifa$gd$V#$d$Ifa$gd$VPd$If^`Pgd$Vbkd#$$IflFp#      44 la1yt$Vifjffffym $$Ifa$gd$V#$d$Ifa$gd$VPd$If^`Pgd$Vbkd$$IflFp#      44 la1yt$Vfffffym $$Ifa$gd$V#$d$Ifa$gd$VPd$If^`Pgd$Vbkd$$IflFp#      44 la1yt$Vfffffpp#$d$&dIfPa$gd$VPd$If^`Pgd$Vbkdg$$IflFp#      44 la1yt$Vfffff#$d$Ifa$gd$Vbkd$$IflFp#      44 la1yt$VffgggpX$d$&dIfPa$gd$V#$d$&dIfPa$gd$VPd$If^`Pgd$VbkdA$$IflFp#      44 la1yt$VgggIhJh;i#h*ihOCJPJaJnHo(tH h*ihOCJPJaJnHtHh*ihAmCJPJaJh*ihAmCJaJ h*ihAmCJPJaJnHtH h*ihAm#h*ihAm>*CJPJaJnH tH #h*ihAm>*CJPJaJnHtH$h*ihAmCJOJQJaJnHtH&h*ihAm5CJPJ\aJnHtHh*ih5CJ\aJ)h*ih5CJPJ\aJnHo(tHlllllmmm mmibkd$$IflFd#      44 la1yt$V$d$Ifa$gd$V %d$Ifgd$VdgdAmd^`gd mmmm mr$d$Ifa$gd$V$d$Ifa$gd$V %d$Ifgd$Vbkd'$$IflFd#      44 la1yt$V m!m0m8m@m||$d$Ifa$gd$V%!d$Ifgd$Vbkd$$IflFd#      44 la1yt$V@mAmdmlmsmr#$d$Ifa$gdO#$d$Ifa$gd$V %d$Ifgd$Vbkd$$IflFd#      44 la1yt$Vrmsmtmmmmmmmmmmmmmmmm6n9n*CJOJPJQJaJnHtH#h*ihAm>*CJPJaJnHtH#h*ihAmCJPJaJnHo(tH#h*ihOCJPJaJnHo(tHh*ihOCJaJh*ihAmCJaJh*ihAmCJOJQJaJh*ihAmhv%BCJPJaJh*ihAmCJPJaJ(h*ihAmCJOJPJQJaJnHtH h*ihAm h*ihAmCJPJaJnHtHsmtmmmmxx#$d$&dIfPa$gd$V %d$Ifgd$Vbkde$$IflFd#      44 la1yt$Vmmmmm$d$Ifa$gd$V %d$Ifgd$Vbkd$$IflFd#      44 la1yt$Vmmmmmx`$d$&dIfPa$gdO$d$&dIfPa$gd$V %d$Ifgd$Vbkd9$$IflFd#      44 la1yt$Vmmm7n8n9n>nCnuff$d$Ifa$gd$V d$Ifgd$V d^gdAm$d^a$gdAmbkd$$IflFd#      44 la1yt$V=n>nAnBnCnDnUnVnXnbncndnnnnnnnnnnoooooo$o,o-oooooosdsh*ih5CJ\aJo()h*ih5CJPJ\aJnHo(tHh*ihAmCJOJQJaJh*ihAmCJPJaJ h*ihAmCJPJaJnHtHh*ihAmCJaJ h*ihAm+h*ihAm>*CJOJPJQJaJnHtH#h*ihAm>*CJPJaJnHtHh*ihAm>*CJaJnH tH "CnDnEnMnUn$d$Ifa$gd$V d$Ifgd$Vbkd$$IflFd#      44 la1yt$VUnVnWnXncnr#$d$Ifa$gd$V#$d$Ifa$gd$V d$Ifgd$Vbkdw$$IflFd#      44 la1yt$Vcndntn|nn#$d$Ifa$gd$V d$Ifgd$Vbkd$$IflFd#      44 la1yt$Vnnnnnu $$Ifa$gd$V#$d$Ifa$gd$V d$Ifgd$Vbkd?$$IflFd#      44 la1yt$Vnnnnnu $$Ifa$gd$V#$d$Ifa$gd$V d$Ifgd$Vbkd$$IflFd#      44 la1yt$Vnn ooott#$d$&dIfPa$gd$Vd$Ifgd$Vbkd$$IflFd#      44 la1yt$Vooooo#$d$Ifa$gd$V d$Ifgd$Vbkd$$IflFd#      44 la1yt$Vooo$o,oxx$d$&dIfPa$gd$V %d$Ifgd$Vbkd$$IflFd#      44 la1yt$V,o-o.oooppppq^N0d^`0gd$V$0d^`0a$gd$Vd^`gddgd$d7$8$H$^a$gdAmbkdc $$IflFd#      44 la1yt$VopppppppppqqqqqrrrrrrNrRrTrbrfrhrrrrrrs~~rr~`~T~̣~h*ih$V5CJaJ#h*ih$V5CJPJaJnHtHh*ih$VCJaJo( h*ih$V#h*ih$V>*CJPJaJnHtHh*ih$V>*CJaJh*ih$VCJaJ#h*ih$VCJPJ\aJnHtHh*ih$VCJ\aJ h*ih$VCJPJaJnHtH)h*ih5CJPJ\aJnHo(tHh*ih5CJ\aJ pppqqq qqbkd $$IflFd#F    44 layt$V$d$Ifa$gd$V d$Ifgd$Vqqqqr#$d$Ifa$gd$V d$Ifgd$Vbkd1!$$IflFd#F    44 layt$VrrNrPrRr#$d$Ifa$gd$V d$Ifgd$Vbkd!$$IflFd#F    44 layt$VRrTrbrdrfr#$d$Ifa$gd$V d$Ifgd$Vbkd!$$IflFd#F    44 layt$Vfrhrrrrrrl]]]#$d$Ifa$gd$VTd$IfVDWD^T`gd$Vd$IfVDXWDj^`gd$Vbkd]"$$IflFd#F    44 layt$Vrrss"s}}#$d$Ifa$gd$Vd$If^gd$Vbkd"$$IflFd#F    44 layt$Vs"s$sdssssssttttttctdtttttttttuuuuOuQuXuYu|uuuuuuuuuuuuuvvv v v&v(v.v/vhvivjvlvmvyvzv{v˿&h*ih!CJPJ\aJnHo(tHh*ih$V5CJaJ#h*ih$V5CJPJaJnHtHh*ih$VCJaJ h*ih$V h*ih$VCJPJaJnHtH>"s$ssss{{#$d$Ifa$gd$Vd$IfWDO`gd$Vbkd+#$$IflFd#F    44 layt$Vsssss{{#$d$Ifa$gd$Vd$IfWDd`gd$Vbkd#$$IflFd#F    44 layt$Vssttt#$d$Ifa$gd$V d$Ifgd$Vbkd#$$IflFd#F    44 layt$Vttttt#$d$Ifa$gd$V d$Ifgd$Vbkdi$$$IflFd#F    44 layt$VttUt\tctuu#$d$Ifa$gd$Vd$IfVDnWD^`gd$Vbkd$$$IflFd#F    44 layt$Vctdttttuu#$d$Ifa$gd$Vd$IfVDnWD^`gd$Vbkd=%$$IflFd#F    44 layt$Vttttt#$d$Ifa$gd$V d$Ifgd$Vbkd%$$IflFd#F    44 layt$Vttttt#$d$Ifa$gd$V d$Ifgd$Vbkd&$$IflFd#F    44 layt$Vtt uuuuu#$d$Ifa$gd$Vd$IfVDWWD^`gd$Vbkd{&$$IflFd#F    44 layt$VuuOuQuXuuu#$d$Ifa$gd$Vd$IfVDWWD^`gd$Vbkd&$$IflFd#F    44 layt$VXuYuuu|uu}}#$d$Ifa$gd$Vd$If^gd$VbkdO'$$IflFd#F    44 layt$Vuuuuu}}#$d$Ifa$gd$Vd$If^gd$Vbkd'$$IflFd#F    44 layt$Vuuuuu}}#$d$Ifa$gd$Vd$If^gd$Vbkd#($$IflFd#F    44 layt$Vuuuuu#$d$Ifa$gd$V d$Ifgd$Vbkd($$IflFd#F    44 layt$Vuuvv v#$d$Ifa$gd$V d$Ifgd$Vbkd($$IflFd#F    44 layt$V v v&v(v.vuu#$d$Ifa$gd$Vd$IfVDWWD^`gd$Vbkda)$$IflFd#F    44 layt$V.v/vivqvyvll#$d$&dIfPa$gd$Vd$IfVDWWD^`gd$Vbkd)$$IflFd#F    44 layt$Vyvzv{vvvxxypaO$Hd1$VD^Ha$gd$V$d^a$gd$V$ & Fd1$a$gdba d^gd$Vnd^n`gd$Vbkd5*$$IflFd#F    44 layt$V{vvvx xzz{{~+Dlqvw~ ')*€ŀǀȀـڀ݀ހ ᪟᪟󟓁zzzz h*ih$V#h*ih$V>*CJPJaJnHtHh*ih$V>*CJaJh*ih$VCJaJ h*ih$VCJPJaJnHtH#h*ih$VCJPJ\aJnH tH &h*ihCJPJ\aJnHo(tH#h*ih$VCJPJ\aJnHtHh*ih$VCJ\aJ0yyzz~~*+XY}ma nd^ngd$V;d^`;gd$VnWd^n`Wgd$V$d^a$gd$V$;d^`;a$gd$V$nWd^n`Wa$gd$V$ & Fd1$a$gdba $da$gd$Hd1$VD^Ha$gd$V$d1$^a$gd$V Y€ǀȀɀрـfbkd*$$IflF]'#g    44 layt$V$d$Ifa$gd$V d$Ifgd$V nd^ngd$V$d^a$gd$V ـڀۀ܀݀#$d$Ifa$gd$V d$Ifgd$Vbkd+$$IflF]'#g    44 layt$V݀ހ#$d$Ifa$gd$V d$Ifgd$Vbkdg+$$IflF]'#g    44 layt$V xx#$d$&dIfPa$gd$V d$Ifgd$Vbkd+$$IflF]'#g    44 layt$V !"#$#$d$Ifa$gd$V d$Ifgd$Vbkd5,$$IflF]'#g    44 layt$V !$%23ԁՁׁXY#$ރ߃ξkUkUkUkUkUkUkUkUkU*h*ihKCJOJPJ\aJnHo(tH'h*ihKCJOJPJ\aJnHtH"h*ihKCJ\aJnHo(tHh*ihKCJ\aJnHtH h*ihKCJPJaJnHtHh*ihK5CJaJh*ihK5CJaJnHtH&h*ih$VCJPJ\aJnHo(tHh*ih$VCJ\aJh*ih$VCJaJ h*ih$V!$%&,2xx#$d$&dIfPa$gd$V d$Ifgd$Vbkd,$$IflF]'#g    44 layt$V234ԁՁvkk[F$d7$8$9DG$^a$gdK$dG$^a$gdK $da$gdK $da$gd$d^a$gd$V nd^ngd$Vbkd -$$IflF]'#g    44 layt$Vqr !"#$%&()*4?GN$d$$Ifa$gdba%$d$Ifa$gdbad$$IfUD]gdba $da$gdKgdK$d7$8$9DG$^a$gdK&)*?FGMNXYnuvwxƆdž܆ކ˼xddddQd$h*ihK0JCJPJaJnHtH'h*ihK0J5CJPJaJnHtHh*ihKCJaJhnHtHh*ihKCJaJnHtHh*ihK5CJaJh*ihK0J5CJaJh*ihKCJaJh*ihKCJOJQJaJh*ihK5CJ\aJ"h*ihK5CJ\aJnHtH'h*ihKCJOJPJ\aJnHtHNYcnv$d$$Ifa$gdba%$d$Ifa$gdba$d$$IfVD<^a$gdbavwxL@11$d$$Ifa$gdba d$$Ifgdbakds-$$IflWr" N#!_0644 laytba.kdL.$$Iflr" N#!_0644 laytba$d$$Ifa$gdba$d$Ifa$gdbaƆ$d$$Ifa$gdba d$$IfgdbaƆdžކ߆L@111$d$$Ifa$gdba d$$Ifgdbakd%/$$Ifl+r" N#!_0644 laytba=1 d$$Ifgdbakd/$$Iflr" N#!_0644 laytba$d$$Ifa$gdbaކ*+>?EFGe‡Ç  #;Ѿ߱Ѡߒ߃߃vjvjvjYvj!h*ihKh6*0J5CJaJh*ihKCJ\aJh*ihKCJPJaJh*ihKCJaJnHtHh*ihK0J5CJaJ h*ihKCJPJaJnHtHh*ihK0JCJaJ$h*ihK0JCJPJaJnHtHh*ihK5CJ\aJh*ihKCJaJ*h*ihK0J5>*CJPJaJnHtH!=1 d$$Ifgdbakd0$$Iflr" N#!_0644 laytba$d$$Ifa$gdba=kd1$$Iflr" N#!_0644 laytba$d$$Ifa$gdba+?F $$Ifa$gdba$d$$Ifa$gdbad$$IfWDd`gdFGepxL:++$d$$Ifa$gdbad$$IfWDd`gdkdq2$$Iflr" N#!_0644 laytbax@.d$$IfWDd`gdkdJ3$$Iflr" N#!_0644 laytba $$Ifa$gdba‡Ç1kd#4$$Iflr" N#!_0644 laytba $$Ifa$gdba$d$$Ifa$gdbaÇ  $$Ifa$gdba$d$$Ifa$gdba$d$$IfVDdWD^`$gd #+<L:++$d$$Ifa$gdbad$$IfWDd`gdkd4$$Iflr" N#!_0644 laytba;<OPWXYrˈ%&234cjntuvw{|}Ɖ߷ߥߗߥ߷ߥߥߥ߷ߗ߷ߊyߊߊy߷ h*ihKCJPJaJnHtHh*ihK0JCJaJh*ihK0J5CJaJ#h*ihK0J5CJaJnHtHh*ihKCJ\aJh*ihKCJPJaJh*ihKCJaJnHtHh*ihKCJaJ)h*ihKh6*0J5CJaJnHtH/<PXYr@.d$$IfWDd`gdkd5$$Iflr" N#!_0644 laytba $$Ifa$gdbarz=kd6$$Iflr" N#!_0644 laytba$d$$Ifa$gdbaˈԈ$d$$Ifa$gdbad$$IfWDd`gd&L:++$d$$Ifa$gdbad$$IfWDd`gdkd7$$Iflr" N#!_0644 laytba&+34c@($d$$IfVDdWD^`$gdkdZ8$$Iflr" N#!_0644 laytba $$Ifa$gdbacjlnuv1kdA9$$IflOr" N#!_0644 laytba $$Ifa$gdba$d$$Ifa$gdbavwxyz{$d$$Ifa$gdba d$$Ifgdba{|}L@111$d$$Ifa$gdba d$$Ifgdbakd(:$$Iflr" N#!_0644 laytba=1 d$$Ifgdbakd;$$Iflr" N#!_0644 laytba$d$$Ifa$gdbaƉ=+d$$IfWDd`gdkd<$$Iflr" N#!_0644 laytba$d$$Ifa$gdbaƉω׉1kd<$$Iflr" N#!_0644 laytba $$Ifa$gdba$d$$Ifa$gdba*+>?FGHdԊՊ֊)FGKLMaԋՋ܋݋ދ"#$%&)*+>?Sghklƌ̌ЌՌ֌׌h*ihK5CJ\aJ h*ihKCJPJaJnHtHh*ihKCJaJnHtHh*ihKCJ\aJh*ihKCJaJh*ihKCJPJaJD+?G $$Ifa$gdba$d$$Ifa$gdbad$$IfWDd`gdGHdmuL:++$d$$Ifa$gdbad$$IfWDd`gdkd=$$Iflr" N#!_0644 laytbau@($d$$IfVDdWD^`$gdkd>$$Iflr" N#!_0644 laytba $$Ifa$gdbaĊɊΊՊ֊1kd?$$Ifllr" N#!_0644 laytba $$Ifa$gdba$d$$Ifa$gdba֊  $$Ifa$gdba$d$$Ifa$gdba$d$$IfVDdWD^`$gd).3L:++$d$$Ifa$gdbad$$IfWDd`gdkdk@$$IflSr" N#!_0644 laytba3GLMa@.d$$IfWDd`gdkdDA$$Iflr" N#!_0644 laytba $$Ifa$gdbaas{1kdB$$Iflr" N#!_0644 laytba $$Ifa$gdba$d$$Ifa$gdbaՋ݋ $$Ifa$gdba$d$$Ifa$gdbad$$IfWDd`gd݋ދL:++$d$$Ifa$gdbad$$IfWDd`gdkdB$$Iflr" N#!_0644 laytba#$%@.d$$IfWDd`gdkdC$$Iflr" N#!_0644 laytba $$Ifa$gdba%&'()*=kdD$$Iflr" N#!_0644 laytba$d$$Ifa$gdba*+6?GR$d$$Ifa$gdbad$$IfWDd`gdRSghijL@111$d$$Ifa$gdba d$$IfgdbakdE$$Iflr" N#!_0644 laytbajkl=+d$$IfWDd`gdkdF$$Iflr" N#!_0644 laytba$d$$Ifa$gdba1kdG$$Iflr" N#!_0644 laytba $$Ifa$gdba$d$$Ifa$gdbaƌ̌ΌЌ֌ $$Ifa$gdba$d$$Ifa$gdbad$$IfWDd`gd֌׌L:++$d$$Ifa$gdbad$$IfWDd`gdkd|H$$Iflr" N#!_0644 laytba ,@.d$$IfWDd`gdkdcI$$Ifl/r" N#!_0644 laytba $$Ifa$gdba ,KL_ȍߍ ;CDhis$%&'()+,R殜"h*ihK5CJ\aJnHtHh*ihK5CJ\aJ h*ihKCJPJaJnHtHh*ihKCJ\aJh*ihKCJPJaJh*ihKCJaJh*ihKCJaJnHtH=,3DL^_1kd?uaRRRR$d$Ifa$gdbaZd$If^Z`gdbakdW$$Iflr kp,"f644 laytba&;^_pqÐĐŐ'()C[\sÑƑǑ=WXkltuv֧}h*ihKCJaJo(h*ihK5CJ\aJo(h*ihKCJaJnHtHh*ihKCJaJnHo(tH#h*ihKCJPJaJnHo(tHh*ihKCJPJaJ h*ihKCJPJaJnHtHh*ihKCJaJh*ihK5CJ\aJ1?@NW_hqsaRRFF $$Ifa$gdba$d$Ifa$gdbad$IfVDG^gdbakdXX$$Iflr kp,"f644 laytbaqr{ucTTHH $$Ifa$gdba$d$Ifa$gdbad$IfVDG^gdbakdX$$Iflr kp,"f644 laytbaÐŐːucKKKK$d$&dIfPa$gdbad$IfVDG^gdbakdY$$Iflr kp,"f644 laytbaː̐͐ΐϐАѐuaRRRR$d$Ifa$gdbaZd$If^Z`gdbakdGXu]N5$Hd$4$If]a$gdba$d$Ifa$gdba$d$IfVDGWD^`$gdbakdL_$$Iflr kp,"f644 laytbaXluviWHH$d$Ifa$gdbad$IfVDG^gdbakd_$$Iflr kp,"f644 laytba $$Ifa$gdbav 34>?@AXYnop~䩗oah*ihK5CJ\aJ&h*ihK5CJPJaJnHo(tH'h*ihKCJOJPJ\aJnHtH"h*ihK5CJ\aJnHtHh*ihK5CJaJnHtHh*ihKCJOJQJaJh*ihKCJPJaJh*ihKCJaJnHtHh*ihKCJaJ h*ihKCJPJaJnHtH!ɒђucKKKK$d$&dIfPa$gdbad$IfVDG^gdbakd`$$Iflr kp,"f644 laytbaucTTTT$d$Ifa$gdbad$IfVDG^gdbakd2a$$Iflr kp,"f644 laytba 4=u\DDDD$d$&dIfPa$gdba%!Zd$If^Z`gdbakda$$Iflr kp,"f644 laytba=>?@ABCu\MMMM$d$Ifa$gdba%!Zd$If^Z`gdbakdvb$$Iflr kp,"f644 laytbaCDEPYbmuaIIII$d$&dIfPa$gdbaZd$If^Z`gdbakdc$$Iflr kp,"f644 laytbamnopqrstusg\GGGGG$d7$8$9DG$^a$gdK $da$gdK $dG$a$gdKkdc$$Ifl?r kp,"f644 laytbauvwxyz{|}~$d$$IfVD<^a$gdba$d$$Ifa$gdba%$d$Ifa$gdbad$$IfUD]gdba $dG$a$gdK$d7$8$9DG$^a$gdKē˓͓̓Γޓ 2489:>?˻折折weOw*h*ihK0J5>*CJPJaJnHtH"h*ihK5CJ\aJnHtH$h*ihK0JCJPJaJnHtHh*ihK5CJ\aJ'h*ihK0J5CJPJaJnHtHh*ihKCJOJQJaJh*ihKCJaJhnHtHh*ihKCJaJnHtHh*ihK5CJaJh*ihKCJaJh*ihK0J5CJaJē͓̓.kd`d$$IflWr@!v," TTv0644 laytba$d$$Ifa$gdba%$d$Ifa$gdba͓Γ֓ޓ$d$Ifa$gdba$d$$Ifa$gdba d$$Ifgdba  L@111$d$$Ifa$gdba d$$Ifgdbakd+e$$Iflr@!v," TTv0644 laytba 4=1 d$$Ifgdbakde$$Ifl+r@!v," TTv0644 laytba$d$$Ifa$gdba456789=kdf$$Iflr@!v," TTv0644 laytba$d$$Ifa$gdba9:;<=>$d$$Ifa$gdba d$$Ifgdba>?RSTUL@111$d$$Ifa$gdba d$$Ifgdbakdg$$Iflrr@!v," TTv0644 laytba?QRVWiptz{|ה$%234JQRSU[\]v}ɻɬɟɓɟɓɟɓɻɟɓp[ɟɓ)h*ihKh6*0J5CJaJnHtH#h*ihK0J5CJaJnHtH!h*ihKh6*0J5CJaJh*ihKCJ\aJh*ihKCJPJaJh*ihKCJaJnHtHh*ihK0J5CJaJh*ihKCJaJ h*ihKCJPJaJnHtHh*ihK5CJ\aJh*ihK0JCJaJ#UVWip=+d$$IfWDd`gdkdEh$$Iflr@!v," TTv0644 laytba$d$$Ifa$gdbaprt{|1kd i$$Iflr@!v," TTv0644 laytba $$Ifa$gdba$d$$Ifa$gdba| $$Ifa$gdba$d$$Ifa$gdbad$$IfWDd`gdהߔL:++$d$$Ifa$gdbad$$IfWDd`gdkdi$$Iflr@!v," TTv0644 laytba@($d$$IfVDdWD^`$gdkdj$$Iflr@!v," TTv0644 laytba $$Ifa$gdba%+341kdkk$$Iflr@!v," TTv0644 laytba $$Ifa$gdba$d$$Ifa$gdba4JQSU\ $$Ifa$gdba$d$$Ifa$gdbad$$IfWDd`gd\]v}L:++$d$$Ifa$gdbad$$IfWDd`gdkd6l$$Iflr@!v," TTv0644 laytba}•Õĕؕߕ   46<>CDEt{ԻԩԕԻԩԻԆԻyhy h*ihKCJPJaJnHtHh*ihK0JCJaJh*ihKCJaJnHtH'h*ihK0J5CJPJaJnHtH#h*ihKCJPJ\aJnHtHh*ihKCJPJaJh*ihKCJ\aJh*ihKCJaJh*ihK0J5CJaJ#h*ihK0J5CJaJnHtH(=+d$$IfWDd`gdkdm$$Iflr@!v," TTv0644 laytba$d$$Ifa$gdbaÕĕ=kdm$$Iflr@!v," TTv0644 laytba$d$$Ifa$gdbaĕؕߕ $$Ifa$gdba$d$$Ifa$gdbad$$IfWDd`gdL:++$d$$Ifa$gdbad$$IfWDd`gdkdn$$Iflr@!v," TTv0644 laytba  4@($d$$IfVDdWD^`$gdkdpo$$Iflr@!v," TTv0644 laytba $$Ifa$gdba46<>DE1kdIp$$Iflr@!v," TTv0644 laytba $$Ifa$gdba$d$$Ifa$gdbaEt{} $$Ifa$gdba$d$$Ifa$gdba$d$$IfVDdWD^`$gdL@111$d$$Ifa$gdba d$$Ifgdbakd"q$$IflOr@!v," TTv0644 laytba=1 d$$Ifgdbakdq$$Ifl:r@!v," TTv0644 laytba$d$$Ifa$gdba–Ö=1 d$$Ifgdbakdr$$Iflr@!v," TTv0644 laytba$d$$Ifa$gdba–ÖƖǖԖ #$%A[\]ȗʗїӗٗڗۗ'/1678Q_ahijŘ٘˼h*ihK5CJ\aJh*ihKCJPJaJh*ihKCJaJnHtHh*ihKCJ\aJ h*ihKCJPJaJnHtHh*ihK0JCJaJh*ihKCJaJ?ÖĖŖƖǖ=kds$$Iflr@!v," TTv0644 laytba$d$$Ifa$gdbaǖԖܖ $$Ifa$gdba$d$$Ifa$gdbad$$IfWDd`gd L:++$d$$Ifa$gdbad$$IfWDd`gdkdt$$Iflr@!v," TTv0644 laytba$%A@.d$$IfWDd`gdkd_u$$Iflr@!v," TTv0644 laytba $$Ifa$gdbaAIPT\]1kd8v$$Iflr@!v," TTv0644 laytba $$Ifa$gdba$d$$Ifa$gdba] $$Ifa$gdba$d$$Ifa$gdba$d$$IfVDdWD^`$gdȗʗїL4%%$d$$Ifa$gdba$d$$IfVDdWD^`$gdkdw$$Ifllr@!v," TTv0644 laytbaїӗڗۗ@($d$$IfVDdWD^`$gdkdw$$IflYr@!v," TTv0644 laytba $$Ifa$gdba 1kdx$$IflSr@!v," TTv0644 laytba $$Ifa$gdba$d$$Ifa$gdba'-/17 $$Ifa$gdba$d$$Ifa$gdbad$$IfWDd`gd78QX_L:++$d$$Ifa$gdbad$$IfWDd`gdkdry$$Iflr@!v," TTv0644 laytba_aij@.d$$IfWDd`gdkd=z$$Iflr@!v," TTv0644 laytba $$Ifa$gdba1kd{$$Iflr@!v," TTv0644 laytba $$Ifa$gdba$d$$Ifa$gdba$d$$Ifa$gdbad$$IfWDd`gdL:++$d$$Ifa$gdbad$$IfWDd`gdkd{$$Ifl:r@!v," TTv0644 laytbaĘŘ٘ژ=1 d$$Ifgdbakd|$$Iflr@!v," TTv0644 laytba$d$$Ifa$gdba٘ژݘޘ#)-234W_afghșʙ͙ԙՙ )+234569:;Z[\]^_buh*ihK5CJ\aJh*ihKCJPJaJh*ihKCJaJnHtHh*ihKCJ\aJ h*ihKCJPJaJnHtHh*ihKCJaJDژۘܘݘޘ=kd}$$Iflr@!v," TTv0644 laytba$d$$Ifa$gdbaޘ $$Ifa$gdba$d$$Ifa$gdbad$$IfWDd`gd#)+L:++$d$$Ifa$gdbad$$IfWDd`gdkd~$$Iflr@!v," TTv0644 laytba+-34W@.d$$IfWDd`gdkdo$$Iflr@!v," TTv0644 laytba $$Ifa$gdbaW]_agh1kdH$$Iflr@!v," TTv0644 laytba $$Ifa$gdba$d$$Ifa$gdbah $$Ifa$gdba$d$$Ifa$gdbad$$IfWDd`gdșʙ͙L4%%$d$$Ifa$gdba$d$$IfVDdWD^`$gdkd$$Iflr@!v," TTv0644 laytba͙ҙԙՙ@.d$$IfWDd`gdkdށ$$IflUr@!v," TTv0644 laytba $$Ifa$gdba1kd$$Iflr@!v," TTv0644 laytba $$Ifa$gdba$d$$Ifa$gdba $$Ifa$gdba$d$$Ifa$gdbad$$IfWDd`gd")L:++$d$$Ifa$gdbad$$IfWDd`gdkd$$Iflr@!v," TTv0644 laytba)+345@.d$$IfWDd`gdkd[$$Iflr@!v," TTv0644 laytba $$Ifa$gdba56789:=kd4$$Ifl:r@!v," TTv0644 laytba$d$$Ifa$gdba:;ELQ[ $$Ifa$gdba$d$$Ifa$gdbad$$IfWDd`gd[\]^_L:++$d$$Ifa$gdbad$$IfWDd`gdkd$$Iflr@!v," TTv0644 laytba_`abu}=1 d$$Ifgdbakd$$Iflr@!v," TTv0644 laytba$d$$Ifa$gdba}1kdۇ$$Iflr@!v," TTv0644 laytba $$Ifa$gdba$d$$Ifa$gdba $$Ifa$gdba$d$$Ifa$gdbad$$IfWDd`gd  *124;<CDLSTVX^`ax衒n[n[n[nn[n衒$h*ihK0JCJPJaJnHtH'h*ihK0J5CJPJaJnHtHh*ihKCJaJhnHtHh*ihKCJaJnHtHh*ihK5CJaJh*ihK0J5CJaJh*ihKCJOJQJaJh*ihK5CJaJnHtHh*ihK5CJ\aJh*ihKCJaJh*ihKCJPJaJ#ȚКL3$$$d$$Ifa$gdba$nd$$IfWD^n`a$gdkdˆ$$Iflr@!v," TTv0644 laytbaКٚ@4 $dG$a$gdKkd$$IflNr@!v," TTv0644 laytba $$Ifa$gdba *2$d$$IfVD^a$gdba$d$$Ifa$gdba%$d$Ifa$gdbaZd$If^Z`gdba 234<DLTuaRRCR$d$Ifa$gdba$d$$Ifa$gdbaZd$If^Z`gdbakd$$Iflr kp,"f644 laytbaTUVWX_`uaRRRR$d$$Ifa$gdbaZd$If^Z`gdbakd2$$Iflr kp,"f644 laytba`auaRRRR$d$Ifa$gdbaZd$If^Z`gdbakdԋ$$Iflr kp,"f644 laytbauaRRRR$d$Ifa$gdbaZd$If^Z`gdbakdp$$Iflr kp,"f644 laytbauaRRRR$d$Ifa$gdbaZd$If^Z`gdbakd$$Iflr kp,"f644 laytbaƛ֛כ"#$%&JOjr|̜֜ޜ 45678=>?ajk֛֌}֛h*ihK5CJ\aJo(h*ihKCJaJnHtHh*ihKCJaJnHo(tH#h*ihKCJPJaJnHo(tHh*ihKCJaJo(h*ihKCJPJaJ h*ihKCJPJaJnHtHh*ihKCJaJh*ihK5CJ\aJ1ƛϛכsaRRFF $$Ifa$gdba$d$Ifa$gdbad$IfVDG^gdbakd$$Iflr kp,"f644 laytbaכ؛ucTTHH $$Ifa$gdba$d$Ifa$gdbad$IfVDG^gdbakdT$$Iflr kp,"f644 laytba"$&,ucKKKK$d$&dIfPa$gdbad$IfVDG^gdbakd$$Iflr kp,"f644 laytba,-./012uaRRRR$d$Ifa$gdbaZd$If^Z`gdbakd$$Iflr kp,"f644 laytba23`jrs|u_PPDDD $$Ifa$gdba$d$Ifa$gdba$d$IfWD^`$gdbakd:$$Iflr kp,"f644 laytbauaIIII$d$&dIfPa$gdbaZd$If^Z`gdbakdܐ$$Iflr kp,"f644 laytbauaRRRR$d$Ifa$gdbaZd$If^Z`gdbakd~$$Iflr kp,"f644 laytba̜֜ޜuaIIII$d$&dIfPa$gdbaZd$If^Z`gdbakd $$Iflr kp,"f644 laytbauaRRRR$d$Ifa$gdbaZd$If^Z`gdbakd’$$Iflr kp,"f644 laytbauaRRRR$d$Ifa$gdbaZd$If^Z`gdbakdd$$Iflr kp,"f644 laytba.468>ucTTHH $$Ifa$gdba$d$Ifa$gdbad$IfVDG^gdbakd$$Iflr kp,"f644 laytba>?bjlu]N5$Hd$4$If]a$gdba$d$Ifa$gdba$d$IfVDGWD^`$gdbakd$$Iflr kp,"f644 laytbaklmnuvwÝ͝ΝϝНѝܝݝޝߝ  ָָָָ֦֦֦֗֗փm*h*ihKCJOJPJ\aJnHo(tH'h*ihKCJOJPJ\aJnHtHh*ihKCJOJQJaJ#h*ihKCJPJaJnHo(tH h*ihKCJPJaJnHtHh*ihKCJPJaJh*ihKCJaJh*ihKCJaJnHo(tHh*ihKCJaJnHtH%lnvwiWHH$d$Ifa$gdbad$IfVDG^gdbakdJ$$Iflr kp,"f644 laytba $$Ifa$gdbaucKKKK$d$&dIfPa$gdbad$IfVDG^gdbakd$$Iflr kp,"f644 laytbaucTTTT$d$Ifa$gdbad$IfVDG^gdbakd$$Iflr kp,"f644 laytbaÝ͝ϝѝ۝u\DDDD$d$&dIfPa$gdba%!Zd$If^Z`gdbakd0$$Iflr kp,"f644 laytba۝ܝݝޝߝu\MMMM$d$Ifa$gdba%!Zd$If^Z`gdbakdҗ$$Iflr kp,"f644 laytbauaIIII$d$&dIfPa$gdbaZd$If^Z`gdbakdt$$Iflr kp,"f644 laytba    s^^^^^^^^^$d7$8$9DG$^a$gdKkd$$Ifl?r kp,"f644 laytba  !+6>E$d$$Ifa$gdba%$d$Ifa$gdbad$$IfUD]gdba$d7$8$9DG$a$gd$d7$8$9DG$^a$gdK !6=>DEOPelmnovw~͞ΞҞӞؾ؋xxxxxxxee%h*ihK5CJ\aJnHo(tH$h*ihK0JCJPJaJnHtH'h*ihK0J5CJPJaJnHtHh*ihKCJaJhnHtHh*ihKCJaJnHtHh*ihK5CJaJh*ihK0J5CJaJh*ihKCJaJh*ihKCJOJQJaJh*ihK5CJ\aJ#EPZem$d$$Ifa$gdba%$d$Ifa$gdba$d$$IfVD<^a$gdbamnowL@11$d$$Ifa$gdba d$$Ifgdbakd$$IflWr" N#!_0644 laytba.kd$$Iflr" N#!_0644 laytba$d$$Ifa$gdba$d$Ifa$gdba$d$$Ifa$gdba d$$IfgdbaԞ՞֞מL@111$d$$Ifa$gdba d$$Ifgdbakdn$$Ifl+r" N#!_0644 laytbaӞԞ؞ٞڞޞߞ  )*123Q[\Ϳ̀͟rffWfWfJ>fh*ihKCJ\aJh*ihKCJPJaJh*ihKCJaJnHtHh*ihKCJaJo(h*ihK0J5CJaJh*ihK0JCJaJo( h*ihKCJPJaJnHtHh*ihK0JCJaJ$h*ihK0JCJPJaJnHtHh*ihK5CJ\aJh*ihKCJaJ*h*ihK0J5>*CJPJaJnHtH"h*ihK5CJ\aJnHtHמ؞ٞڞ۞ܞ=1 d$$IfgdbakdA$$Ifl1r" N#!_0644 laytba$d$$Ifa$gdbaܞݞޞߞ=1 d$$Ifgdbakd$$Iflr" N#!_0644 laytba$d$$Ifa$gdba=kd$$Iflr" N#!_0644 laytba$d$$Ifa$gdba  *2 $$Ifa$gdba$d$$Ifa$gdbad$$IfWDd`gdba23Q\dL:++$d$$Ifa$gdbad$$IfWDd`gdbakd$$Iflr" N#!_0644 laytba\cdklvwxܟݟ)*34;<=>UV]^lmuvh*ihKCJaJnHtH#h*ihK0J5CJaJnHtHh*ihK0J5CJaJh*ihKCJ\aJh*ihKCJ\aJo(h*ihKCJPJaJh*ihKCJaJh*ihKCJaJo(9dlwx@.d$$IfWDd`gdbakd$$Iflr" N#!_0644 laytba $$Ifa$gdba1kdl$$Iflr" N#!_0644 laytba $$Ifa$gdba$d$$Ifa$gdbaݟ $$Ifa$gdba$d$$Ifa$gdba$d$$IfVDdWD^`$gdba*L:++$d$$Ifa$gdbad$$IfWDd`gdbakdE$$Iflr" N#!_0644 laytba*4<=V@.d$$IfWDd`gdbakd$$Iflr" N#!_0644 laytba $$Ifa$gdbaV^mv=kd$$Iflr" N#!_0644 laytba$d$$Ifa$gdbaˠԠ$d$$Ifa$gdbad$$IfWDd`gdbaʠˠӠԠՠ֠$%./5678eʼ{gXʼh*ihKCJaJnHtH'h*ihK0J5CJPJaJnHtH#h*ihKCJPJ\aJnHtH&h*ihKCJPJ\aJnHo(tHh*ihKCJPJaJh*ihK0J5CJaJh*ihKCJ\aJo(h*ihKCJ\aJ#h*ihK0J5CJaJnHtHh*ihKCJaJh*ihKCJaJo("ԠՠL:++$d$$Ifa$gdbad$$IfWDd`gdbakdУ$$Iflr" N#!_0644 laytba@.d$$IfWDd`gdbakd$$Iflr" N#!_0644 laytba $$Ifa$gdba%/671kd$$Iflr" N#!_0644 laytba $$Ifa$gdba$d$$Ifa$gdba7fn} $$Ifa$gdba$d$$Ifa$gdba$d$$IfVDdWD^`$gdbaefmn|}͡Ρϡҡӡԡߡ !)*1267?@Aܳܳܳܢh*ihKCJ\aJo(h*ihK0JCJaJo( h*ihKCJPJaJnHtHh*ihK0JCJaJh*ihKCJPJaJh*ihKCJaJnHtHh*ihKCJaJh*ihKCJaJo(h*ihKCJ\aJ4L@111$d$$Ifa$gdba d$$Ifgdbakdw$$IflOr" N#!_0644 laytba=1 d$$Ifgdbakd^$$Iflr" N#!_0644 laytba$d$$Ifa$gdbaΡϡ=1 d$$IfgdbakdS$$Iflr" N#!_0644 laytba$d$$Ifa$gdbaϡСѡҡӡ=kd:$$Iflr" N#!_0644 laytba$d$$Ifa$gdbaӡ $$Ifa$gdba$d$$Ifa$gdbad$$IfWDd`gdba!*2L:++$d$$Ifa$gdbad$$IfWDd`gdbakd!$$Iflr" N#!_0644 laytba27@Ak@($d$$IfVDdWD^`$gdbakd$$Iflr" N#!_0644 laytba $$Ifa$gdbaABjkqrvw{|ǢȢѢҢ٢ڢۢܢ  )*01?@IJPQRjkrsyzǣȣɣʣٲٲٲٲٲh*ihKCJaJnHtHh*ihKCJPJaJh*ihKCJaJh*ihKCJaJo(h*ihKCJ\aJo(h*ihKCJ\aJFkrw|1kd$$Ifllr" N#!_0644 laytba $$Ifa$gdba$d$$Ifa$gdbaȢҢڢ $$Ifa$gdba$d$$Ifa$gdba$d$$IfVDdWD^`$gdbaڢۢ L4%%$d$$Ifa$gdba$d$$IfVDdWD^`$gdbakd$$IflYr" N#!_0644 laytba *@.d$$IfWDd`gdbakd$$IflSr" N#!_0644 laytba $$Ifa$gdba*1@JQR1kdl$$Iflr" N#!_0644 laytba $$Ifa$gdba$d$$Ifa$gdbaRksz $$Ifa$gdba$d$$Ifa$gdbad$$IfWDd`gdbaL:++$d$$Ifa$gdbad$$IfWDd`gdbakdE$$Iflr" N#!_0644 laytbaȣɣʣ@.d$$IfWDd`gdbakd,$$Iflr" N#!_0644 laytba $$Ifa$gdbaʣˣ̣ͣΣϣ=kd!$$Iflr" N#!_0644 laytba$d$$Ifa$gdbaʣˣΣϣУڣۣ   '(0189BCKLMN^_efghinopء̒̅ءuuh*ihKCJaJnHo(tHh*ihKCJPJaJh*ihKCJaJnHtHh*ihKCJ\aJo(h*ihK5CJ\aJo(h*ihK5CJ\aJh*ihKCJaJo(h*ihKCJ\aJ h*ihKCJPJaJnHtHh*ihKCJaJ.ϣУۣ$d$$Ifa$gdbad$$IfWDd`gdba   L@111$d$$Ifa$gdba d$$Ifgdbakd$$Iflr" N#!_0644 laytba(1=+d$$IfWDd`gdbakd$$Iflr" N#!_0644 laytba$d$$Ifa$gdba19CLM1kd$$Iflr" N#!_0644 laytba $$Ifa$gdba$d$$Ifa$gdbaM_egio $$Ifa$gdba$d$$Ifa$gdbad$$IfWDd`gdbaopL:++$d$$Ifa$gdbad$$IfWDd`gdbakd˴$$Iflr" N#!_0644 laytbaͤΤؤ٤*+56ABGHNOP[\]cdejklmwxåĥťƥǥȥ˥ h*ihKCJPJaJnHtHh*ihKCJaJnHo(tHh*ihKCJ\aJh*ihKCJ\aJo(h*ihKCJPJaJh*ihKCJaJnHtHh*ihKCJaJo(h*ihKCJaJ6Τ@.d$$IfWDd`gdbakd$$IflZr" N#!_0644 laytba $$Ifa$gdbaΤӤ٤ߤ1kd$$Iflr" N#!_0644 laytba $$Ifa$gdba$d$$Ifa$gdba!) $$Ifa$gdba$d$$Ifa$gdbad$$IfWDd`gdba)*6;BL:++$d$$Ifa$gdbad$$IfWDd`gdbakdd$$Iflr" N#!_0644 laytbaBHOP[@.d$$IfWDd`gdbakd=$$Iflr" N#!_0644 laytba $$Ifa$gdba[]cekl1kd$$$Iflr" N#!_0644 laytba $$Ifa$gdba$d$$Ifa$gdbalx $$Ifa$gdba$d$$Ifa$gdbad$$IfWDd`gdbaL:++$d$$Ifa$gdbad$$IfWDd`gdbakd $$Iflr" N#!_0644 laytba=+d$$IfWDd`gdbakd$$Iflr" N#!_0644 laytba$d$$Ifa$gdbaĥť1kd$$Iflr" N#!_0644 laytba $$Ifa$gdba$d$$Ifa$gdbaťƥǥȥɥʥ$d$$Ifa$gdbad$$IfWDd`gdbaʥ˥ޥL@11$d$$Ifa$gdba d$$Ifgdbakdμ$$Iflr" N#!_0644 laytba˥̥ݥޥ)*QRSUVkrsyzؿخؚ؋}qbRh*ihKCJaJhnHtHh*ihKCJaJnHtHh*ihK5CJaJh*ihK0J5CJaJh*ihKCJOJQJaJ'h*ihKCJOJPJ\aJnHtH h*ihKCJPJaJnHtHh*ihKCJ\aJh*ihKCJPJaJh*ihKCJaJh*ihK5CJ\aJo(h*ihK5CJ\aJ@.d$$IfWDd`gdbakdý$$Iflr" N#!_0644 laytba $$Ifa$gdba1kd$$Iflr" N#!_0644 laytba $$Ifa$gdba$d$$Ifa$gdba*5>GR $$Ifa$gdba$d$$Ifa$gdba$nd$$IfWD^n`a$gdbaRSTUL77$d7$8$9DG$^a$gdKkd$$IflNr" N#!_0644 laytbaUV`ksz$d$$IfVD^a$gdba$d$$Ifa$gdba%$d$Ifa$gdbaZd$If^Z`gdba æĦƦȦΦЦѦ%-.56>?GHR\]delmwxvivih*ihKCJPJaJ h*ihKCJPJaJnHtHh*ihKCJaJo(h*ihK5CJ\aJh*ihKCJaJnHtH h}B5CJPJaJnHo(tHh*ihK5CJaJ$h*ihK0JCJPJaJnHtHh*ihKCJaJ'h*ihK0J5CJPJaJnHtH)ĦuaRRCR$d$Ifa$gdba$d$$Ifa$gdbaZd$If^Z`gdbakd$$Iflr kp,"f644 laytbaĦŦƦǦȦϦЦuaRRRR$d$$Ifa$gdbaZd$If^Z`gdbakdD$$Iflr kp,"f644 laytbaЦѦuaRRRR$d$Ifa$gdbaZd$If^Z`gdbakd$$Iflr kp,"f644 laytbas_PPPP$d$Ifa$gdbaZd$If^Z`gdbakd$$IflXr kp,"f644 laytbauaRRRR$d$Ifa$gdbaZd$If^Z`gdbakd($$Iflr kp,"f644 laytba%.6?HsaRRFF $$Ifa$gdba$d$Ifa$gdbad$IfVDG^gdbakd$$Iflr kp,"f644 laytbaHIR]emxucTTHH $$Ifa$gdba$d$Ifa$gdbad$IfVDG^gdbakdp$$Iflr kp,"f644 laytbaxyucKKKK$d$&dIfPa$gdbad$IfVDG^gdbakd$$Iflr kp,"f644 laytba֧ۧ /67EFMNU]jtu}~Ϩ֨ר$%34=>FGHRSh*ihK5CJ\aJo(h*ihK5CJ\aJh*ihKCJPJaJh*ihKCJaJnHtH h*ihKCJPJaJnHtHh*ihKCJaJo(h*ihKCJaJ>uaRRRR$d$Ifa$gdbaZd$If^Z`gdbakd$$Iflr kp,"f644 laytba u_PPDD $$Ifa$gdba$d$Ifa$gdba$d$IfWD^`$gdbakdV$$Iflr kp,"f644 laytba/7FNVuaIIII$d$&dIfPa$gdbaZd$If^Z`gdbakd$$Iflr kp,"f644 laytbaVWXYZ[\uaRRRR$d$Ifa$gdbaZd$If^Z`gdbakd$$Iflr kp,"f644 laytba\]ju~uaIIII$d$&dIfPa$gdbaZd$If^Z`gdbakd<$$Iflr kp,"f644 laytbauaRRRR$d$Ifa$gdbaZd$If^Z`gdbakd$$Iflr kp,"f644 laytbauaRRRR$d$Ifa$gdbaZd$If^Z`gdbakd$$Iflr kp,"f644 laytbaϨרucTTHH $$Ifa$gdba$d$Ifa$gdbad$IfVDG^gdbakd"$$Iflr kp,"f644 laytba%4u]N5$Hd$4$If]a$gdba$d$Ifa$gdba$d$IfVDGWD^`$gdbakd$$Iflr kp,"f644 laytba4>GHS\ku~iWHH$d$Ifa$gdbad$IfVDG^gdbakdf$$Iflr kp,"f644 laytba $$Ifa$gdbaS[\jktu}~ȩɩשة234P蘄&h*ihK5CJPJaJnHo(tH'h*ihKCJOJPJ\aJnHtHh*ihKCJOJQJaJh*ihKCJPJaJh*ihKCJaJnHtH h*ihKCJPJaJnHtHh*ihKCJaJh*ihKCJaJo(,~ucKKKK$d$&dIfPa$gdbad$IfVDG^gdbakd$$Iflr kp,"f644 laytbaucTTTT$d$Ifa$gdbad$IfVDG^gdbakd$$Iflr kp,"f644 laytbaɩةu\DDDD$d$&dIfPa$gdba%!Zd$If^Z`gdbakdL$$Iflr kp,"f644 laytbau\MMMM$d$Ifa$gdba%!Zd$If^Z`gdbakd$$Iflr kp,"f644 laytbauaIIII$d$&dIfPa$gdbaZd$If^Z`gdbakd$$Iflr kp,"f644 laytba !"#$%s^^^^^^^^^$d7$8$9DG$^a$gdKkd2$$Ifl?r kp,"f644 laytba %&'()*+,-./01234>IQ%$!d$Ifa$gdba%$d$Ifa$gdbaZd$If^Z`gdba $dG$a$gdK$d7$8$9DG$^a$gdKPQWXcѪ#ʵʪ|j^M;#h*ihK5CJPJaJnHtH h*ihKCJPJaJnHtH *h*ihKCJaJ"h*ihK5CJaJhnHtH"h*ihK5CJaJnHo(tHh*ihK5CJaJh*ihKCJaJnHo(tHh*ihKCJaJ(h*ihKCJOJPJQJaJnHtH'h*ihKCJOJQJaJhnH tH h*ihKCJOJQJaJ$h*ihKCJOJQJaJnH tH QXcmxGkd$$Ifrr/ by=$ 3+$44 aytba%$d$Ifa$gdba%$!d$IfVD|WD^`a$gdbaSkd$$Ifrr/ by=$ 3+$44 aytba$d$Ifa$gdbaZd$If^Z`gdba ŪЪѪXDZd$If^Z`gdbakd:$$Ifrr/ by=$ 3+$44 aytba$d$Ifa$gdba$d$Ifa$gdbagSDDD$d$Ifa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytba$d$Ifa$gdba$,7gSZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytba$d$Ifa$gdba#$[\bcquvƫǫΫϫЫݫ $%89ABCUwx¬լ֬߬їh*ihKCJaJo(h*ihKCJPJaJ#h*ihK5CJPJaJnHtHh*ihKCJaJnHtH h*ihKCJPJaJnHtHh*ihKCJaJ# *h*ihKCJPJaJnHtH878FR\covbS;;;$d$&dIfPa$gdba$d$Ifa$gdbaZd$If^Z`gdbakd8$$Ifrr/ by=$ 3+$44 aytbaopqrstuvbSSSS$d$Ifa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytbauvvbSSGG $$Ifa$gdba$d$Ifa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytbaǫϫt`QQEE $$Ifa$gdba$d$Ifa$gdbaZd$If^Z`gdbakdL$$IfVrr/ by=$ 3+$44 aytbaϫЫݫvbSSGG $$Ifa$gdba$d$Ifa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytba !%9vbS@4 $$Ifa$gdba$d$Ifa$gdba$d$Ifa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytba9BCeoxjVGG$d$Ifa$gdbaZd$If^Z`gdbakdH$$Ifrr/ by=$ 3+$44 aytba $$Ifa$gdba¬֬vbSSGG $$Ifa$gdba$d$Ifa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytbavbJJ55$$&dIfPa$gdba$d$&dIfPa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytba !vbSSSS$d$Ifa$gdbaZd$If^Z`gdbakd@$$Ifrr/ by=$ 3+$44 aytba!"4CD`hxyɭݭޭ#$-EMN^_no÷ΓÄxxh*ihKCJaJhh*ihKCJaJnHtH#h*ihKCJPJaJnHo(tH#h*ihK5CJPJaJnHtH *h*ihKCJaJh*ihKCJaJ h*ihKCJPJaJnHtH&h*ihKhCJPJaJnHtHh*ihK5CJaJ*!"4<DLTvbSSSS$d$Ifa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytbaTUhqy~vbJJJJ$d$&dIfPa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytbavbSSSS$d$Ifa$gdbaZd$If^Z`gdbakd8$$Ifrr/ by=$ 3+$44 aytba­vbJJJJ$d$&dIfPa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytba­íĭŭƭǭȭvbSSSS$d$Ifa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytbaȭɭvbOO:O$nd$4$If]na$gdba$nd$If]na$gdbaZd$If^Z`gdbakd0$$Ifrr/ by=$ 3+$44 aytba $,vdUUBU$d$Ifa$gdba$d$Ifa$gdbad$IfVDG^gdbakd$$Ifrr/ by=$ 3+$44 aytba,-GN_govdLLLL$d$&dIfPa$gdbad$IfVDG^gdbakd$$Ifrr/ by=$ 3+$44 aytbaopqrstuvbSSSS$d$Ifa$gdbaZd$If^Z`gdbakd($$Ifrr/ by=$ 3+$44 aytbauvwvbJJJJ$d$&dIfPa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytbavbSSSS$d$Ifa$gdbaZd$If^Z`gdbakdx$$Ifrr/ by=$ 3+$44 aytbavqeQBB%$d$Ifa$gdbaZd$If^Z`gdba $dG$a$gdKgdKkd $$Ifrr/ by=$ 3+$44 aytbaŮƮЮѮ?ijkvwλλλyyiyWyHyh*ihKCJaJnHtH"h*ihK5CJaJnHo(tHh*ihKCJaJnHo(tHh*ihK5CJaJh*ihKCJaJ+h*ihK5CJOJPJQJaJnHtH(h*ihKCJOJPJQJaJnHtH$h*ihKCJOJQJaJnH tH h*ihKCJOJQJaJ#h*ihK5CJPJaJnHtHh*ihK5CJaJnHtHƮѮۮSkd$$Ifrr zI7P"A44 aytba%$d$Ifa$gdba%$!d$Ifa$gdbaDkdp$$Ifrr zI7P"A44 aytba$d$Ifa$gdba$d$Ifa$gdbaZd$If^Z`gdba!+,3>?wXDZd$If^Z`gdbakd$$Ifrr zI7P"A44 aytba$d$Ifa$gdba$d$Ifa$gdbawxyz{|}~bNZd$If^Z`gdbakd$$Ifrr zI7P"A44 aytba%$!d$Ifa$gdbaw{|}ʯۯܯݯޯ ³볝|m]mG+h*ihKCJOJPJQJaJnHo(tHh*ihKCJaJnH o(tH h*ihKCJaJnH tH h*ihKCJaJo((h*ihKCJOJPJQJaJnHtH+h*ihKCJOJPJQJaJhnHtHh*ihKCJOJQJaJ#h*ihK5CJPJaJnHtHh*ihK5CJaJh*ihKCJaJ(h*ihKCJOJPJQJaJnHtHbN2%$!d$&dIfPa$gdbaZd$If^Z`gdbakdz$$Ifrr zI7P"A44 aytba%$!d$Ifa$gdbaܯZDJd$IfWDj^J`gdbakd"$$Ifrr zI7P"A44 aytba%$!d$&dIfPa$gdbaܯݯޯ߯!#bNd$If^`gdbakd$$Ifrr zI7P"A44 aytba%$!d$Ifa$gdba !"#$%&'(SjkrsְIʹʞt랉ʹdt랉ʹh*ihKCJaJnH o(tH (h*ihKCJOJPJQJaJnHtH(h*ihKCJOJPJQJaJnHtHh*ihKCJOJQJaJh*ihKCJaJo( h*ihKCJPJaJnHtHh*ihKCJaJ+h*ihKCJOJPJQJaJnHo(tH(h*ihKCJOJPJQJaJnHtH$#%'(ksbNd$If^`gdbakdr$$Ifrr zI7P"A44 aytba%$!d$Ifa$gdbav`LLLL%$!d$Ifa$gdba4d$IfWDt^4`gdbakd$$Ifrr zI7P"A44 aytba_hyv`DDDD%$!d$&dIfPa$gdba4d$IfWDt^4`gdbakd$$Ifrr zI7P"A44 aytbaIJ_ghxy±ʱα۱;͸͎ͣ͸͸wiwWw͸͎ͣ͸͎w#h*ihK5CJPJaJnHtHh*ihK5CJaJo(h*ihK5CJaJh*ihKCJaJ(h*ihKCJOJPJQJaJnHtH(h*ihKCJOJPJQJaJnHtH(h*ihKCJOJPJQJaJnHtHh*ihKCJOJQJaJ h*ihKCJPJaJnHtH#h*ihKCJPJaJnHo(tH"vbNNNN%$!d$Ifa$gdbaZd$If^Z`gdbakdj$$Ifrr zI7P"A44 aytba۱v`DDDD%$!d$&dIfPa$gdba:d$IfWD^`:gdbakd$$Ifrr zI7P"A44 aytbavbNNNN%$!d$Ifa$gdbaZd$If^Z`gdbakd$$Ifrr zI7P"A44 aytba@IQ^J..%$!d$&dIfPa$gdbaZd$If^Z`gdbakdb$$Ifrr zI7P"A44 aytba%$!d$If]a$gdba;?@HIPQXYabdhòIJԲղܲݲ <ҽҨҽҽҝҽҨҽҽҽҨҽҽҽҽҨҽҽ'h*ihKCJOJPJ\aJnHtHh*ihKCJaJ(h*ihKCJOJPJQJaJnHtH(h*ihKCJOJPJQJaJnHtHh*ihKCJOJQJaJh*ihK5CJaJ#h*ihK5CJPJaJnHtH/QYbcdeZF2%$!d$Ifa$gdbaZd$If^Z`gdbakd $$Ifrr zI7P"A44 aytba%$!d$&dIfPa$gdbaefghibPnd$IfWD2`ngdbakd$$Ifrr zI7P"A44 aytba%$!d$Ifa$gdba IJղݲvdHHHH%$!d$&dIfPa$gdband$IfWD2`ngdbakdZ$$Ifrr zI7P"A44 aytbavbNNNN%$!d$Ifa$gdbaZd$If^Z`gdbakd$$Ifrr zI7P"A44 aytbavbFFFF%$!d$&dIfPa$gdbaZd$If^Z`gdbakd$$Ifrr zI7P"A44 aytbavaaaaaaaaaa$d7$8$9DG$^a$gdKkdX$$Ifrr zI7P"A44 aytba  *5=DOYdl|%$!d$IfVD|WD^`a$gdba%$!d$Ifa$gdba%$d$Ifa$gdbaZd$If^Z`gdba$d1$7$8$9DG$^a$gdK$d7$8$9DG$^a$gdK<=CDOkl;Eʵʪ~raOa=a# *h*ihKCJPJaJnHtH#h*ihK5CJPJaJnHtH h*ihKCJPJaJnHtH *h*ihKCJaJh*ihK5CJaJnHtHh*ihK5CJaJh*ihKCJaJnHo(tHh*ihKCJaJ(h*ihKCJOJPJQJaJnHtH'h*ihKCJOJQJaJhnH tH h*ihKCJOJQJaJ$h*ihKCJOJQJaJnH tH lmnv~vbSSSS$d$Ifa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytbavbSSSDD$d$Ifa$gdba$d$Ifa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytbavbSSSS$d$Ifa$gdbaZd$If^Z`gdbakd\$$Ifrr/ by=$ 3+$44 aytbavbSSSS$d$Ifa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytba vbSSSS$d$Ifa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytba !/;EKWvbS;;;$d$&dIfPa$gdba$d$Ifa$gdbaZd$If^Z`gdbakdZ$$Ifrr/ by=$ 3+$44 aytbaEVY]^jkôĴŴ̴ʹδԴܴ )*+45Xabclmզ՚զզզh*ihKCJaJo(h*ihKCJaJnHo(tHh*ihKCJPJaJ#h*ihK5CJPJaJnHtH h*ihKCJPJaJnHtHh*ihKCJaJh*ihKCJaJnHtH:WXYZ[\]vbSSSS$d$Ifa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytba]^ksz}vbSSGG $$Ifa$gdba$d$Ifa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytbat`QQEE $$Ifa$gdba$d$Ifa$gdbaZd$If^Z`gdbakdn$$IfVrr/ by=$ 3+$44 aytbaôŴʹvbSSGG $$Ifa$gdba$d$Ifa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytbaʹδݴvbS@4 $$Ifa$gdba$d$Ifa$gdba$d$Ifa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytba )+5jVGG$d$Ifa$gdbaZd$If^Z`gdbakdj$$Ifrr/ by=$ 3+$44 aytba $$Ifa$gdba56NXacmvbSSGG $$Ifa$gdba$d$Ifa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytbamn|vbSSGG $$Ifa$gdba$d$Ifa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytbaǵɵvbJJJJ$d$&dIfPa$gdbaZd$If^Z`gdbakdb$$Ifrr/ by=$ 3+$44 aytbaǵȵɵʵ˵̵ϵе&8Hjlr  ,048:DtŶ蚆zhŦ覶#h*ihK5CJPJaJnHtH *h*ihKCJaJ&h*ihKhCJPJaJnHtHh*ihK5CJaJh*ihKCJaJnHo(tHh*ihKCJaJnHtH h*ihKCJPJaJnHtH#h*ihKCJPJaJnHo(tHh*ihKCJaJ *h*ihKCJaJ(ɵʵ˵̵͵εϵvbSSSS$d$Ifa$gdbaZd$If^Z`gdbakd $$Ifrr/ by=$ 3+$44 aytbaϵеvbSSSS$d$Ifa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytba&8HRdvbJJJJ$d$&dIfPa$gdbaZd$If^Z`gdbakdZ$$Ifrr/ by=$ 3+$44 aytbadfhjlnpvbSSSS$d$Ifa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytbaprƶԶvbJJJJ$d$&dIfPa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytbaԶֶضڶܶ޶vbSSSS$d$Ifa$gdbaZd$If^Z`gdbakdR$$Ifrr/ by=$ 3+$44 aytba,.068vbOO:O$nd$4$If]na$gdba$nd$If]na$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytba8:ftvdUUBU$d$Ifa$gdba$d$Ifa$gdbad$IfVDG^gdbakd$$Ifrr/ by=$ 3+$44 aytbaD D vdLLLL$d$&dIfPa$gdbad$IfVDG^gdbakdJ$$Ifrr/ by=$ 3+$44 aytbaD D D D D 5D 7D 8D 9D UD VD \D ]D gD hD D D D D D D tt_It+h*ihK5CJOJPJQJaJnHtH(h*ihKCJOJPJQJaJnHtH$h*ihKCJOJQJaJnH tH h*ihKCJOJQJaJ#h*ihK5CJPJaJnHtHh*ihK5CJaJnHtHh*ihK5CJaJU#h*ihKCJPJaJnHo(tHh*ihKCJaJh h*ihKCJPJaJnHtHh*ihKCJaJ410,83837,29414,349(2,667)48,976 The Group(excludingXincat)XincatAdjustmentThe Group(includingXincat)RMB000RMB000RMB000RMB000(as originallyreported)(Note)(Restated)Results for the year ended 31 December 2013 (Continued)Profit for the year37,29414,349(2,667)48,976Other comprehensive (expense) incomeItems that maybe reclassified subsequently to profit or loss:----Exchange differences arising on translation of a foreign operation(456)--(456)Fair value (loss) gain arising on available-for-sale financial assets (28,891)--(28,891)Income tax relating to components of other comprehensive income4,334--4,334Other comprehensive (expense) income for the year, net of tax(25,013)--(25,013)Total comprehensive income for the year12,28114,349(2,667)23,963Owners of the Company10,80014,349(11,941)13,208Non-controlling interests1,481 -9,27410,755 12,28114,349(2,667)23,963Note The adjustment comprise of elimination of the inter-group transactions and inter-group current accounts, elimination of the net assets of Xincat against the investment cost and non-controlling interests.The fair value of consideration for the acquisition of 40% equity interest of Xincat amounted to approximately RMB102,000,000.Net cash outflow from business combinationsRMB000Cash consideration paid102,000Earnings per share basic and dilutedThe effects of adoption merger accounting for common control combination on the Groups basic and diluted earnings per share for the year ended 2014 and 2013:20142013RMBRMB(Restated)Reported figures before adjustments0.1090.078Adjustments arising on common control combination-0.005Restated figures after adjustments0.1090.083By Order of the BoardShandong Xinhua Pharmaceutical Company LimitedZhang DaimingChairman27 March 2015, Zibo, PRCAs at the date of this announcement, the board of directors comprises: Executive Directors:Mr. Zhang Daiming (Chairman)Mr. Du DepingIndependent Non-executive Directors:Mr. Du GuanhuaMr. Li WenmingMr. Chan Chung Kik, LewisNon-executive Directors: Mr. Ren FulongMr. Xu Lie Mr. Zhao Bin PAGE PAGE  D D D D D D D vbSSSS$d$Ifa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytbaD D D D D 'D .D vbJJJJ$d$&dIfPa$gdbaZd$If^Z`gdbakd$$Ifrr/ by=$ 3+$44 aytba.D /D 0D 1D 2D 3D 4D vbSSSS$d$Ifa$gdbaZd$If^Z`gdbakdB$$Ifrr/ by=$ 3+$44 aytba4D 5D 7D 8D 9D CD ND vqeQBB%$d$Ifa$gdbaZd$If^Z`gdba $dG$a$gdKgdKkd$$Ifrr/ by=$ 3+$44 aytbaND VD ]D hD rD }D D D Skd$$Ifrr zI7P"A44 aytba%$d$Ifa$gdba%$!d$Ifa$gdbaD D D D D D D D Dkd:$$Ifrr zI7P"A44 aytba$d$Ifa$gdba$d$Ifa$gdbaZd$If^Z`gdbaD D D E E E E E E E E (E -E 3E 4E ;E IE JE ^E oE pE qE rE tE uE ششآwk\Mh*ihKCJOJQJaJh*ihKCJaJnH tH h*ihKCJaJo((h*ihKCJOJPJQJaJnHtH+h*ihKCJOJPJQJaJhnHtH#h*ihK5CJPJaJnHtH(h*ihKCJOJPJQJaJnHtHh*ihKCJaJnHtHh*ihK5CJaJh*ihKCJaJh*ihKCJaJnHo(tHD D D D D D D E XDZd$If^Z`gdbakd$$Ifrr zI7P"A44 aytba$d$Ifa$gdba$d$Ifa$gdbaE E E E E E E E E bNZd$If^Z`gdbakd$$Ifrr zI7P"A44 aytba%$!d$Ifa$gdbaE E E E -E 4E bN2%$!d$&dIfPa$gdbaZd$If^Z`gdbakdD$$Ifrr zI7P"A44 aytba%$!d$Ifa$gdba4E ;E CE JE KE pE ZDJd$IfWDj^J`gdbakd$$Ifrr zI7P"A44 aytba%$!d$&dIfPa$gdbapE qE rE sE tE uE E E E bNd$If^`gdbakd$$Ifrr zI7P"A44 aytba%$!d$Ifa$gdbauE E E E E E E E E E E E E E E F F F F F F F ʵʵʵʵwbL7ʵw(h*ihKCJOJPJQJaJnHtH+h*ihKCJOJPJQJaJnHo(tH(h*ihKCJOJPJQJaJnHtH+h*ihKCJOJPJQJaJnHo(tHh*ihKCJaJo( h*ihKCJPJaJnHtHh*ihKCJaJ(h*ihKCJOJPJQJaJnHtH+h*ihKCJOJPJQJaJnHo(tHh*ihKCJaJnH tH h*ihKCJaJnH o(tH E E E E E F F F F bNd$If^`gdbakd<$$Ifrr zI7P"A44 aytba%$!d$Ifa$gdbaF F F F 'F /F EF UF WF _F `F aF bF cF dF lF mF nF F F F Ͽϳϝr\G5#h*ihKCJPJaJnHo(tH(h*ihKCJOJPJQJaJnHtH+h*ihKCJOJPJQJaJnHo(tH(h*ihKCJOJPJQJaJnHtH+h*ihKCJOJPJQJaJnHo(tH+h*ihKCJOJPJQJaJnHo(tHh*ihKCJaJo(h*ihKCJaJnH o(tH h*ihKCJPJaJnHtHh*ihKCJaJ(h*ihKCJOJPJQJaJnHtHF F WF `F bF dF mF v`LLLL%$!d$Ifa$gdba4d$IfWDt^4`gdbakd$$Ifrr zI7P"A44 aytbamF nF F F F F F F v`DDDDD%$!d$&dIfPa$gdba4d$IfWDt^4`gdbakd$$Ifrr zI7P"A44 aytbaF F F F F F F F F F F F F F F F F F G G G G Ծ~sdsXJX8XԾ#h*ihK5CJPJaJnHtHh*ihK5CJaJo(h*ihK5CJaJh*ihKCJOJQJaJh*ihKCJaJ+h*ihKCJOJPJQJaJnHo(tH(h*ihKCJOJPJQJaJnHtH(h*ihKCJOJPJQJaJnHtH+h*ihKCJOJPJQJaJnHo(tH(h*ihKCJOJPJQJaJnHtH+h*ihKCJOJPJQJaJnHo(tHF F F F F F F vbNNNN%$!d$Ifa$gdbaZd$If^Z`gdbakd4$$Ifrr zI7P"A44 aytbaF F G G G G G G v`DDDDD%$!d$&dIfPa$gdba:d$IfWD^`:gdbakd$$Ifrr zI7P"A44 aytbaG G G G G G G G G G #G $G GG KG LG OG RG SG ZG iG kG oG G G G G G G G G ֪{֊o]o땊{땊#h*ihK5CJPJaJnHtHh*ihK5CJaJh*ihKCJOJQJaJh*ihKCJaJ(h*ihKCJOJPJQJaJnHtH+h*ihKCJOJPJQJaJnHo(tH+h*ihKCJOJPJQJaJnHo(tH(h*ihKCJOJPJQJaJnHtH(h*ihKCJOJPJQJaJnHtHG G G G G !G "G vbNNNN%$!d$Ifa$gdbaZd$If^Z`gdbakd $$Ifrr zI7P"A44 aytba"G #G $G LG SG ZG ^J..%$!d$&dIfPa$gdbaZd$If^Z`gdbakd, $$Ifrr zI7P"A44 aytba%$!d$If]a$gdbaZG bG iG jG kG lG ZF2%$!d$Ifa$gdbaZd$If^Z`gdbakd $$Ifrr zI7P"A44 aytba%$!d$&dIfPa$gdbalG mG nG oG pG G G G G G bPnd$IfWD2`ngdbakd| $$Ifrr zI7P"A44 aytba%$!d$Ifa$gdba G G G G G G G vdHHHH%$!d$&dIfPa$gdband$IfWD2`ngdbakd$ $$Ifrr zI7P"A44 aytbaG G G G G G G G G G G G G G G H H I .J /J =J @J MJ NJ ԿԿ}n^n^^Nh*ihK5CJaJnHtHh*ihKCJaJnHo(tHh*ihKCJaJnHtH#h*ihKCJPJaJnHo(tH+h*ihKCJOJPJQJaJnHo(tHh*ihKCJOJQJaJh*ihKCJaJ(h*ihKCJOJPJQJaJnHtH(h*ihKCJOJPJQJaJnHtH+h*ihKCJOJPJQJaJnHo(tHG G G G G G G vbNNNN%$!d$Ifa$gdbaZd$If^Z`gdbakd $$Ifrr zI7P"A44 aytbaG G G G G G G vbFFFF%$!d$&dIfPa$gdbaZd$If^Z`gdbakdt$$Ifrr zI7P"A44 aytbaG G G MJ NJ zJ J vj_jF7$d$Ifa$gdba%!Zd$If^Z`gdba $da$gdK $dG$a$gdKkd$$Ifrr zI7P"A44 aytbaNJ PJ yJ zJ J J J J J J J J J J 'K (K kK mK nK oK pK tK uK yK zK {K |K K K K K K K K K K K K K K K L L L *L 4L 5L ðÖÖvvvvvvÖÖÖvÖÖvh*ihKCJaJnHo(tHh*ihK5CJaJnHtHh*ihKCJaJh*ihKCJaJnHtH$h*ihK0JCJPJaJnHtHh*ihKCJOJQJaJ+h*ihK5CJOJPJQJaJnHtH.h*ihK5CJOJPJQJaJnHo(tH.J J J J J J 5Qkd$$$Ifl0,"644 laytba$d$Ifa$gdba%!Zd$If^Z`gdbaQkd$$Ifl0,"644 laytbaJ J J J J J oK pK uK zK fWW$d$Ifa$gdba%!Zd$If^Z`gdba $da$gdK $dG$a$gdKQkd$$Ifl0,"644 laytba$d$&dIfPa$gdba zK {K |K K K ss$d$Ifa$gdba%!Zd$If^Z`gdbadkd$$IflF,">%%6    44 laytbaK K K K K ss$d$Ifa$gdba%!Zd$If^Z`gdbadkdL$$IflF,">%%6    44 laytbaK K K K K ss$d$Ifa$gdba%!Zd$If^Z`gdbadkd$$IflF,">%%6    44 laytbaK K K K K ss$d$Ifa$gdba%!Zd$If^Z`gdbadkd$$IflF,">%%6    44 laytbaK K K K L jj$d$&dIfPa$gdba%!Zd$If^Z`gdbadkd$$IflF,">%%6    44 laytbaL L L L L ss$d$Ifa$gdba%!Zd$If^Z`gdbadkd$$IflF,">%%6    44 laytbaL L *L 0L 6L jj$d$&dIfPa$gdba%!Zd$If^Z`gdbadkdT$$IflF,">%%6    44 laytba5L 6L 7L 8L 9L :L PL ~L L L L L Ҿz\>(+h*ihm6B*CJOJQJ]aJph:h*ihm5B*CJOJPJQJ\aJnHo(phtH:h*ihzU5B*CJOJPJQJ\aJnHo(phtH+h*ihm5B*CJOJQJ\aJph%h*ihmB*CJOJQJaJph4h*ihmB*CJOJPJQJaJnHo(phtH&h*ih}CJPJ\aJnHo(tH&h*ih0CJPJ\aJnHo(tHh*ihKCJaJh*ihKCJaJnHtH 6L 7L 8L 9L :L PL L L L ~\\P $ ^ a$gdq"$0TPL HD@< ^ a$$ ^ a$^gdvd $da$gdx.dkd$$IflF,">%%6    44 laytbaL L L L L L L L L L L ĩs`E`,1h*ihmB*CJOJPJQJaJnHphtH4h*ihmB*CJOJPJQJaJnHo(phtH%h*ihmB*CJOJQJaJph4h*ihzUB*CJOJPJQJaJnHo(phtH4h*ih}B*CJOJPJQJaJnHo(phtH4h*ihpMSB*CJOJPJQJaJnHo(phtH4h*ihiB*CJOJPJQJaJnHo(phtH@h*ihm56B*CJOJPJQJ\]aJnHo(phtH L L L L L L M ,M :M ;M `M oM ~M M M M Gkd$$$If0!64 a )$$Ifa$$7$8$H$Ifgd} $7$8$H$If)$a$$^a$L L L L L L L M M M M ,M :M ;M `M dM nM oM sM uM }M ~M M M M M M ²tdTdIh*ihmKHaJh*ihmKHPJnHo(tHh*ih}KHPJnHo(tHh*ih7)KHPJnHo(tH,h*ihmB*OJPJQJnHo(phtH,h*ih}B*OJPJQJnHo(phtHh*ihqKHPJnHo(tHh*ih{6KHPJnHo(tHh*ihmKH)h*ihmB*OJPJQJnHphtHh*ihmB*OJQJphM M M M M M M M M M M M M M M M Gkd$$If0!64 a $7$8$H$If$7$8$H$IfgdpMS )$$Ifa$M M M M M M M M M M M M M M M M M M M M M M M M M M M    تءxtxtxtxtjdjd`jdj^SjdhZe0J$mHnHuUh*i h*i0J$jh*i0J$UhnjhnU+h*ihmCJOJPJQJaJnHo(tHh*ihmKHaJh*ihmKH,h*ihmB*OJPJQJnHo(phtH,h*ih{6B*OJPJQJnHo(phtHh*ihmB*OJQJphh*ihpMSKHPJnHo(tHh*ihpMSKHM M M M      #$a$##&`#$11     +h*ihmCJOJPJQJaJnHo(tHhnh*i h*io(90P/R :p=y:/ =!"#$n% nu*l?xK-PNG  IHDRryJzgAMA pHYsLLXtcPLTE#$ 84*&'"51;7.*?;2-2./+40)%(#,(=9950,+'=83.627383B>B?A=C?@=QNUQNJFBJFXU\Y^[DAZWIF]ZOKHDWSQMMJKHSOD@YUVSLISPFCYV[W^ZROLHOLWTb_`\a^b^`]iftrfc}pn|ymjxupmvtywc`li~{}{wt}{rogdvsda~{xuebnkkgkholtqheqnpnspzw{x~}ƵG'IDATx}|yNg˲$Dz6d[r^ 8&!iP*`Ԙ˒lbh^ZQ@!M#'MI4mt/kvӦMO$nwvgyfgwgt7<3(Z8˱!}t%O_dKU}*meDW܇lL7{]+>IcMC|l4IzO̚*Irìi.! gKz8T*%,佫X ˏ<&K$]vUtɑ,VEzIyH.#Ϛ!tifPIѳf$]Nfx$]F䜳fX$]>.fpHl]Κatg&o#K>k.8ietgƾUFI9|֌4&(D2I$ʴ[K\Co~$]YgȎ*FC$A#eY/c#"OFj+ <#۠1kZǮWM?f5$=Y!R+K.>k*qبPެM`$oY _&I1k̊/ 6/~"G̚J]Y͠E-%B$cJME.s`SϒrĬ9ö"^}2JOfdGʶ*Fwt%YSYw-V21 1y oU2l"lJK=G5ڠ}>i&{1kF%03%)Iy?|Tjzώ|vK{Áw돳L&)sI:i<";ZKܔ{< 5$1FT=twLW|^2? 6{) _%R;I1fI~3Dv F)+I3kFf4b[jNv)I3k* 5lc557{"bcfMsWz_&[lJ@E"̚ K,iM%]r̬IUlr̙p +颐cfM ߽٨Ɇ7t1QQai˿.9fdUll)] @5mB*ëN* tQ~͗26w_pS Iw5km{ޕCL3u B]!G͚,6gt9fִ: qsѪ”%(Y(iD TW#fMA$)/pY AA8z=CfMQ`J/{]MYS:Naq&(D08J;0tCfMQ@ "4\ҝfȶsidz?t;"G͚DtGaJJrܬs"paL IE5yBRlLB ͚.BSl鱊1;K;O9kz~"bsz s[QG#gMe~6iDjcLI!GΚ~ؤS\m%]Κ~$N#)}BܬQ`]j]|sa\Q#y0Y >/ <ʔ>&FzQœt/8EXlFt<ʔ_k=+= 071ox ɕpAqQj] *>~.6Q,tzM (Q_6\#frRLQB]uIRvpzM eۣ|mwJ63;VVX RԣLQ']iѧ3O޵ˍznq(ybE>)ΉFIX88S:U ,U3sdθT`"NBBonaEBORVV+x2j ' s%NR08E=ƓGVhbf#i+zbiӪ8SR"DKnb5rSWMu;6rH[!V#3S0Ow.Bd.A#[̕`XPg #ȂE#/93fZeɌ\S{<03Ol#4 2)J{d<=`[Sԗ ˀ\S%-x,-|@u=݅}55FJ77(\dcs'`}IIFKgnFmNڳw8B?Hz,s-ډ-}ֽ-V,a \954O|\*Kѹ\nW"ZO_^6MSa&y <07t|-s<7{<2*C6m,^YZ=@9Q(iE0b+ANlzQ~O9Q_\jVv^X !*y{F0DiR#ϲӓO5||@c|ȋA^Ɍ=t*"GIgPݙ-M> 9RP86uimڰJsp>/;|(|=i :\2noi@ Wߍ}kj qg@>a19i?K]~되>>7xlgߗ@g sh.~K|~ xs>"¹7U­Ůһ4vvg^i4so8xgkSdpG+'rmS}̈́ð)wh39jkku?ʒa@VfN6:%BwSTjc9u h5#p%k _=ANWvm)eͯlW+RuKw)]zYv})K-_%)kxb[nZ TVdxN~Uwjb;? bPVWȵ!|,<}qP ~9kZgL/g}lIV6z tNyPw\ܵ!1[gtwA[h%#N0y@d z|+C ŕ5G.Yn1<'`MMM7}dy(B#,yKg\7S;w²n r<0w :ҹ0)oux9֖~e⯖gs4[_Sۿ[ rf;G^8}EO{뢂G\Y/XId(Wp=Lh+ve7(so+}Gi'Mp_kk'KD74mфG-1 >cUƱe9 +5?r/:i@~D Gu݅fIZ`UEN 'D%=u\ 3A~ YoaEٷs7Dޠ_E8@-J1|s )rOAO.мE%!185<Ӧi_r`/qc/*!wR?̱+[=aǎ0{̱~}ee];Mf-nz1_W<o5O_cc>YF3>xפ@r.GΏcM]G}EuT)My+78ϻﵱ7Wa=U=_sYjr uK7xCuQ_?Yf n% ؜G-Y`n9 R9؆۳˔F„܀?mG^ {:Fߘ2C7CTk=\@pFk}j&'jv r5qC[:+@ުv߈MarCij BNԓ~P-w9j| 4E"G9 eljUc9!~sS̊PSFF:"YeSC\yHf GL2;6h3c&TiWyf|;tk$o59Yh{w{QȉJN,tΐH#\2*ّ$ʥ ~G0M}"'߇ǽ#FCx#;]vkr"']yVjMN\wn^ZǡWZ#Oo3w,J1G%EBOM_!X#ׯͦۡ"'rLQ5r})mx }M(%r3>QH}/yfN^܌ur"ȹOf5Z.\F|ߩch !~ kn*e#7vReUS8%!G~e`[pCheeAUsn+dz.~#GF3ܟ 9fu<' tW:H<:Kg I;N]:֜op?vԼ,Bkm܍VE8'w c$a_SPTVn58pi.7Ȋ|֜N)meX>wK*)07f^xz)G4w0oVjtP\RQ^so= PկMAwoIң_:û]ul#t0tHq}g:v.;'ѻ\^Vz9WʽRm5ݪ~yv N}Y!Pr&lj&(9f4@k|9!KE\oEqo*<#Z8kcu#QMe"w,:p/ė%"'W+S3'rN"Cr{\]^-P:~pOqL /r[+:@0#ֳ!9bb0,~[;|oB-l$rS't| !G4>ޱ ANg\RSVtDåZ-rTuif=˿1ȭ$K!O8f;`ŽsݦFvzozpWލ+++^=aG>@W2۱ή^=":۷{Eeu}sǂX>h#'Jg 3'U y>K ;rMyUQ v77- ?r*3arCޛ}u7^=n^n7]Vjz~T,PT|' %zo^ IL]" *^e6rg2OCy|l oPVmR rK?1f>B7pvk^77eT$r*gFE/AFj69iF= )N75u cy~iFƧ s|n14#kꑎ,EwA"^(m<x$|Drn=2P Wʻ Sp J<񉲋Jܔ3U=F/5>JtM"@4j|:@ !,rE/*քU5lώU}Mmy=wMu%{nA܇+ߒnzkݼhMBt#`+iyWw T?%EeM}'jӖb76f5`D<$Z $}7uQdk"%Z CrŃ⏤79#㦪5ǥDxOQEWaTnePu}?L(*hc^*R^QbEP/{ |%.#;f?d ?iKz $"l+is=x(J|kc.85`(hJ(l_sY^c%NQHiЕĶXĻCY#+=raDF+CBb~X?ĉx >< ptAwEԜӇjZRI7f. qmZ8CbeA!x%%p/ =K5Q$ݴkG\#^UC6I7rfU;o6n^6 _)ꊝeml 1vi,w.x4̉J.8IoIýlw'kmb JSQ>c釐<7 HһGGZSKG{WD{s{i\^6 <$=ߍq3htcS<W} 4|lMbϛvU*=8N1g,3{6]"Iqԋ[$|V'[g 4rgrH:X^6rWoqH8*n+t0E}hW f%&PQ U籤CE<L%.Iq`JmDCB555A5?4 yte$$If!vh5555555#v#v#v#v#v#v#v:V 0,,5 55>555A5?4 yte$$If!vh5555555#v#v#v#v#v#v#v:V 0,,5 55>555A5?4 yte$$If!vh5555555#v#v#v#v#v#v#v:V 0,,5 55>555A5?4 yte$$If!vh5555555#v#v#v#v#v#v#v:V 0,,5 55>555A5?4 yte$$If!vh5555555#v#v#v#v#v#v#v:V 0,,5 55>555A5?4 yte$$If!vh5555555#v#v#v#v#v#v#v:V 0,,5 55>555A5?4 yte"$$If!vh5555555#v#v#v#v#v#v#v:V 0,,5 55>555A5?/ 4 yte$$If!vh5555|5|55#v#v#v#v|#v:V 0,,555;55<4 yt$V$$If!vh5555|5|55#v#v#v#v|#v:V 0555;55<4 yt$V$$If!vh5555|5|55#v#v#v#v|#v:V 0,555;55<4 yt$V$$If!vh5555|5|55#v#v#v#v|#v:V 0,,555;55</ 4 yt$V$$If!vh5555|5|55#v#v#v#v|#v:V 0,,555;55</ 4 yt$V$$If!vh5555|5|55#v#v#v#v|#v:V 0,,555;55</ 4 yt$V$$If!vh5555555#v#v#v#v#v#v#v:V 0,,,5 552555@5E4 yte$$If!vh5555555#v#v#v#v#v#v#v:V 0,5 552555@5E4 yte$$If!vh5555555#v#v#v#v#v#v#v:V 0,5 552555@5E4 yte$$If!vh5555555#v#v#v#v#v#v#v:V 0,,5 552555@5E4 yte$$If!vh5555555#v#v#v#v#v#v#v:V 0,,5 552555@5E4 yte$$If!vh5555555#v#v#v#v#v#v#v:V 0,,5 55=555(5=4 yt$V$$If!vh5555555#v#v#v#v#v#v#v:V 0,,,5 55=555(5=4 yt#$$If!vh5555555#v#v#v#v#v#v#v:V 0,,5 55=555@5E4 yte$$If!vh5555555#v#v#v#v#v#v#v:V 0,,5 55=555@5E4 yte$$If!vh5555555#v#v#v#v#v#v#v:V 0,,5 55=555@5E4 yte$$If!vh5555555#v#v#v#v#v#v#v:V 0,,5 55=555@5E4 yte"$$If!vh5555555#v#v#v#v#v#v#v:V 0,,5 55=555@5E/ 4 yte$$IfS!vh5N55n555o5o#vN#v#vn#v#vo:V 0%,,5N55n55o4 aSyt$V$$IfS!vh5N55n555o5o#vN#v#vn#v#vo:V 0%5N55n55o4 aSyt$V$$IfS!vh5N55n555o5o#vN#v#vn#v#vo:V 0%,5N55n55o4 aSyt$V$$IfS!vh5N55n555o5o#vN#v#vn#v#vo:V 0%,5N55n55o/ 4 aSyt$V$$IfS!vh5N55n555o5o#vN#v#vn#v#vo:V 0%,5N55n55o/ 4 aSyt$V$$IfS!vh5N55n555o5o#vN#v#vn#v#vo:V 0%,5N55n55o/ 4 aSyt$Vo$$IfS!vh5&5 #v&#v :V 49!,5&5 4 aSf4yt$Vy$$IfS!vh5&55#v&#v#v:V 9!5&554 aSyt$V$$IfS!vh5&55#v&#v#v:V 9!,5&554 aSyt$Vy$$IfS!vh5&55#v&#v#v:V 9!5&554 aSyt$V$$IfS!vh5&55#v&#v#v:V 9!,5&554 aSyt$V$$IfS!vh5&55#v&#v#v:V 9!,5&554 aSyt$V$$IfS!vh5&55#v&#v#v:V 9!,5&554 aSyt$V$$IfS!vh5&55#v&#v#v:V 9!,5&554 aSyt$V$$IfS!vh5&55#v&#v#v:V 9!,5&554 aSyt$V$$IfS!vh5&55#v&#v#v:V 9!,5&554 aSyt$Vb$$If1!vh555#v#v:V l8!55a1yt$Vh$$If1!vh555#v#v:V l8!,55a1yt$Vb$$If1!vh555#v#v:V l8!55a1yt$Vb$$If1!vh555#v#v:V l8!55a1yt$Vh$$If1!vh555#v#v:V l8!,55a1yt$Vh$$If1!vh555#v#v:V l8!,55a1yt$Vv$$If1!vh555#v#v:V l8!,55/ a1yt$Vv$$If1!vh555#v#v:V l8!,55/ a1yt$Vh$$If1!vh555#v#v:V l8!,55a1yt$Vv$$If1!vh555#v#v:V l8!,55/ a1yt$Vv$$If1!vh555#v#v:V l8!,55/ a1yt$Vh$$If1!vh555#v#v:V l8!,55a1yt$Vh$$If1!vh555#v#v:V l8!,55a1yt$Vv$$If1!vh555#v#v:V l8!,55/ a1yt$Vv$$If1!vh555#v#v:V l8!,55/ a1yt_l$$If1!vh555#v#v:V lP8!,55a1yt_b$$If1!vh555#v#v:V l8!55a1yt$Vh$$If1!vh555#v#v:V l8!,55a1yt$Vb$$If1!vh555#v#v:V l8!55a1yt$Vb$$If1!vh555#v#v:V l8!55a1yt$Vh$$If1!vh555#v#v:V l8!,55a1yt$Vh$$If1!vh555#v#v:V l8!,55a1yt$Vh$$If1!vh555#v#v:V l8!,55a1yt$Vh$$If1!vh555#v#v:V l8!,55a1yt$Vh$$If1!vh555#v#v:V l8!,55a1yt$Vh$$If1!vh555#v#v:V l8!,55a1yt$Vh$$If1!vh555#v#v:V l8!,55a1yt$Vh$$If1!vh555#v#v:V l8!,55a1yt$Vb$$If1!vh5 55#v #v:V l 5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vf$$If1!vh5 55#v #v:V lt 5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vp$$If1!vh5&55#v&#v#v:V l!5&55a1yt$Vv$$If1!vh5&55#v&#v#v:V l!,5&55a1yt$Vp$$If1!vh5&55#v&#v#v:V l!5&55a1yt$Vv$$If1!vh5&55#v&#v#v:V l!,5&55a1yt$Vv$$If1!vh5&55#v&#v#v:V l!,5&55a1yt$Vv$$If1!vh5&55#v&#v#v:V l!,5&55a1yt$Vv$$If1!vh5&55#v&#v#v:V l!,5&55a1yt$Vv$$If1!vh5&55#v&#v#v:V l!,5&55a1yt$Vv$$If1!vh5&55#v&#v#v:V l!,5&55a1yt$Vv$$If1!vh5&55#v&#v#v:V l!,5&55a1yt$V|$$If1!vh5&55#v&#v#v:V l!,,5&55a1yt$V|$$If1!vh5&55#v&#v#v:V l!,,5&55a1yt$Vv$$If1!vh5&55#v&#v#v:V l!,5&55a1yt$Vv$$If1!vh5&55#v&#v#v:V l!,5&55a1yt$Vv$$If1!vh5&55#v&#v#v:V l!,5&55a1yt$Vv$$If1!vh5&55#v&#v#v:V l!,5&55a1yt$Vv$$If1!vh5&55#v&#v#v:V l!,5&55a1yt$Vv$$If1!vh5&55#v&#v#v:V l!,5&55a1yt$Vv$$If1!vh5&55#v&#v#v:V l!,5&55a1yt$Vv$$If1!vh5&55#v&#v#v:V l!,5&55a1yt$Vv$$If1!vh5&55#v&#v#v:V l!,5&55a1yt$Vv$$If1!vh5&55#v&#v#v:V l!,5&55a1yt$V|$$If1!vh5&55#v&#v#v:V l!,,5&55a1yt$Vv$$If1!vh5&55#v&#v#v:V l!,5&55a1yt$Vv$$If1!vh5&55#v&#v#v:V l!,5&55a1yt$Vp$$If1!vh5&55#v&#v#v:V l!5&55a1yt$Vv$$If1!vh5&55#v&#v#v:V l!,5&55a1yt$Vp$$If1!vh5&55#v&#v#v:V l!5&55a1yt$Vp$$If1!vh5&55#v&#v#v:V l!5&55a1yt$Vp$$If1!vh5&55#v&#v#v:V l!5&55a1yt$Vv$$If1!vh5&55#v&#v#v:V l!,5&55a1yt$Vp$$If1!vh5&55#v&#v#v:V l!5&55a1yt$Vv$$If1!vh5&55#v&#v#v:V l!,5&55a1yt$Vb$$If1!vh5 55#v #v:V l 5 5a1yt$Vb$$If1!vh5 55#v #v:V l 5 5a1yt$Vb$$If1!vh5 55#v #v:V l 5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vl$$If1!vh5 55#v #v:V l) ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vb$$If1!vh5 55#v #v:V l 5 5a1yt$Vb$$If1!vh5 55#v #v:V l 5 5a1yt$Vb$$If1!vh5 55#v #v:V l 5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vb$$If1!vh5 55#v #v:V l 5 5a1yt$Vb$$If1!vh5 55#v #v:V l 5 5a1yt$Vb$$If1!vh5 55#v #v:V l 5 5a1yt$Vr$$If1!vh5 55#v #v:V l> ,,5 5a1yt$Vn$$If1!vh5 55#v #v:V l ,,5 5a1yt$Vn$$If1!vh5 55#v #v:V l ,,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vg$$If1!vh5 55#v #v:V l 5 5a1yt$Vg$$If1!vh5 55#v #v:V l 5 5a1yt$Vg$$If1!vh5 55#v #v:V l 5 5a1yt$Vs$$If1!vh5 55#v #v:V l ,,5 5a1yt$Vs$$If1!vh5 55#v #v:V l ,,5 5a1yt$Vs$$If1!vh5 55#v #v:V l ,,5 5a1yt$Vq$$If1!vh5 55#v #v:V l\ ,5 5a1yt$Vm$$If1!vh5 55#v #v:V l ,5 5a1yt$Vb$$If1!vh5 55#v #v:V l 5 5a1yt$Vb$$If1!vh5 55#v #v:V l 5 5a1yt$Vb$$If1!vh5 55#v #v:V l 5 5a1yt$Vn$$If1!vh5 55#v #v:V l ,,5 5a1yt$Vn$$If1!vh5 55#v #v:V l ,,5 5a1yt$Vn$$If1!vh5 55#v #v:V l ,,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vb$$If1!vh5 55#v #v:V l 5 5a1yt$Vb$$If1!vh5 55#v #v:V l 5 5a1yt$Vb$$If1!vh5 55#v #v:V l 5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vb$$If1!vh5 55#v #v:V l 5 5a1yt$Vb$$If1!vh5 55#v #v:V l 5 5a1yt$Vn$$If1!vh5 55#v #v:V l ,,5 5a1yt$Vn$$If1!vh5 55#v #v:V l ,,5 5a1yt$Vn$$If1!vh5 55#v #v:V l ,,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vh$$If1!vh5 55#v #v:V l ,5 5a1yt$Vb$$If!vh5F55#vF#v:V l5F5ayt$Vb$$If!vh5F55#vF#v:V l5F5ayt$Vb$$If!vh5F55#vF#v:V l5F5ayt$Vb$$If!vh5F55#vF#v:V l5F5ayt$Vb$$If!vh5F55#vF#v:V l5F5ayt$Vh$$If!vh5F55#vF#v:V l,5F5ayt$Vh$$If!vh5F55#vF#v:V l,5F5ayt$Vh$$If!vh5F55#vF#v:V l,5F5ayt$Vh$$If!vh5F55#vF#v:V l,5F5ayt$Vh$$If!vh5F55#vF#v:V l,5F5ayt$Vh$$If!vh5F55#vF#v:V l,5F5ayt$Vh$$If!vh5F55#vF#v:V l,5F5ayt$Vh$$If!vh5F55#vF#v:V l,5F5ayt$Vh$$If!vh5F55#vF#v:V l,5F5ayt$Vh$$If!vh5F55#vF#v:V l,5F5ayt$Vh$$If!vh5F55#vF#v:V l,5F5ayt$Vh$$If!vh5F55#vF#v:V l,5F5ayt$Vh$$If!vh5F55#vF#v:V l,5F5ayt$Vh$$If!vh5F55#vF#v:V l,5F5ayt$Vh$$If!vh5F55#vF#v:V l,5F5ayt$Vh$$If!vh5F55#vF#v:V l,5F5ayt$Vh$$If!vh5F55#vF#v:V l,5F5ayt$Vh$$If!vh5F55#vF#v:V l,5F5ayt$Vh$$If!vh5F55#vF#v:V l,5F5ayt$Vb$$If!vh555#v#v:V lg55ayt$Vb$$If!vh555#v#v:V lg55ayt$Vb$$If!vh555#v#v:V lg55ayt$Vh$$If!vh555#v#v:V lg,55ayt$Vh$$If!vh555#v#v:V lg,55ayt$Vh$$If!vh555#v#v:V lg,55ayt$Vh$$If!vh555#v#v:V lg,55ayt$V$$If!vh5 5{555"#v #v{#v#v#v":V lW06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l+06555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V lO06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ / ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V ll06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V lS06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ / ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ / ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l/06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l/06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l/06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ / ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ / ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ / ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ / ytba$$If!vh5 5{555"#v #v{#v#v#v":V lN06,555!55_/ / ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l?6,555f55ytba$$If!vh555U5U5a#v#v#vU#va:V lW06,5 55T5vytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5vytba$$If!vh555U5U5a#v#v#vU#va:V l+065 55T5vytba$$If!vh555U5U5a#v#v#vU#va:V l065 55T5vytba$$If!vh555U5U5a#v#v#vU#va:V lr065 55T5vytba$$If!vh555U5U5a#v#v#vU#va:V l065 55T5vytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5vytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5vytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5vytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5vytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5vytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5vytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5vytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5v/ ytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5v/ ytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5v/ ytba$$If!vh555U5U5a#v#v#vU#va:V lO06,5 55T5v/ ytba$$If!vh555U5U5a#v#v#vU#va:V l:06,5 55T5v/ / ytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5v/ ytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5v/ ytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5vytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5v/ ytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5v/ ytba$$If!vh555U5U5a#v#v#vU#va:V ll06,5 55T5vytba$$If!vh555U5U5a#v#v#vU#va:V lY06,5 55T5vytba$$If!vh555U5U5a#v#v#vU#va:V lS06,5 55T5vytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5vytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5v/ ytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5v/ / ytba$$If!vh555U5U5a#v#v#vU#va:V l:06,5 55T5v/ / ytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5v/ ytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5v/ ytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5v/ ytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5v/ ytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5vytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5vytba$$If!vh555U5U5a#v#v#vU#va:V lU06,5 55T5vytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5v/ ytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5v/ ytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5v/ ytba$$If!vh555U5U5a#v#v#vU#va:V l:06,5 55T5v/ / ytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5v/ ytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5v/ / ytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5v/ / ytba$$If!vh555U5U5a#v#v#vU#va:V l06,5 55T5v/ / ytba$$If!vh555U5U5a#v#v#vU#va:V lN06,5 55T5v/ / ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l?6,555f55ytba$$If!vh5 5{555"#v #v{#v#v#v":V lW06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l+06555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l106555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V lO06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ / ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V ll06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V lY06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V lS06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ / ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ / ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V lZ06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ / ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ / ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ / ytba$$If!vh5 5{555"#v #v{#v#v#v":V l06,555!55_/ / ytba$$If!vh5 5{555"#v #v{#v#v#v":V lN06,555!55_/ / ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6555f55ytba$$If!vh5 5555#v #v#v#v#v:V lX6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l6,555f55ytba$$If!vh5 5555#v #v#v#v#v:V l?6,,555f55ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,,,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,,,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+5/ 4 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+5/ 4 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V V$,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,,,,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,,,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,,,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+5/ 4 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+5/ 4 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V V$,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5 5355+5#v #v3#v#v+#v:V $,5 5355+54 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,,,,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba$$If!vh5( 5555#v( #v#v#v#v:V ,555A554 ytba^$$If!vh55#v#v:V l6,55ytba^$$If!vh55#v#v:V l6,55ytba^$$If!vh55#v#v:V l6,55ytbaf$$If!vh5t55#vt#v:V l6,5>5%ytbaf$$If!vh5t55#vt#v:V l6,5>5%ytbaf$$If!vh5t55#vt#v:V l6,5>5%ytbaf$$If!vh5t55#vt#v:V l6,5>5%ytbaf$$If!vh5t55#vt#v:V l6,5>5%ytbaf$$If!vh5t55#vt#v:V l6,5>5%ytbaf$$If!vh5t55#vt#v:V l6,5>5%ytbaf$$If!vh5t55#vt#v:V l6,5>5%ytba[$$If!vh55#v:V 6544 [$$If!vh55#v:V 6544 000D@D cke1$ CJKH_HaJmH nHsH tHn@n h 1,Section Heading$$dBTJ@&5CJ,KH,\aJ,V@V h 2$$d@&5CJ OJPJ QJ\aJ J@J h 3$$d@&5CJ \aJ V@V h 4$$dx"@&5CJOJPJ QJ\aJJ@J h 5$$dx"@&5CJ\aJN@N h 6$$d@@@&5OJPJ QJ\B@B h 7$$d@@@&5\H@H h 8$$d@@@& OJPJ QJz @z h 9,Legal Level 1.1.1.1. $$d@@@&CJOJPJ QJaJ$A@$ ؞k=W[SOFi@F nfhO> 0NotesdB*CJaJphO Body textc$>TPL HD@<Td1$7$8$H$^Ta$-B*CJOJ QJ _HaJmH nHphsH tHHOH Subhead 1Td^T ;CJaJ~O~ Subhead 2B$'PL HD@<Q^`a$5B*\phLZ@L ~e,g$a$$CJOJPJQJaJmHnHsHtH<O< write $a$CJPJnHtHpOpChar Char Char Char!d1$CJKHPJaJmHnHtHu.". yblFhe,g"CJaJ6 @26 0u#9r G$CJaJ)@A uxP@RP 0u w%!d1$CJKHOJPJ QJaJtH 0b0 le,g&G$CJaJPOrP Anrede' 1$KHOJPJQJaJtH VOV W[CQ W[CQ(d1$CJKHPJaJmHnHtHudOd Default)1$7$8$H$-B*CJOJQJ_HaJmH nHphsH tH O med1HH  Balloon Text+CJOJQJ^JaJ4O4 cke1,B*OJQJph0`@0 HTML 0W@W-6]Be@B  HTML @P h/$<@&a$5CJ OJPJQJ\^JaJ K@ y|T0([@( 5uP[N~{T1\J@"\ oRh2$d8<@&a$"5CJ KHOJPJQJ\^JaJ -2 [e,g43 ` @ 1$3$5$7$8$G$0CJKHOJPJQJ^J_HaJmH nHsH tH6%@B6 [ON0W@W4G$ OJQJ^J.?@R. ~_g5dVD4^d4/@b4 Rh68WD8^`8<2@r< Rh 27d8VDWD8^d`8<3@< Rh 38d8VDWD8^d`8<4@< Rh 49d8VDXWD8^d`8<5@< Rh 5:d8VD WD8^d`8,1@, RhS ; & F0:@0 RhS 2 < & F0;@0 RhS 3 = & F0<@0 RhS 4 > & F0=@0 RhS 5 ? & F4D@4 Rhc~@xVD^8E@8 Rhc~ 2AHxVD^H8F@"8 Rhc~ 3BxVDX^8G@28 Rhc~ 4CxVD ^8H@B8 Rhc~ 5D4xVD^400@R0 Rhyv&{S E & F46@b4 Rhyv&{S 2 F & F47@r4 Rhyv&{S 3 G & F48@4 Rhyv&{S 4 H & F 49@4 Rhyv&{S 5 I & F $@$vU_ 1J00vU_ 2KVD^00vU_ 3LHVD^H00vU_ 4MVDX^00vU_ 5NVD ^00vU_ 6O4VD^400vU_ 7P VD^ 00vU_ 8Q| VDx^| 00vU_ 9R VD@^ $@2$ TybleW[SROAR Ss Char Char1$CJKHPJ_HaJmH nHsH tH*j@12* Vybl;NU5\VOaV Us Char Char*5CJKHPJ\_HaJmH nHsH tH(^@r( nf(Qz)W,@@, ~{TXdVD4^d,L@, egYdVD ^dX$@X 6eON0W@W(Zd&+D/G$VDx^d OJQJ^J$ @$"}_ 1[0 0"}_ 2\VD^0 0"}_ 3]VD^00"}_ 4^XVDX^X00"}_ 5_ VD ^ 00"}_ 6`VD^00"}_ 7aVD^00"}_ 8bxVDx^x00"}_ 9c@VD@^@6!6 "}_hd5OJQJ\^J8"@8 leCJOJPJ QJ^JaJ4#4 VhvU_f8VDWD8`8(+r( >\le,ggG$>T@> e,gWWhxUDVD]^8Y8 ech~gVi-D M I@ Oo`hoj8$d%d&d'd-DM NOPQVDWD ^8` OJQJ^J0,0 _evU_kVD^<.< _evU_hlxOJPJQJ^J(B@( ckee,gmx4M@4 ckeL)ۏnWDd`8C@8 ckee,g)ۏoxVD^8N@8 ckeL)ۏ 2pWD`0@0 cke)ۏqWD`2P@"2 ckee,g 2 rdx4Q@24 ckee,g 3sxCJaJBR@BB ckee,g)ۏ 2tdxVD^DS@RD ckee,g)ۏ 3uxVD^CJaJ*O@* lʑhv$a$6Oq6 short_text1CJaJ8O8 medium_text1CJaJ4O4 long_text1CJaJvOv T Report Text-z$d1$5$7$8$9DH$^a$KHPJ aJmH sH tH JOJ T body text{xx1$CJKHaJtH VOV T RQk=|d1$WD`CJKHOJPJ QJaJtH O z hps`` sQ*B* ph@fOf 4jp Char Char1 Chard1$CJKHOJPJQJaJtH &O!& e_4hps atnJO1J %IA^0 Char Char3OJPJ QJ_HmH sH tH ROAR #IA^0 Char Char4$CJKHPJ_HaJmH nHsH tH"W@Q" 3Pp5\VObV JvnUk=d1$VD^CJKHOJPJ QJaJtH JOqJ -s Char Char2OJPJ QJ_HmH sH tH NON i Char Char6 CJKHPJ_HmH nHsH tHO nordinary-output target-outputdd1$[$\$KHOJPJQJ^JnHtH4O4 nhigh-light-bg4FOF SAHPa2dB*OJPJQJnHphtHJOJ  Header CharOJPJ QJ^JmHsHtH JOJ  Footer CharOJPJ QJ^JmHsHtH jOj KList Paragraphd1$VD^CJKHOJPJ QJaJtH XOX _ RQk=1d1$WD`CJKHOJPJ QJaJtH $&@ $ Kl_(uH*('@ ( Kybl_(uCJaJBO" B Kckee,g1xx1$CJKHaJtH >2 >K0O1OJPJ QJ_HmH sH tH JOA J K Char Char5CJKHOJPJQJnHtHOR K E-Body text.$3d,1$7$8$H$a$5B*CJOJPJQJ^J_HaJmH nHphsH tHROb R KgQe1dh1$9DH$ CJOJ PJ _HmH nHsH tH.Oq . K label_list1*O! * Knote56 %+38CHPQRS^ijr| -4;AB|   !"/9CMN`lx   G 5555 ^!^@0@0@0@0@0@0@0@0@0@0@0@0@0@00@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@v0@0@0@0@0 @0@0@0@0@0@0@0@0@0 @0@0 @0@0 @0@0 @0 @00@00@00@00@00@0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0@ 0ʑ0k0l0 ʑ0m0nP0 ʑ0o0p4?0! ʑ0q0r5?o0 ʑ0s0t85?0 ʑ0u0vp5?f ʑ0w0x5?0 0qrtuv"CD %+38CHPQRS^ijr| -4;AB|   !"/9CMN`lx   G H b c h m t y } ~   ( 9 J [ ` q  1 @ N ] d r   , 0 _ v z { | } &+<MNEFG| ./CDValy!23E&'RS01~01 ! " !!""##%%9&:&(() )))W*X***R.S.T.h.i.t/u///B2C244q6r6&8'8E9F999t<u<==>>??AABBBBCCDD*F+FfGgG`HaHnHoHKLMMMMNNnQoQSS7T8TUUVV1X2XXXYY[[]]^]_]g_h_aaaabbAdBdddIfJf`fafxfyf&g'ggghhhhii}i~iiiiiiiiiiijj'j(jajmjjjjjjjjj kk-k4k6k7k>kFkNkOkfkjkmknkkkkkkkkkkkkkklll:lLl^l_lelllsltlllllllllmm!m"m(m0m8m9mFmNm_m`mmmnnooJpKp1q2qMqNqrrss9s:sssttkvlvmvww w!wwwww|y}yyyzz{{{{(|)|*|0|5|:|;|<|=|E|M|N|O|P|Q|\|]|e|f|p|z|{||||||||||||||||||||||||}}}} })}*}L}M}W}a}b}z}{}}}}}}}}}}}}}}}}}}}}}}~~~~~~~~~$~+~,~-~.~/~0~1~V~W~X~Y~Z~p~q~x~~~~~~~~~~~~~~~~~~~~~~~~~~NOPUZ_`abjrstuv^_gmnŀƀ  ^_fopqrstu߁!")123456789AHIJKxyzɂԂՂ34>HRSlmu}Ƀʃ$,45IJQX_`ijlrxy  *+:;<=>?LMU]efυхم!'(STV]deԆՆ܆ކ )*2:BCDEFGHIJKU_ij~ʇˇчׇ݇އ<=DV_`lmsyˆÈˈ͈ψЈ܈݈ !"#DEOW_`abcdef‰ÉĉʼnƉԉՉ݉01:@FGHIJKLMz{Êʊˊ̊͊ΊϊЊъފߊ !:;BHOPst|‹Ëʋҋًڋۋ܋݋ދߋ#$%&jk$%yz“\]]^*,rsʚ˚ۛܛ !7ano֜9xZסm΢ϢRS<=ABmnij/-.ab}~\]67kl =>T̶Ͷ*YZt}ķŷ߷MNrɸʸ !d67 ǾȾ89 G"#&'STefIJ{|YZ23tuNO&'wxDE()op de34()ghklWX,-pq78  `a          JKLMNef+{|}?@defg|}~ $,-./0123456>?@ABCDEFWaiqy !"#$%;DLT]cdlmnopqrstuv6789NOP]^t)3;CKQS]^rx#'(0123456789:MNOPQRSZ[pqrtuvw`a&';<=RS`v!)0:;XYZ[\]efghijklmn  -./012<=>_`avw $.6>FMWXuvwxyz()*+,-./01JKLMNOYZ[!!w"x"""""#####*#@#\#########################$ $$$e$m$t$z$$$$$$$$$$$$$T%]%f%h%l%n%w%x%%%%%%%%%& &&&&&&&5&;&?&B&D&F&L&M&&&&&&&&&&&&&&&&&'''&','.'4'5'6'''''}(~(((((((((()) )))!)")*)+),)-).)/)0)1)2)3)C)I)O)R)V)X)^)_)m)v))))))))))))))))**T*U*V*k*l*y*************++++++++ + +1+9+@+F+M+O+W+X+++++++++,,, ,$,&,*,+,,,,,,,,,,,,,,---!-'-+-.-0-2-8-9-t-y-~--------------......".#.$.....t/u/v///////////00000!0"0#0$0%0&0'0(0)0*0:0@0D0H0L0O0U0V0d0m0v0x00000000000000001111111111111111222!2"2)2=2E2F2N2b2j2k2r2222222222222n3o33344444444444444555555B5I5P5Q55555555555555555J6R6Z6[6\6]6^6_6`6g6n6o6666666666666666666677 7 7 777777*7+7M7N7O7P7]7d7k7l7777777777777777777777777777778899::;;E<F<G<L<Q<R<S<[<c<d<e<f<q<r<<<<<<<<<<<<<====i=o=t=u=========">*>2>3>[>a>d>e>>>>>>>??5?=?C?D?c?i?o?p?q?r?s?t???????`@a@{@|@@@@@@@@@@@@@@@A$A,A-ATAZA`AaAAAAAAAAAAAAAABBBBBBB+B/B3B4BlBsBzB{BBBBBBBBBBBCCCCCC0C6C8C9C:C;CMBMFMHMIMJMKMNNOOOOOOOOOOOOOOOOOOPP"P#PNPRPVPWPXPYPZP[PaPiPqPrPsPQQSSTTT TTTTT!T"T#T$T/T0T@TFTMTNTvTzT~TTTTTTTTTTTTTTTEVFVVVVVVVVVVVVVVVVVVVVVVV#W)W/W0WMWQWUWVWWWXWYWZWiWpWwWxWyWXXYYYYYYYYYYZZZZZZ!Z(Z.Z/ZJZNZSZTZyZ{ZZZZZZZZZZZZZZZZ[[\\;]<]\]]]^]c]h]i]j]r]z]{]|]}]]]]]]]]]]]]^ ^ ^ ^^^^^^ ^!^"^^^^^^^^^^^^^^^^^^^__$_%_S_Y___`_r_x_~____________`````^a_a`aeajakalata|a}a~aaaaaaaaaaaaaaaaaab bbbeblbnbobpbqbrbsbbbbbbbbbbbbb*c0c6c7c8c9c:c;cPcQcRcScccccccccccdd=d@dBdCdTdXdZd[d\d]d^d_ddddddddddddddeeGgHgshth;iENVW`jqxߊ ')0789:;<=>KU]fpqrstuvw  &.02:;<=>?@ABLNPZ[\]^_`ablt}Čόٌ)*1<=STUVWXYZ[\]^qrstuvЍۍ(12\elr{|Վݎ(1@JSThpw|!)2=>MNOPQR_hpz.?GQYZɑБё  #,4>GHIJKLMNOZcitu’˒̒ޒ *12MRX^deǓΓϓړܓ*28CDEFGHIJ]fns|}~ƔєҔӔԔՔߔ!"#+3;CDEFGNOPqrstuvwxyz{|Ǖȕѕܕ&0789:;<=>kvŖ͖Ֆ֖זٖؖږۖܖ012345NVeowxƗǗҗۗ%/789:;<=>?HWajklmnopqr}ȘИט !"#2<=DOP|}~řљۙ  !3:>FNO\ej~š .8AU_`nw}Û˛ӛԛ    !)19ABCDEFGHmnorstƜ͜ޜ !+6>EPZemnow%-56[\]^_` goޟ ZbsȠРؠ!"<CT\defghijklu}áΡء()0;<hijklmnopqrs{Ģʢ֢עآ٢ڢۢܢݢ!#)*7?BDLM\egirsͣף  6<>FHIJKLMNOahow~̤Ӥڤ29@QXYsy{¥ͥեܥ&'(7ABITU¦ɦʦ2468:;~֧ߧ.4679?@ABCDEF˨Ҩ٨ #$>EGMUVWXYZ[\]dksz{|̪ͪ%&'NO:@FGy{Ϭ /0xy߭3BN\]^_abdeghjktuv000000000000000000000 000000 00000 00000 00000 00000 00000 00000 v0000 00000000 00000 00000 00000 00000 00000 0000 0 00000 00 00 00 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 00 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000 00 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000 00 00 0 0 0 0 0 v 0 0 0 v 0 0 0  0 0 0  0 0 0  0 0 0 0 0 0 0  0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0  0 0 0 0 0 0 0 0 0 0 0 000000000000000000)0000000000000000000000000000 %0 %0 %0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 #0 #0 0 0000000 0 %0 %0 0 0 0 %0 %0 0  0 %0 %0 0  0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0  0 %0 %0 0  00 %0 %0 0 0 0 %0 %0 0  0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 %0 0  0 %0 %0 0  0 %0 %0 0 0 0 %0 %0 0 0 0 %0 %0 0 00000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 %0 0 0 0 0 0 %0 0 0 0 0 0 0 0 0 0 0 0 000000000000000000000000000000000 0 0  0 0 0 0 0 0 0 0 0 0 0 00000000 0 0 0000000000000000 0 0 00000000000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0   0 0 0 0 0000000000000)0 00 00 00 0 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000  0   0   0   0   0   0   0   0   0   0 00 00 00 00 0  000 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 00 00 0  000 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000  00 0 0  00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000  00 0 0  00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 000   0 0  00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 0  0 0  00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0   0 0  00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 0 00 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  %0 0  %0 %0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000000000 %0 %0 0 0 0 0 0 0 '0 '0 0 0 '0 '0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0000 %0 %0 0 0 0 0 0 0 '0 '0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 #0 #0 0 %0 0 0 0 000000000 %0 %0 0 0 0 0 0 0 '0 '0 0 0 0 0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0  #0 #0 0  #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 %0 0 0 0 000000 %0 %0 0  0 0 0  #0 #0 0  #0 0 0  #0 0 0  #0 0 0  #0 #0 0  #0 #0 0  #0 #0 0  #0 #0 0  #0 0 0  #0 0 0  #0 #0 0  #0 #0 0  #0 #0 0  #0 #0 0  #0 #0 0  #0 #0 0  #0 #0 0  #0 #0 0 0 #0 #0 0  #0 0 0   0 0  #0 0 0  #0 #0 0 000 %0 %0 0  0 0 0  '0 '0 0  '0 '0 0  '0 '0 0  '0 '0 0  '0 '0 0  0 0 0 000000000000 0 0 0 0 0 0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 %0 0 0 0 %0 0 0 0 % 0 0 0 % 0 0 0 % 0 0 0 0 #0 #0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 00000 0 0 0  0 0 0  #0 #0 0  #0 #0 0  #0 #0 0  #0 #0 0 000000 0 0 0 0 0 0 0 0 #0 #0 0 0 #0 0 0 % #0 0 0 % #0 0 0 0 #0 #0 0 %0 0 0 0 00000000 0 0 0 0 0 0 0 0 #0 #0 0 0 #0 0 0 % #0 0 0 % #0 0 0 0 #0 #0 0 %0 #0 0 0 000000 0 0 0 0 0 0 0 0 #0 #0 0 0 #0 0 0 0 #0 0 0 0 #0 0 0 0 #0 #0 0 #0 #0 #0 0 0 #0 0 0 0000000 0 0 0 0 0 0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 0 0 0 000000000%0 0 0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 %0 #0 #0 0 %0 #0 #0 0 %0 0 0 0 %0 0 0 0 0000 0 0 0 0 0 0 0 0 #0 #0 0 0 #0 #0 0 0 #0 0 0 0 #0 0 0 0 #0 #0 0 0 #0 #0 0 %0 0 0 0 00000000 0 0 0 0 0 0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0  #0 #0#0 0 0 #0 #0 0  #0 #0 0  #0 #0 0 0 #0 #0 0 0 #0 #0 0  #0 #0 0  #0 #0 0 0 #0 #0 0 0 #0 #0 0  #0 #0 0  #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0  #0 #0 0  #0 #0 0 000 0000 00000000000 0 0 0 0 0 0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 0 #0 #0 0 00000000000000000000 %0%00 0  %0%00 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 00 %0%00 0  %0%00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 %0 0 0 0 0 0 %0 0 0 0 0 0 0 0 0 0 0 0 00000000000000000 %0%00 0  %0%00 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 00 %0%00 0  %0%00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 %0 0 0 0 0 0 %0 0 0 0 0 0 0 0 0 0 0 0 00000000000000000000000 %0%00 0  %0%00 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 000 %0%00 0  %0%00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 %0 0 0 0 0 0 %0 0 0 0 0 0 0 0 0 0 0 0 000000000000000000000000 %0%0%0 % %0 %0%0%0 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000 %0%0%0 %0 %0 %0%0%0 0 0 0 0 0 0 0 0 00 0 0 0 0 0 %0 %0 %0 %0 0 0 %0 %0 %0 %0 0 0 %0 %0 %0 %0 0  %0 %0 %0 %0 0 0 %0 %0 %0 %0 0 0 %0 %0 %0 %0 0  %0 %0 %0 %0 0  %0 %0 %0 %0 0 0 %0 %0 %0 %0 0  %0 %0 %0 %0 0 0 %0 %0 %0%0 %0 0 0 %0 %0 %0 %0 0 0 %0 %0 %0 %0 0  %0 %0 %0 %0 0  %0 %0 %0 %0 0 0 %0 %0 %0 %0 0 0 %0 %0 %0 %0 0 0000000000000000 %0%0%0 % %0 %0%0%0 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000 %0%0%0 %0 %0 %0%0%0 0 0 0 0 0 0 0 0 00 0 0 0 0 0 %0 %0 %0 %0 0 0 %0 %0 %0 %0 0 0 %0 %0 %0 %0 0  %0 %0 %0 %0 0 0 %0 %0 %0 %0 0 0 %0 %0 %0 %0 0  %0 %0 %0 %0 0  %0 %0 %0%0 %0 0 0 %0 %0 %0 %0 0  %0 %0 %0%0 %0 0 0 %0 %0 %0%0 %0 0 0 %0 %0 %0 %0 0 0 %0 %0 %0 %0 0  %0 %0 %0 %0 0  %0 %0 %0 %0 0 0 %0 %0 %0 %0 0 0 %0 %0 %0 %0 0 000%0 0 0 %0 0 0 %0 0 0 0000%0 0 0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 %0 0 0 0 0000000000)0)00000 0)0000 0 )00)0)0 0 0 ȑ00@0ȑ00G@0ȑ00G@0ȑ00G@0ȑ00G@#0@#0@0@#0@#0@0ȑ00Gqrtuv"CD %+38CHPQRS^ijr| -4;AB|   !"/9CMN`lx   G H b c h m t y } ~   (  1   , 0 _ v z { MNEFG|./CDV23E'RS01 ! " !!"" )))W*X***R.S.h.i.iiii'j(jjjjj kk6k7k>kNkOkfkmknkkkkkkkkkkkkll:l^l_lelsltllllllllm!m"m(m8m9mFm_m`m]^@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0 @0@0 @0@0 @0@0 @0 @0 @0 @0 @0 @0 @0@0@0@0@0 @0@0@0@0@0 @0@0@0@0@0 @0@0@0@0@0 @0@0@0@0@0 @v0@0@0@0@0 @0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0 @0@ 0@0@0@0@0@0@0@0@0@0@0@0@00m0n 0m0n8@0 0m0n8@0 @0 00@0 @0 00@0@000@0 @0 00 @0 @0 00  @0@0@0@0@0@0@0@000 008@0 0m0n8@0008@0@00k03 l@0@00n02 o@0 @0@0@0@0@0 @0@0@0@0@0 `0 @0@0@0@0@0 @0 0w0( xS@0 @0 @0 @0 00@0 @0 00@0 @0 00+8@0 @0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0@0K01K00 K003K0000 K0000 @000 @000 @000 @0K0000 @0K0000 @0K0000 @0K0000 @2 K00 @0 @0 @0 K0 0 00 @ K0 000 @0K0000 @0K00@0 @0 @0 K0000 @0 K0000 @Ẍ́ K0000 K0%0:K0 0!00 aqab#bd ʑ00 tqʑ00J0 %%%(T ?:)]H )(+Z25:Nh*r*uMuvxzM{~T4 kh} ` 9  "#%8&)++-123i68!;x=6@rA[DD|F.GbKfL O]PQRTzUuWYy[g^)`#filrm=nos{v ކ;R&v?}٘k Ӟ\eAʣ˥SP#w I;<ED uE F F G G NJ 5L L L M    !"%')*,39?CDFGHJLVbinx$6CH]cw}".38;IQZcow|*;NWdmsy!-358;AEOQSUYmz*~|j1g\/w-Qg)OUzEtH+";N_Tp+uwuu,vjvvvv xtxxxdyy z)z~zzzz}0҉:?^'JOqËȋAFW\ BGp] EJ͏8Ra̐Ib͑UÒ֒Ji5GXxڔݔOcvՕ$7guݖ%D^ߗ2cvژ 1[tz5noƹ ;] 0BFq#         #!$!d!e!m!n!!!!!" """\"^"""""""6#8#($c$d$$$$$$$$$5%6%>%?%%%%%%%%%%%&&6&7&?&@&`&a&)U*W*********++)+++1+F+q++++++++y,{,,,,,,---"-7-F-H-N-c---------12 2Q2R2Y2Z222$3%33344u4v44444@5A55555,777777777,8-8k8l8'9n9o9999999f:g:::<;=;;;;;Z<\<<=t=v=?????????#@$@_@a@mAAAAAB&B*B@BqDDDDD'EZE^EnEEEF9FgFkF{FFFFFG4G8GHGLGiGmG}GKK L*L.LtLL MLMMMMCNNNO O2OPdPvPPPP?QnQrQQQQRMRQRRRRR1SSSS7TTTTUUJU|UUUUpYYYY9Z=ZOZSZZZZ>[B[R[V[[\\\\\\>_Z_h_____ `ccccdJdNdcd#f?fMfifffffgUp|4\ĕ4EÖǖA]ї7_ژޘ+Wh͙)5:[_}К2T`כ,2>l۝Emמܞ2d*VԠ7ϡӡ2kڢ *Rʣϣ1MoΤ)B[lťʥRUĦЦHxV\4~%Q7ouϫ9!T­ȭ,ouwܯ#Qel W]ʹ5mɵϵdpԶ8 D D .D 4D ND D D E E 4E pE E F mF F F G "G ZG lG G G G G J J zK K K K K L L 6L L M M      #$&(+-./01245678:;<=>@ABEIKMNOPQRSTUWXYZ[\]^_`acdefghjklmopqrstuvwyz{|}~     !"#%&'()*+,-./012345789:;<=>?@ABDEFGIJKLMNOPQRSTUVWXYZ[\^_`abdefghijklmnopqrstuvxyz{|~     !#$%&'()*+,-/01245679:<=>?@ABCDEFGHJKLMNOPRSTUVWXY[\]^_`abdefghijklmnpqrstuvxyz{}~     !"#$%&'()+,-./0123456789:<=>?@ABCDEFGHIJKLMOPQRSTUVXYZ[\]^_`abcefghijklnopqrtuvwxz{|}~     '()*+,./0124679:<=>?@BCDFGHIJKLMNPRTV !(!!t  ,b$l?xK-}*; @H 0(  (  t  c 6A!SHANDON"?B S  ?r]t OLE_LINK6 OLE_LINK1 OLE_LINK2 OLE_LINK10 OLE_LINK11 OLE_LINK8 OLE_LINK9 OLE_LINK7 OLE_LINK13 OLE_LINK14 OLE_LINK18 OLE_LINK22 OLE_LINK100 OLE_LINK101_Hlk252804176 OLE_LINK30 OLE_LINK26_Hlk252956248Myyх334NMWY Q؅`Š$444OPWY#&N!'N,!(N!)N!*N|!+N",N$!"-N!".N""/ND#"0N$"1Nd%"2N$&"3N !4N; 5N< 6N4!7N!8N!9N5 :N ;N!<N =N = >NL= ?N,O"@NlO"ANO"BNO"CN,P"DNlP"ENP"FNP"GN,Q"HNlQ"rii)j)jllsszrr 1 1"2F2F28UcUcccdd%%     !"ii-j-jllttzvv'1'1(2M2M29YcYcccdd))  !"B"*urn:schemas-microsoft-com:office:smarttagscountry-region;*urn:schemas-microsoft-com:office:smarttagschsdate<!*urn:schemas-microsoft-com:office:smarttagschmetcnv9#*urn:schemas-microsoft-com:office:smarttagsplace8*urn:schemas-microsoft-com:office:smarttagsCity E( 011220132014 30731283031aDayFalseHasSpace IsLunarDate IsROCDateMonthNegative NumberType SourceValueTCSCTrueUnitNameYear#"! #####   #####"##"#####vMWRXY_k#q####$$$&&&&''''+ +P1[1(3/3V7\77799,<5<7<B<G<R<>>I IZZaZcZjZ^^fipijjlloompvpVt\ttt`ugunuwuzzntŽǎIWZdqt #.0:$.nq il ۼ'̾־_hopKWeqak@JefCL()&$2$$$%%%%i+u+++,,55::R;X;P>Z>>>>>>>? ?*?4?aAmAAAAASB]BBBC#COCYCE"EEEBWLWZZaaaabbggggOhVhthzhhhhhi jsqxqqqrrrrrr,s2sXs^s;tAttttttt~~~~@~F~"CIzÌȘΘИ֘6<>Dek¡ͥӥեۥ CP  ;A__aabbdeghjkpv!S]^h  KRhfkikjklklmtt&/ŽȎmtjkbeֱٱ]`!bd457GS<H7:HQ'hlJVNY + 5y-}-88HH;YCYU[][l\t\\\aaeehhmmnn*o-o$r,r@P|˪__aabbdeghjksv3333333333333333333333333333333333333333333333333 B| I } 1 0 _ N|ET.i.~iij(jjjjjjjk-k7k>kkllEllllmmmww*|N|Q|||||}}1~Z~~~P_nƀ _uIz34lmIJijyLM(TeԆՆ)*އ=È܈݈fԉՉM{:;Pt‹Ë$ 7o֜x1Zb~ >TͶ*ʸNf+gCDKLST\]bdkv9"#'=>Zx""###$e$$$$T%x%%%&M&&&&5'''()V* +1+X+++,+,,,,9-t---$...v/01245B5Q55555J6o6667+7S7l777G<<<<==i=u=====">3>[>e>>>>?5?D?c?t???@@AaAA4BlB{BBBBC0C=CCCC DKD]DDDDE1EWEYEzEEEF*FIIIVJJJJKMK[KKKKKLKMOOP#PNPrPTETFTNTvTyTzTTTTTTTTVV#WyWYTZyZZ<]]]"^^^_%_S__`aaabebbbb*cSccccd=dddddekxPHt!` gޟZ<s6U2;~֧.F˨{'Gy03B__aabbdeghjkll__aabbdeghjk|0b?}8.>~ڟL=R<4-I:H VGd GpG^JľVT[O!ZL\Eqkb bWnjeJA>w=< x d VD WD8^`. TTVDXWD8^T`. VDWD8^`.   VDWD8^ `. VD WD8^`OJQJo(l TTVDXWD8^T`OJQJo(l VDWD8^`OJQJo(l   VDWD8^ `OJQJo(lhhWD8^h`. hhWD8^h`OJQJo(l0^`0PJo(. D\D^D`\hH)  \ ^ `\hH.  \ ^ `\hH. 0\0^0`\hH) \^`\hH. x\x^x`\hH. \^`\hH) \^`\hH.H^H`o(() ^` 0 ^` .`  ^` ` .@  ^@ ` 0  ^ ` . ^` . ^` 0 ^` . ^` OJPJQJo($   ^` OJQJo(n p ^p` OJQJo(u P  ^P ` OJQJo(l 0  ^0 ` OJQJo(n  ^` OJQJo(u  ^` OJQJo(l  ^` OJQJo(n  ^` OJQJo(u   ^ ` CJOJQJo(hHl ^` OJQJo(hHne e^e` OJQJo(hHuE  E ^E ` OJQJo(hHl%  % ^% ` OJQJo(hHn ^` OJQJo(hHu ^` OJQJo(hHl ^` OJQJo(hHn ^` OJQJo(hHu,^`OJPJQJ^Jo(-j\^j`\OJQJo(hHn\^`\OJQJo(hHu\^`\OJQJo(hHlV\^V`\OJQJo(hHn \^ `\OJQJo(hHu \^ `\OJQJo(hHlB\^B`\OJQJo(hHn\^`\OJQJo(hHu  ^` OJQJo(  ^` OJQJo(n  ^` OJQJo(u b  ^b ` OJQJo(l B  ^B ` OJQJo(n " ^"` OJQJo(u  ^` OJQJo(l  ^` OJQJo(n  ^` OJQJo(u ^ `o(. ^`hH. L^`LhH. | ^| `hH. L^L`hH. L^`LhH. ^`hH. ^`hH. L^`LhH.$0$^$`0PJo(() \^`\hH) @\@^@`\hH. \^`\hH.  \ ^ `\hH) , \, ^, `\hH.  \ ^ `\hH. t\t^t`\hH) \^`\hH.A^A`o(. ^`hH. L^`LhH.  ^ `hH. ^`hH. QL^Q`LhH. !^!`hH. ^`hH. L^`LhH.hh^h`PJo(. H\H^H`\hH) \^`\hH. \^`\hH. 4\4^4`\hH)  \ ^ `\hH. | \| ^| `\hH.  \ ^ `\hH) \^`\hH. @ ^@` OJQJo(  ^ ` OJQJo(hHn  ^ ` OJQJo(hHu  ^ ` OJQJo(hHl  ^ ` OJQJo(hHn ^` OJQJo(hHu ^` OJQJo(hHl` ^`` OJQJo(hHn@ ^@` OJQJo(hHu ^` OJPJQJo(hH$  ^` OJQJo(hHnp p^p` OJQJo(hHuP  P ^P ` OJQJo(hHl0  0 ^0 ` OJQJo(hHn ^` OJQJo(hHu ^` OJQJo(hHl ^` OJQJo(hHn ^` OJQJo(hHuhh^h`PJo(. H\H^H`\hH) \^`\hH. \^`\hH. 4\4^4`\hH)  \ ^ `\hH. | \| ^| `\hH.  \ ^ `\hH) \^`\hH.^`o(. r  r ^r ` hH0 R  R ^R ` hH. 2 2^2` hH.  ^` hH0  ^` hH.  ^` hH.  ^` hH0  ^` hH.@ ^@` OJQJo(hHl  ^ ` OJQJo(hHn  ^ ` OJQJo(hHu  ^ ` OJQJo(hHl  ^ ` OJQJo(hHn ^` OJQJo(hHu ^` OJQJo(hHl` ^`` OJQJo(hHn@ ^@` OJQJo(hHuhh^h`PJo(. H\H^H`\hH) \^`\hH. \^`\hH. 4\4^4`\hH)  \ ^ `\hH. | \| ^| `\hH.  \ ^ `\hH) \^`\hH.dd^d`PJo(. D\D^D`\hH)  \ ^ `\hH.  \ ^ `\hH. 0\0^0`\hH) \^`\hH. x\x^x`\hH. \^`\hH) \^`\hH.D^D`OJPJQJ^Jo(-$\^$`\OJQJo(hHn\^`\OJQJo(hHul\^l`\OJQJo(hHl \^ `\OJQJo(hHn \^ `\OJQJo(hHuX \^X `\OJQJo(hHl\^`\OJQJo(hHn\^`\OJQJo(hHudd^d`PJo(. D\D^D`\hH)  \ ^ `\hH.  \ ^ `\hH. 0\0^0`\hH) \^`\hH. x\x^x`\hH. \^`\hH) \^`\hH. ^` OJPJQJo($   ^` OJQJo(n p ^p` OJQJo(u P  ^P ` OJQJo(l 0  ^0 ` OJQJo(n  ^` OJQJo(u  ^` OJQJo(l  ^` OJQJo(n  ^` OJQJo(u  ^` OJQJo(  ^` OJQJo(n d ^d` OJQJo(u D  ^D ` OJQJo(l $  ^$ ` OJQJo(n  ^` OJQJo(u  ^` OJQJo(l  ^` OJQJo(n  ^` OJQJo(u~}|`wxWnjetxx15=?VT\LG@fD!!T        l'                :ؘ        ΋        h2        Шh                ~        0\        h2                 ڙ                         dj        DI        2s        HT        Ԙx        Ƈ"        h62        ]dM        4l*e-=B9=-DbP//%piB~L/y    )9Ru+71ueQQR>VP{7V.l*@0S0*>l_2N!MrcwWB5WB7+870EUZB9/%Z (tj]`q)/y I,+j?7,`q)x/.22.25*Z3+87x/.+7( mue-=b%@@0=-D*Z3B~L ()9R<8hkEU2R>V:1W{7V}:1W7>iZ*>wm6Zpitj]ul_m6Z!MrcS<8hkRfw( mu%@Rfw/&yI,+w}j?1uenms!1&68{:[<5Z:40QX|llomq&`OObfhhl5=Ft!|=VM}Y+BU6||. 0UptfyD o 0 A 1I a Yg m z  ! ~N *n A: Z\ oa Ui s %*EFTem}0/4(Ds [<9L[>\#2.2@IR]i$?MbCi]kIJnfQth@.&?X]  Q!1#$%9Gmhil}v{kbao4q:=~%2ns}a5&SSoVz @pKN?`TGe|uK8O8 N [ ^ 7m !L9!u""s""N"U"#!#~0#?#Q#X#$M$1`$$ %T%e%i%\~%]P&'''3'T'['g'(#(x+(-(-1(~(7)F$)|6)A)`)}r)**,*T<*C*o*$+["+H+|+ ,-,3,i,q,{,I-6+-mT-]-5.O._.a.-/:/B/0I0L0H]0!f0#l0t0?)1~81F1o1122EN2X2<_2~233^3444654e_4la4{v4565#)5,595X5wc5jy5z5qW7:78pO8ET8W8Z8[8x8-9n9x ::(:_W:=y:; ;dG;X<<7<5=W=q=H>>>wC>3T>Z>]>O%?h,?@?A?Y?@5@:R@?U@^@xn@AA% AA|(AH3A:A6XA{kAoACB}B* Ca,Ca1C8C8^C6DX*D7DinDE4EJE0F:)F`)F8F;FNFG)GHiG>HH7H->HSAHxWHpHhyHaIIBIXIuIhJzKK_lV_Qs_`\`b a}aJb_b4Ec&scd;d1Yd~`dvdUeR'e/e4eDeHe$`e]4fAfRf*tfg'g2;gJgzgq|g#h!Kh=Nhbh iMi4iPiati_|i0jq#j4jHj. k2l'lbslm*mAmimz n%ynzn+o`oao kouoO(pApJp4jpyp q!qqAqi`qjqDrqrmr s"sp-sNs{Xs!fshsqs"tKStgtrtuGJuWuvvx?vJvwv|v=!w=wPwQw^wDxox%yy.3yZiyy/Azzz{0{eu{8|?|-}U>}jy} z}E~hl~w~C VX(*iPi'N3PUi[d T~e1|0GPvb1twHz= M)DZO2| #!Fo)9Nmn}?.1@@_7n-stRvz o9*}qm gRGNN %45dW8h>KP/CY_hk} ^0g{d a=\gRh} CUx:ml!+uG Pu&I3Jhdh-!;[K %hes}aR;q@Jc`` as K ]{^"x$&'X&7J. F7az xq~+`KnU9;<$VHl q'f*yB+Zcdx.U}B#A0?KRS3eg|]Wj!kB.|.='z%=CYe~-Ay2 ,,0t;egm~@:*MRSM|.Poq2Q)M"5[9"Fh~00AjAbIms')1} A`dFUVlsb[?X4+J08OnJ6Pg|"49GjWp 3#BxeHw\`'8$2qu} !O.qRPfh/37x  +Li<)$6O cvx#&':~Xa{ kAmR':@D!I MLUksz AjV,4BiX}c~,~-%9up);.Ff[r*~P[q (5%n9~A]'-6M\al}T"Tq:h. C!!0V+ O6R"'gT[ ispR*1[5]`rd&'"C]Nj(pL/'>2UZe2AJW=]=^?ju'~ :YaY#(?uP|A-R18Iu) LyeZm ]$:')1`,-?DrOl"h%00<bBn*$I,3Ce'h/S]qks@)SSWrJYZ]eg/Hc]Y (oE  &^,/u7r:FLO {4.FJpLdV_n E;z)f;oks!B\\-u6 4`V\ aZkBp4!KU`broAsxyC\dhn| 6{6Tkm8gIKUkv=0>_`#$vH ZhN0W}kKp!:(EPob{ %3CPQRS^ijr| -4;AB|   !"/9CMN`lx  I c h t }   ( 9 J [ ` q  1 @ N ] d r  0 _ z { | } &+<MNEFG ./CDValy!23~iiiiiiiiijj'j(jajmjjjjjjjjj kk-k4k6k7k>kFkNkOkfkjkmknkkkkkkkkkkkkkklll:lLl^l_lelllsltlllllllllmm!m"m(m0m8m9mFmNm_m`moMq9sst{(|)|*|0|5|:|;|<|=|E|M|N|O|P|Q|\|]|e|f|p|z|{||||||||||||||||||||||||}}}} })}*}L}M}W}a}b}z}{}}}}}}}}}}}}}}}}}}}}}}~~~~~~~~~$~+~,~-~.~/~0~1~V~W~X~Y~Z~p~q~x~~~~~~~~~~~~~~~~~~~~~~~~~~NOPUZ_`abjrstuv^_gmnŀƀ  ^_fopqrstu߁!")123456789AHIxyzɂԂՂ34>HRSlmu}Ƀʃ$,45IJQX_`ijlrxy  *+:;<=>?LMU]efυхم!'(STV]deԆՆ܆ކ )*2:BCDEFGHIJKU_ij~ʇˇчׇ݇އ<=DV_`lmsyˆÈˈ͈ψЈ܈݈ !"#DEOW_`abcdef‰ÉĉʼnƉԉՉ݉01:@FGHIJKLMz{Êʊˊ̊͊ΊϊЊъފߊ !:;BHOPst|‹Ëʋҋًڋۋ܋݋ދߋ#$&˚ۛܛ !7no֜x =>T̶Ͷ*YZ}ķŷMNrɸʸ JKLMNf+{|def| $,-./0123456>?@ABCDEFWaiqy !"#$%;DLT]cdlmnopqrstuv678N]t)3;CKQS]^rx#'(0123456789:MNOPQRSZ[pqrtuvw;<=R`v!)0:;XYZ[\]efghijklmn  -./012<=_`av $.6>FMWXuvwxyz()*+,-./01JKLMNOYZ####*#@#\########################$ $$$e$m$t$z$$$$$$$$$$$$$T%]%f%h%l%n%w%x%%%%%%%%%& &&&&&&&5&;&?&B&D&F&L&M&&&&&&&&&&&&&&&&&'''&','.'4'5'}(~(((((((()) )))!)")*)+),)-).)/)0)1)2)3)C)I)O)R)V)X)^)_)m)v)))))))))))))))T*U*V*k*y************++++++++ + +1+9+@+F+M+O+W+X+++++++++,,, ,$,&,*,+,,,,,,,,,,,,,,---!-'-+-.-0-2-8-9-t-y-~--------------......".#.t/u/v/////////00000!0"0#0$0%0&0'0(0)0*0:0@0D0H0L0O0U0V0d0m0v0x00000000000001111111111111111222!2"2)2=2E2F2N2b2j2k2r2222222222224444444444444555555B5I5P5Q55555555555555555J6R6Z6[6\6]6^6_6`6g6n6o666666666666666666677 7 7 777777*7+7M7N7O7P7]7d7k7l77777777777777777777777777777E<F<G<L<Q<R<S<[<c<d<e<f<q<r<<<<<<<<<<<<<====i=o=t=u=========">*>2>3>[>a>d>e>>>>>>>??5?=?C?D?c?i?o?p?q?r?s?t?????@@@@@@@@@@@@@@A$A,A-ATAZA`AaAAAAAAAAAAAAAABBBBBBB+B/B3B4BlBsBzB{BBBBBBBBBBBCCCCCC0C6C8C9C:C;CMBMFMHMIMOOOOOOOOOOOOOOOOOOPP"P#PNPRPVPWPXPYPZP[PaPiPqPrPTTT TTTTT!T"T#T$T/T0T@TFTMTNTvTzT~TTTTTTTTTTTTTTVVVVVVVVVVVVVVVVVVVVVV#W)W/W0WMWQWUWVWWWXWYWZWiWpWwWxWYYYYYYYYZZZZZZ!Z(Z.Z/ZJZNZSZTZyZ{ZZZZZZZZZZZZZZZ\]]]^]c]h]i]j]r]z]{]|]}]]]]]]]]]]]]^ ^ ^ ^^^^^^ ^!^^^^^^^^^^^^^^^^^^^__$_%_S_Y___`_r_x_~__________^a_a`aeajakalata|a}a~aaaaaaaaaaaaaaaab bbbeblbnbobpbqbrbsbbbbbbbbbbbbb*c0c6c7c8c9c:c;cPcQcRcScccccccccccdd=d@dBdCdTdXdZd[d\d]d^d_ddddddddddddddn:o;oENVW`jqxߊ ')0789:;<=>KU]fpqrstuvw  &.02:;<=>?@ABLNPZ[\]^_`ablt}Čό)*1<=STUVWXYZ[\]^qrstuvЍۍ(12\elr{|Վݎ(1@JSThpw|!)2=>MNOPQR_hpz.?GQYZɑБё  #,4>GHIJKLMNOZcitu’˒̒ޒ *12MRX^deǓΓϓړܓ*28CDEFGHIJ]fns|}~ƔєҔӔԔՔ!"#+3;CDEFGNOPqrstuvwxyz{|Ǖȕѕܕ&0789:;<=>kvŖ͖Ֆ֖זٖؖږۖܖ012345NVeowxƗǗҗۗ%/789:;<=>?HWajklmnopqr}Иט !"#<=DOP|}~řљۙ  !3:>FNO\ej~š .8AU_`nw}Û˛ӛԛ    !)19ABCDEFGHmnorstƜ͜ޜ !>EPmnow%-56[\]^_` goޟ ZbsȠРؠ!"<CT\defghijklu}áΡ()0;<hijklmnopqrs{Ģʢ֢עآ٢ڢۢܢݢ!#)*7?BDLM\egirsͣף  6<>FHIJKLMNOahow~̤Ӥڤ29@QXYsy{եܥ&'(ABITU¦ɦʦ2468:;~֧ߧ.469?@ABCDEF˨Ҩ٨ #$>EGMUVWXYZ[\]dksz{|̪ͪ%&O:@FGy{xy\]^- 7!7- C}o]- 9O=c"['=*u/+217y<sAF?J+MgPUWqZ'_o`/cMy0yvW{y7gq@llllvvSSShkhlhhh-h.ab~@@@ @@@@@(@@x@@@"@H@@<@|@@r@@@@@@H @@@`@Unknowncharlie cheungGz Times New Roman5Symbol3& z ArialC .PMingLiUe0}fԚ7&{ @Calibri;[SOSimSunGTimes LT Std[SO] Times-BoldTimes New RomanU Arial Unicode MSArial[DFPFangSongW4-B5PMingLiU?5 .MingLiU0}fԚ;ўSOSimHei3Times?5 z Courier New;& Helvetica5& zaTahoma7&  VerdanaUOptimaTimes New Roman;Wingdings F3 <@#n<@#n!xx2qHX?8|2 2006 ANNUAL RESULTS ANNOUNCEMENTWonderful SkyhggSf                          Oh+'0(8 HT t  $2006 ANNUAL RESULTS ANNOUNCEMENTWonderful Sky$generated by an Adobe applicationNormal769Microsoft Office Word@^Sf@9@Tb@vvh<@#n՜.+,0 `h Wonderful Skyx'   !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnoqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxy{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root Entry FvhData p1TablezU%WordDocument SummaryInformation(DocumentSummaryInformation8CompObjm  FMicrosoft Office Word ĵ MSWordDocWord.Document.89q